Motif 551 (n=175)
Position-wise Probabilities
Download
uniprot | genes | site | source | protein | function |
---|---|---|---|---|---|
A0A0B4J203 | None | S244 | ochoa | receptor protein-tyrosine kinase (EC 2.7.10.1) | None |
A8MYA2 | CXorf49; | S65 | ochoa | Uncharacterized protein CXorf49 | None |
H3BQZ7 | HNRNPUL2-BSCL2 | S185 | ochoa | Heterogeneous nuclear ribonucleoprotein U-like protein 2 | None |
H7BY64 | ZNF511-PRAP1 | S151 | ochoa | ZNF511-PRAP1 readthrough | None |
H8Y6P7 | GCOM1 | S541 | ochoa | DNA-directed RNA polymerase II subunit GRINL1A (DNA-directed RNA polymerase II subunit M) (Glutamate receptor-like protein 1A) | None |
O14646 | CHD1 | S1371 | ochoa | Chromodomain-helicase-DNA-binding protein 1 (CHD-1) (EC 3.6.4.-) (ATP-dependent helicase CHD1) | ATP-dependent chromatin-remodeling factor which functions as substrate recognition component of the transcription regulatory histone acetylation (HAT) complex SAGA. Regulates polymerase II transcription. Also required for efficient transcription by RNA polymerase I, and more specifically the polymerase I transcription termination step. Regulates negatively DNA replication. Not only involved in transcription-related chromatin-remodeling, but also required to maintain a specific chromatin configuration across the genome. Is also associated with histone deacetylase (HDAC) activity (By similarity). Required for the bridging of SNF2, the FACT complex, the PAF complex as well as the U2 snRNP complex to H3K4me3. Functions to modulate the efficiency of pre-mRNA splicing in part through physical bridging of spliceosomal components to H3K4me3 (PubMed:18042460, PubMed:28866611). Required for maintaining open chromatin and pluripotency in embryonic stem cells (By similarity). {ECO:0000250|UniProtKB:P40201, ECO:0000269|PubMed:18042460, ECO:0000269|PubMed:28866611}. |
O14776 | TCERG1 | S638 | ochoa | Transcription elongation regulator 1 (TATA box-binding protein-associated factor 2S) (Transcription factor CA150) | Transcription factor that binds RNA polymerase II and inhibits the elongation of transcripts from target promoters. Regulates transcription elongation in a TATA box-dependent manner. Necessary for TAT-dependent activation of the human immunodeficiency virus type 1 (HIV-1) promoter. {ECO:0000269|PubMed:11604498, ECO:0000269|PubMed:9315662}. |
O14974 | PPP1R12A | S678 | psp | Protein phosphatase 1 regulatory subunit 12A (Myosin phosphatase-targeting subunit 1) (Myosin phosphatase target subunit 1) (Protein phosphatase myosin-binding subunit) | Key regulator of protein phosphatase 1C (PPP1C). Mediates binding to myosin. As part of the PPP1C complex, involved in dephosphorylation of PLK1. Capable of inhibiting HIF1AN-dependent suppression of HIF1A activity. {ECO:0000269|PubMed:18477460, ECO:0000269|PubMed:19245366, ECO:0000269|PubMed:20354225}. |
O15266 | SHOX | S106 | psp | Short stature homeobox protein (Pseudoautosomal homeobox-containing osteogenic protein) (Short stature homeobox-containing protein) | Controls fundamental aspects of growth and development. |
O43318 | MAP3K7 | S393 | ochoa | Mitogen-activated protein kinase kinase kinase 7 (EC 2.7.11.25) (Transforming growth factor-beta-activated kinase 1) (TGF-beta-activated kinase 1) | Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway (PubMed:10094049, PubMed:11460167, PubMed:12589052, PubMed:16845370, PubMed:16893890, PubMed:21512573, PubMed:8663074, PubMed:9079627). Plays an important role in the cascades of cellular responses evoked by changes in the environment (PubMed:10094049, PubMed:11460167, PubMed:12589052, PubMed:16845370, PubMed:16893890, PubMed:21512573, PubMed:8663074, PubMed:9079627). Mediates signal transduction of TRAF6, various cytokines including interleukin-1 (IL-1), transforming growth factor-beta (TGFB), TGFB-related factors like BMP2 and BMP4, toll-like receptors (TLR), tumor necrosis factor receptor CD40 and B-cell receptor (BCR) (PubMed:16893890, PubMed:9079627). Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade and the p38 MAPK signal transduction cascade through the phosphorylation and activation of several MAP kinase kinases like MAP2K1/MEK1, MAP2K3/MKK3, MAP2K6/MKK6 and MAP2K7/MKK7 (PubMed:11460167, PubMed:8663074). These MAP2Ks in turn activate p38 MAPKs and c-jun N-terminal kinases (JNKs); both p38 MAPK and JNK pathways control the transcription factors activator protein-1 (AP-1) (PubMed:11460167, PubMed:12589052, PubMed:8663074). Independently of MAP2Ks and p38 MAPKs, acts as a key activator of NF-kappa-B by promoting activation of the I-kappa-B-kinase (IKK) core complex (PubMed:12589052, PubMed:8663074). Mechanistically, recruited to polyubiquitin chains of RIPK2 and IKBKG/NEMO via TAB2/MAP3K7IP2 and TAB3/MAP3K7IP3, and catalyzes phosphorylation and activation of IKBKB/IKKB component of the IKK complex, leading to NF-kappa-B activation (PubMed:10094049, PubMed:11460167). In osmotic stress signaling, plays a major role in the activation of MAPK8/JNK1, but not that of NF-kappa-B (PubMed:16893890). Promotes TRIM5 capsid-specific restriction activity (PubMed:21512573). Phosphorylates RIPK1 at 'Ser-321' which positively regulates RIPK1 interaction with RIPK3 to promote necroptosis but negatively regulates RIPK1 kinase activity and its interaction with FADD to mediate apoptosis (By similarity). Phosphorylates STING1 in response to cGAMP-activation, promoting association between STEEP1 and STING1 and STING1 translocation to COPII vesicles (PubMed:37832545). {ECO:0000250|UniProtKB:Q62073, ECO:0000269|PubMed:10094049, ECO:0000269|PubMed:11460167, ECO:0000269|PubMed:12589052, ECO:0000269|PubMed:16845370, ECO:0000269|PubMed:16893890, ECO:0000269|PubMed:21512573, ECO:0000269|PubMed:37832545, ECO:0000269|PubMed:8663074, ECO:0000269|PubMed:9079627}. |
O43900 | PRICKLE3 | S482 | ochoa | Prickle planar cell polarity protein 3 (LIM domain only protein 6) (LMO-6) (Prickle-like protein 3) (Pk3) (Triple LIM domain protein 6) | Involved in the planar cell polarity (PCP) pathway that is essential for the polarization of epithelial cells during morphogenetic processes, including gastrulation and neurulation (By similarity). PCP is maintained by two molecular modules, the global and the core modules, PRICKLE3 being part of the core module (By similarity). Distinct complexes of the core module segregate to opposite sides of the cell, where they interact with the opposite complex in the neighboring cell at or near the adherents junctions (By similarity). Involved in the organization of the basal body (By similarity). Involved in cilia growth and positioning (By similarity). Required for proper assembly, stability, and function of mitochondrial membrane ATP synthase (mitochondrial complex V) (PubMed:32516135). {ECO:0000250|UniProtKB:A8WH69, ECO:0000269|PubMed:32516135}. |
O60565 | GREM1 | S44 | ochoa | Gremlin-1 (Cell proliferation-inducing gene 2 protein) (Cysteine knot superfamily 1, BMP antagonist 1) (DAN domain family member 2) (Down-regulated in Mos-transformed cells protein) (Increased in high glucose protein 2) (IHG-2) | Cytokine that may play an important role during carcinogenesis and metanephric kidney organogenesis, as a BMP antagonist required for early limb outgrowth and patterning in maintaining the FGF4-SHH feedback loop. Down-regulates the BMP4 signaling in a dose-dependent manner (By similarity). Antagonist of BMP2; inhibits BMP2-mediated differentiation of osteoblasts (in vitro) (PubMed:27036124). Acts as inhibitor of monocyte chemotaxis. Can inhibit the growth or viability of normal cells but not transformed cells when is overexpressed (By similarity). {ECO:0000250|UniProtKB:O35793, ECO:0000250|UniProtKB:O70326, ECO:0000269|PubMed:27036124}. |
O75069 | TMCC2 | S75 | ochoa | Transmembrane and coiled-coil domains protein 2 (Cerebral protein 11) | May be involved in the regulation of the proteolytic processing of the amyloid precursor protein (APP) possibly also implicating APOE. {ECO:0000269|PubMed:21593558}. |
O75376 | NCOR1 | S388 | ochoa | Nuclear receptor corepressor 1 (N-CoR) (N-CoR1) | Mediates transcriptional repression by certain nuclear receptors (PubMed:20812024). Part of a complex which promotes histone deacetylation and the formation of repressive chromatin structures which may impede the access of basal transcription factors. Participates in the transcriptional repressor activity produced by BCL6. Recruited by ZBTB7A to the androgen response elements/ARE on target genes, negatively regulates androgen receptor signaling and androgen-induced cell proliferation (PubMed:20812024). Mediates the NR1D1-dependent repression and circadian regulation of TSHB expression (By similarity). The NCOR1-HDAC3 complex regulates the circadian expression of the core clock gene ARTNL/BMAL1 and the genes involved in lipid metabolism in the liver (By similarity). {ECO:0000250|UniProtKB:Q60974, ECO:0000269|PubMed:14527417, ECO:0000269|PubMed:20812024}. |
O75449 | KATNA1 | S93 | ochoa | Katanin p60 ATPase-containing subunit A1 (Katanin p60 subunit A1) (EC 5.6.1.1) (p60 katanin) | Catalytic subunit of a complex which severs microtubules in an ATP-dependent manner. Microtubule severing may promote rapid reorganization of cellular microtubule arrays and the release of microtubules from the centrosome following nucleation. Microtubule release from the mitotic spindle poles may allow depolymerization of the microtubule end proximal to the spindle pole, leading to poleward microtubule flux and poleward motion of chromosome. Microtubule release within the cell body of neurons may be required for their transport into neuronal processes by microtubule-dependent motor proteins. This transport is required for axonal growth. {ECO:0000255|HAMAP-Rule:MF_03023, ECO:0000269|PubMed:10751153, ECO:0000269|PubMed:11870226, ECO:0000269|PubMed:19287380}. |
O94880 | PHF14 | S208 | ochoa | PHD finger protein 14 | Histone-binding protein (PubMed:23688586). Binds preferentially to unmodified histone H3 but can also bind to a lesser extent to histone H3 trimethylated at 'Lys-9' (H3K9me3) as well as to histone H3 monomethylated at 'Lys-27' (H3K27ac) and trimethylated at 'Lys-27' (H3K27me3) (By similarity). Represses PDGFRA expression, thus playing a role in regulation of mesenchymal cell proliferation (By similarity). Suppresses the expression of CDKN1A/p21 by reducing the level of trimethylation of histone H3 'Lys-4', leading to enhanced proliferation of germinal center B cells (By similarity). {ECO:0000250|UniProtKB:A0A286Y9D1, ECO:0000250|UniProtKB:Q9D4H9, ECO:0000269|PubMed:23688586}. |
O94885 | SASH1 | S614 | ochoa | SAM and SH3 domain-containing protein 1 (Proline-glutamate repeat-containing protein) | Is a positive regulator of NF-kappa-B signaling downstream of TLR4 activation. It acts as a scaffold molecule to assemble a molecular complex that includes TRAF6, MAP3K7, CHUK and IKBKB, thereby facilitating NF-kappa-B signaling activation (PubMed:23776175). Regulates TRAF6 and MAP3K7 ubiquitination (PubMed:23776175). Involved in the regulation of cell mobility (PubMed:23333244, PubMed:23776175, PubMed:25315659). Regulates lipolysaccharide (LPS)-induced endothelial cell migration (PubMed:23776175). Is involved in the regulation of skin pigmentation through the control of melanocyte migration in the epidermis (PubMed:23333244). {ECO:0000269|PubMed:23333244, ECO:0000269|PubMed:23776175, ECO:0000269|PubMed:25315659}. |
O94886 | TMEM63A | S739 | ochoa | Mechanosensitive cation channel TMEM63A (Transmembrane protein 63A) (hTMEM63A) | Mechanosensitive cation channel with low conductance and high activation threshold (PubMed:30382938, PubMed:31587869, PubMed:37543036). In contrast to TMEM63B, does not show phospholipid scramblase activity (PubMed:39716028). Acts as a regulator of lysosomal morphology by mediating lysosomal mechanosensitivity (By similarity). Important for the baby's first breath and respiration throughout life (PubMed:38127458). Upon lung inflation conducts cation currents in alveolar type 1 and 2 cells triggering lamellar body exocytosis and surfactant secretion into airspace (PubMed:38127458). Also acts as an osmosensitive cation channel preferentially activated by hypotonic stress (By similarity). {ECO:0000250|UniProtKB:Q91YT8, ECO:0000269|PubMed:30382938, ECO:0000269|PubMed:31587869, ECO:0000269|PubMed:37543036, ECO:0000269|PubMed:38127458, ECO:0000269|PubMed:39716028}. |
O95155 | UBE4B | S124 | ochoa | Ubiquitin conjugation factor E4 B (EC 2.3.2.27) (Homozygously deleted in neuroblastoma 1) (RING-type E3 ubiquitin transferase E4 B) (Ubiquitin fusion degradation protein 2) | Ubiquitin-protein ligase that probably functions as an E3 ligase in conjunction with specific E1 and E2 ligases (By similarity). May also function as an E4 ligase mediating the assembly of polyubiquitin chains on substrates ubiquitinated by another E3 ubiquitin ligase (By similarity). May regulate myosin assembly in striated muscles together with STUB1 and VCP/p97 by targeting myosin chaperone UNC45B for proteasomal degradation (PubMed:17369820). {ECO:0000250|UniProtKB:P54860, ECO:0000250|UniProtKB:Q9ES00, ECO:0000269|PubMed:17369820}. |
O95674 | CDS2 | S21 | ochoa | Phosphatidate cytidylyltransferase 2 (EC 2.7.7.41) (CDP-DAG synthase 2) (CDP-DG synthase 2) (CDP-diacylglycerol synthase 2) (CDS 2) (CDP-diglyceride pyrophosphorylase 2) (CDP-diglyceride synthase 2) (CTP:phosphatidate cytidylyltransferase 2) | Catalyzes the conversion of phosphatidic acid (PA) to CDP-diacylglycerol (CDP-DAG), an essential intermediate in the synthesis of phosphatidylglycerol, cardiolipin and phosphatidylinositol (PubMed:25375833). Exhibits specificity for the nature of the acyl chains at the sn-1 and sn-2 positions in the substrate, PA and the preferred acyl chain composition is 1-stearoyl-2-arachidonoyl-sn-phosphatidic acid (PubMed:25375833). Plays an important role in regulating the growth and maturation of lipid droplets which are storage organelles at the center of lipid and energy homeostasis (PubMed:26946540, PubMed:31548309). {ECO:0000269|PubMed:25375833, ECO:0000269|PubMed:26946540, ECO:0000269|PubMed:31548309}. |
P00488 | F13A1 | S124 | ochoa | Coagulation factor XIII A chain (Coagulation factor XIIIa) (EC 2.3.2.13) (Protein-glutamine gamma-glutamyltransferase A chain) (Transglutaminase A chain) | Factor XIII is activated by thrombin and calcium ion to a transglutaminase that catalyzes the formation of gamma-glutamyl-epsilon-lysine cross-links between fibrin chains, thus stabilizing the fibrin clot. Also cross-link alpha-2-plasmin inhibitor, or fibronectin, to the alpha chains of fibrin. {ECO:0000269|PubMed:27363989}. |
P0CAP2 | POLR2M | S144 | ochoa | DNA-directed RNA polymerase II subunit GRINL1A (DNA-directed RNA polymerase II subunit M) (Glutamate receptor-like protein 1A) | [Isoform 1]: Appears to be a stable component of the Pol II(G) complex form of RNA polymerase II (Pol II). Pol II synthesizes mRNA precursors and many functional non-coding RNAs and is the central component of the basal RNA polymerase II transcription machinery. May play a role in the Mediator complex-dependent regulation of transcription activation. Acts as a negative regulator of transcriptional activation; this repression is relieved by the Mediator complex, which restores Pol II(G) activator-dependent transcription to a level equivalent to that of Pol II. {ECO:0000269|PubMed:16769904, ECO:0000269|PubMed:30190596}. |
P11717 | IGF2R | S2409 | ochoa|psp | Cation-independent mannose-6-phosphate receptor (CI Man-6-P receptor) (CI-MPR) (M6PR) (300 kDa mannose 6-phosphate receptor) (MPR 300) (Insulin-like growth factor 2 receptor) (Insulin-like growth factor II receptor) (IGF-II receptor) (M6P/IGF2 receptor) (M6P/IGF2R) (CD antigen CD222) | Mediates the transport of phosphorylated lysosomal enzymes from the Golgi complex and the cell surface to lysosomes (PubMed:18817523, PubMed:2963003). Lysosomal enzymes bearing phosphomannosyl residues bind specifically to mannose-6-phosphate receptors in the Golgi apparatus and the resulting receptor-ligand complex is transported to an acidic prelysosomal compartment where the low pH mediates the dissociation of the complex (PubMed:18817523, PubMed:2963003). The receptor is then recycled back to the Golgi for another round of trafficking through its binding to the retromer (PubMed:18817523). This receptor also binds IGF2 (PubMed:18046459). Acts as a positive regulator of T-cell coactivation by binding DPP4 (PubMed:10900005). {ECO:0000269|PubMed:10900005, ECO:0000269|PubMed:18046459, ECO:0000269|PubMed:18817523, ECO:0000269|PubMed:2963003}. |
P12429 | ANXA3 | S146 | ochoa | Annexin A3 (35-alpha calcimedin) (Annexin III) (Annexin-3) (Inositol 1,2-cyclic phosphate 2-phosphohydrolase) (Lipocortin III) (Placental anticoagulant protein III) (PAP-III) | Inhibitor of phospholipase A2, also possesses anti-coagulant properties. Also cleaves the cyclic bond of inositol 1,2-cyclic phosphate to form inositol 1-phosphate. |
P12882 | MYH1 | S1832 | ochoa | Myosin-1 (Myosin heavy chain 1) (Myosin heavy chain 2x) (MyHC-2x) (Myosin heavy chain IIx/d) (MyHC-IIx/d) (Myosin heavy chain, skeletal muscle, adult 1) | Required for normal hearing. It plays a role in cochlear amplification of auditory stimuli, likely through the positive regulation of prestin (SLC26A5) activity and outer hair cell (OHC) electromotility. {ECO:0000250|UniProtKB:Q5SX40}. |
P13521 | SCG2 | S395 | ochoa | Secretogranin-2 (Chromogranin-C) (Secretogranin II) (SgII) [Cleaved into: Secretoneurin (SN); Manserin] | Neuroendocrine protein of the granin family that regulates the biogenesis of secretory granules. {ECO:0000269|PubMed:19357184}. |
P16157 | ANK1 | S1666 | ochoa | Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin) | Component of the ankyrin-1 complex, a multiprotein complex involved in the stability and shape of the erythrocyte membrane (PubMed:35835865). Attaches integral membrane proteins to cytoskeletal elements; binds to the erythrocyte membrane protein band 4.2, to Na-K ATPase, to the lymphocyte membrane protein GP85, and to the cytoskeletal proteins fodrin, tubulin, vimentin and desmin. Erythrocyte ankyrins also link spectrin (beta chain) to the cytoplasmic domain of the erythrocytes anion exchange protein; they retain most or all of these binding functions. {ECO:0000269|PubMed:12456646, ECO:0000269|PubMed:35835865}.; FUNCTION: [Isoform Mu17]: Together with obscurin in skeletal muscle may provide a molecular link between the sarcoplasmic reticulum and myofibrils. {ECO:0000269|PubMed:12527750}. |
P16383 | GCFC2 | S180 | ochoa | Intron Large complex component GCFC2 (GC-rich sequence DNA-binding factor) (GC-rich sequence DNA-binding factor 2) (Transcription factor 9) (TCF-9) | Involved in pre-mRNA splicing through regulating spliceosome C complex formation (PubMed:24304693). May play a role during late-stage splicing events and turnover of excised introns (PubMed:24304693). {ECO:0000269|PubMed:24304693}. |
P17028 | ZNF24 | S132 | ochoa | Zinc finger protein 24 (Retinoic acid suppression protein A) (RSG-A) (Zinc finger and SCAN domain-containing protein 3) (Zinc finger protein 191) (Zinc finger protein KOX17) | Transcription factor required for myelination of differentiated oligodendrocytes. Required for the conversion of oligodendrocytes from the premyelinating to the myelinating state. In the developing central nervous system (CNS), involved in the maintenance in the progenitor stage by promoting the cell cycle. Specifically binds to the 5'-TCAT-3' DNA sequence (By similarity). Has transcription repressor activity in vitro. {ECO:0000250, ECO:0000269|PubMed:10585455}. |
P20338 | RAB4A | S190 | ochoa | Ras-related protein Rab-4A (EC 3.6.5.2) | The small GTPases Rab are key regulators of intracellular membrane trafficking, from the formation of transport vesicles to their fusion with membranes. Rabs cycle between an inactive GDP-bound form and an active GTP-bound form that is able to recruit to membranes different sets of downstream effectors directly responsible for vesicle formation, movement, tethering and fusion (PubMed:15907487, PubMed:16034420). RAB4A is involved in protein transport (PubMed:29425100). Also plays a role in vesicular traffic. Mediates VEGFR2 endosomal trafficking to enhance VEGFR2 signaling (PubMed:29425100). Acts as a regulator of platelet alpha-granule release during activation and aggregation of platelets (By similarity). {ECO:0000250|UniProtKB:P56371, ECO:0000269|PubMed:15907487, ECO:0000269|PubMed:16034420, ECO:0000269|PubMed:29425100}. |
P21860 | ERBB3 | S1104 | ochoa | Receptor tyrosine-protein kinase erbB-3 (EC 2.7.10.1) (Proto-oncogene-like protein c-ErbB-3) (Tyrosine kinase-type cell surface receptor HER3) | Tyrosine-protein kinase that plays an essential role as cell surface receptor for neuregulins. Binds to neuregulin-1 (NRG1) and is activated by it; ligand-binding increases phosphorylation on tyrosine residues and promotes its association with the p85 subunit of phosphatidylinositol 3-kinase (PubMed:20682778). May also be activated by CSPG5 (PubMed:15358134). Involved in the regulation of myeloid cell differentiation (PubMed:27416908). {ECO:0000269|PubMed:15358134, ECO:0000269|PubMed:20682778, ECO:0000269|PubMed:27416908}. |
P23458 | JAK1 | S857 | ochoa | Tyrosine-protein kinase JAK1 (EC 2.7.10.2) (Janus kinase 1) (JAK-1) | Tyrosine kinase of the non-receptor type, involved in the IFN-alpha/beta/gamma signal pathway (PubMed:16239216, PubMed:28111307, PubMed:32750333, PubMed:7615558, PubMed:8232552). Kinase partner for the interleukin (IL)-2 receptor (PubMed:11909529) as well as interleukin (IL)-10 receptor (PubMed:12133952). Kinase partner for the type I interferon receptor IFNAR2 (PubMed:16239216, PubMed:28111307, PubMed:32750333, PubMed:7615558, PubMed:8232552). In response to interferon-binding to IFNAR1-IFNAR2 heterodimer, phosphorylates and activates its binding partner IFNAR2, creating docking sites for STAT proteins (PubMed:7759950). Directly phosphorylates STAT proteins but also activates STAT signaling through the transactivation of other JAK kinases associated with signaling receptors (PubMed:16239216, PubMed:32750333, PubMed:8232552). {ECO:0000269|PubMed:11909529, ECO:0000269|PubMed:12133952, ECO:0000269|PubMed:16239216, ECO:0000269|PubMed:28111307, ECO:0000269|PubMed:32750333, ECO:0000269|PubMed:7615558, ECO:0000269|PubMed:7657660, ECO:0000269|PubMed:8232552}. |
P23759 | PAX7 | S207 | ochoa | Paired box protein Pax-7 (HuP1) | Transcription factor that is involved in the regulation of muscle stem cells proliferation, playing a role in myogenesis and muscle regeneration. {ECO:0000269|PubMed:31092906}. |
P23760 | PAX3 | S209 | ochoa | Paired box protein Pax-3 (HuP2) | Transcription factor that may regulate cell proliferation, migration and apoptosis. Involved in neural development and myogenesis. Transcriptional activator of MITF, acting synergistically with SOX10 (PubMed:21965087). {ECO:0000269|PubMed:16951170, ECO:0000269|PubMed:21965087}. |
P25686 | DNAJB2 | S264 | psp | DnaJ homolog subfamily B member 2 (Heat shock 40 kDa protein 3) (Heat shock protein J1) (HSJ-1) | Functions as a co-chaperone, regulating the substrate binding and activating the ATPase activity of chaperones of the HSP70/heat shock protein 70 family (PubMed:22219199, PubMed:7957263). In parallel, also contributes to the ubiquitin-dependent proteasomal degradation of misfolded proteins (PubMed:15936278, PubMed:21625540). Thereby, may regulate the aggregation and promote the functional recovery of misfolded proteins like HTT, MC4R, PRKN, RHO and SOD1 and be crucial for many biological processes (PubMed:12754272, PubMed:20889486, PubMed:21719532, PubMed:22396390, PubMed:24023695). Isoform 1 which is localized to the endoplasmic reticulum membranes may specifically function in ER-associated protein degradation of misfolded proteins (PubMed:15936278). {ECO:0000269|PubMed:12754272, ECO:0000269|PubMed:15936278, ECO:0000269|PubMed:20889486, ECO:0000269|PubMed:21625540, ECO:0000269|PubMed:21719532, ECO:0000269|PubMed:22219199, ECO:0000269|PubMed:22396390, ECO:0000269|PubMed:24023695, ECO:0000269|PubMed:7957263}. |
P29374 | ARID4A | S455 | ochoa | AT-rich interactive domain-containing protein 4A (ARID domain-containing protein 4A) (Retinoblastoma-binding protein 1) (RBBP-1) | DNA-binding protein which modulates activity of several transcription factors including RB1 (retinoblastoma-associated protein) and AR (androgen receptor) (By similarity). May function as part of an mSin3A repressor complex (PubMed:14581478). Has no intrinsic transcriptional activity (By similarity). Plays a role in the regulation of epigenetic modifications at the PWS/AS imprinting center near the SNRPN promoter, where it might function as part of a complex with RB1 and ARID4B (By similarity). Involved in spermatogenesis, together with ARID4B, where it acts as a transcriptional coactivator for AR and enhances expression of genes required for sperm maturation. Regulates expression of the tight junction protein CLDN3 in the testis, which is important for integrity of the blood-testis barrier (By similarity). Plays a role in myeloid homeostasis where it regulates the histone methylation state of bone marrow cells and expression of various genes involved in hematopoiesis. May function as a leukemia suppressor (By similarity). {ECO:0000250|UniProtKB:F8VPQ2, ECO:0000269|PubMed:14581478}. |
P42331 | ARHGAP25 | S474 | ochoa | Rho GTPase-activating protein 25 (Rho-type GTPase-activating protein 25) | GTPase activator for the Rho-type GTPases by converting them to an inactive GDP-bound state. {ECO:0000250}. |
P46013 | MKI67 | S3082 | ochoa | Proliferation marker protein Ki-67 (Antigen identified by monoclonal antibody Ki-67) (Antigen KI-67) (Antigen Ki67) | Protein that associates with the surface of mitotic chromosomes and acts both as a chromosome repellent during early mitosis and chromosome attractant during late mitosis (PubMed:27362226, PubMed:32879492, PubMed:35513709, PubMed:39153474). Required to maintain individual mitotic chromosomes dispersed in the cytoplasm following nuclear envelope disassembly (PubMed:27362226). During early mitosis, relocalizes from nucleoli to the chromosome surface where it forms extended brush structures that cover a substantial fraction of the chromosome surface (PubMed:27362226). The MKI67 brush structure prevents chromosomes from collapsing into a single chromatin mass by forming a steric and electrostatic charge barrier: the protein has a high net electrical charge and acts as a surfactant, dispersing chromosomes and enabling independent chromosome motility (PubMed:27362226). During mitotic anaphase, the MKI67 brush structure collapses and MKI67 switches from a chromosome repellent to a chromosome attractant to promote chromosome clustering and facilitate the exclusion of large cytoplasmic particles from the future nuclear space (PubMed:32879492, PubMed:39153474). Mechanistically, dephosphorylation during mitotic exit and simultaneous exposure of a conserved basic patch induce the RNA-dependent formation of a liquid-like condensed phase on the chromosome surface, promoting coalescence of neighboring chromosome surfaces and clustering of chromosomes (PubMed:39153474). Binds premature ribosomal RNAs during anaphase; promoting liquid-liquid phase separation (PubMed:28935370, PubMed:39153474). Binds DNA, with a preference for supercoiled DNA and AT-rich DNA (PubMed:10878551). Does not contribute to the internal structure of mitotic chromosomes (By similarity). May play a role in chromatin organization; it is however unclear whether it plays a direct role in chromatin organization or whether it is an indirect consequence of its function in mitotic chromosome (PubMed:24867636). {ECO:0000250|UniProtKB:E9PVX6, ECO:0000269|PubMed:10878551, ECO:0000269|PubMed:24867636, ECO:0000269|PubMed:27362226, ECO:0000269|PubMed:28935370, ECO:0000269|PubMed:32879492, ECO:0000269|PubMed:35513709, ECO:0000269|PubMed:39153474}. |
P46100 | ATRX | S1322 | ochoa | Transcriptional regulator ATRX (EC 3.6.4.12) (ATP-dependent helicase ATRX) (X-linked helicase II) (X-linked nuclear protein) (XNP) (Znf-HX) | Involved in transcriptional regulation and chromatin remodeling. Facilitates DNA replication in multiple cellular environments and is required for efficient replication of a subset of genomic loci. Binds to DNA tandem repeat sequences in both telomeres and euchromatin and in vitro binds DNA quadruplex structures. May help stabilizing G-rich regions into regular chromatin structures by remodeling G4 DNA and incorporating H3.3-containing nucleosomes. Catalytic component of the chromatin remodeling complex ATRX:DAXX which has ATP-dependent DNA translocase activity and catalyzes the replication-independent deposition of histone H3.3 in pericentric DNA repeats outside S-phase and telomeres, and the in vitro remodeling of H3.3-containing nucleosomes. Its heterochromatin targeting is proposed to involve a combinatorial readout of histone H3 modifications (specifically methylation states of H3K9 and H3K4) and association with CBX5. Involved in maintaining telomere structural integrity in embryonic stem cells which probably implies recruitment of CBX5 to telomeres. Reports on the involvement in transcriptional regulation of telomeric repeat-containing RNA (TERRA) are conflicting; according to a report, it is not sufficient to decrease chromatin condensation at telomeres nor to increase expression of telomeric RNA in fibroblasts (PubMed:24500201). May be involved in telomere maintenance via recombination in ALT (alternative lengthening of telomeres) cell lines. Acts as a negative regulator of chromatin incorporation of transcriptionally repressive histone MACROH2A1, particularily at telomeres and the alpha-globin cluster in erythroleukemic cells. Participates in the allele-specific gene expression at the imprinted IGF2/H19 gene locus. On the maternal allele, required for the chromatin occupancy of SMC1 and CTCTF within the H19 imprinting control region (ICR) and involved in esatblishment of histone tails modifications in the ICR. May be involved in brain development and facial morphogenesis. Binds to zinc-finger coding genes with atypical chromatin signatures and regulates its H3K9me3 levels. Forms a complex with ZNF274, TRIM28 and SETDB1 to facilitate the deposition and maintenance of H3K9me3 at the 3' exons of zinc-finger genes (PubMed:27029610). {ECO:0000269|PubMed:12953102, ECO:0000269|PubMed:14990586, ECO:0000269|PubMed:20504901, ECO:0000269|PubMed:20651253, ECO:0000269|PubMed:21029860, ECO:0000269|PubMed:22391447, ECO:0000269|PubMed:22829774, ECO:0000269|PubMed:24500201, ECO:0000269|PubMed:27029610}. |
P46940 | IQGAP1 | S1414 | ochoa | Ras GTPase-activating-like protein IQGAP1 (p195) | Plays a crucial role in regulating the dynamics and assembly of the actin cytoskeleton. Recruited to the cell cortex by interaction with ILK which allows it to cooperate with its effector DIAPH1 to locally stabilize microtubules and allow stable insertion of caveolae into the plasma membrane (By similarity). Binds to activated CDC42 but does not stimulate its GTPase activity. Associates with calmodulin. May promote neurite outgrowth (PubMed:15695813). May play a possible role in cell cycle regulation by contributing to cell cycle progression after DNA replication arrest (PubMed:20883816). {ECO:0000250|UniProtKB:Q9JKF1, ECO:0000269|PubMed:15695813, ECO:0000269|PubMed:20883816}. |
P49321 | NASP | S321 | ochoa | Nuclear autoantigenic sperm protein (NASP) | Component of the histone chaperone network (PubMed:22195965). Binds and stabilizes histone H3-H4 not bound to chromatin to maintain a soluble reservoir and modulate degradation by chaperone-mediated autophagy (PubMed:22195965). Required for DNA replication, normal cell cycle progression and cell proliferation. Forms a cytoplasmic complex with HSP90 and H1 linker histones and stimulates HSP90 ATPase activity. NASP and H1 histone are subsequently released from the complex and translocate to the nucleus where the histone is released for binding to DNA. {ECO:0000250|UniProtKB:Q99MD9, ECO:0000269|PubMed:22195965}.; FUNCTION: [Isoform 1]: Stabilizes soluble histone H3-H4. {ECO:0000269|PubMed:22195965}.; FUNCTION: [Isoform 2]: Stabilizes soluble histone H3-H4. {ECO:0000269|PubMed:22195965}. |
P49792 | RANBP2 | S1110 | ochoa | E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (358 kDa nucleoporin) (Nuclear pore complex protein Nup358) (Nucleoporin Nup358) (Ran-binding protein 2) (RanBP2) (p270) | E3 SUMO-protein ligase which facilitates SUMO1 and SUMO2 conjugation by UBE2I (PubMed:11792325, PubMed:12032081, PubMed:15378033, PubMed:15931224, PubMed:22194619). Involved in transport factor (Ran-GTP, karyopherin)-mediated protein import via the F-G repeat-containing domain which acts as a docking site for substrates (PubMed:7775481). Binds single-stranded RNA (in vitro) (PubMed:7775481). May bind DNA (PubMed:7775481). Component of the nuclear export pathway (PubMed:10078529). Specific docking site for the nuclear export factor exportin-1 (PubMed:10078529). Inhibits EIF4E-dependent mRNA export (PubMed:22902403). Sumoylates PML at 'Lys-490' which is essential for the proper assembly of PML-NB (PubMed:22155184). Recruits BICD2 to the nuclear envelope and cytoplasmic stacks of nuclear pore complex known as annulate lamellae during G2 phase of cell cycle (PubMed:20386726). Probable inactive PPIase with no peptidyl-prolyl cis-trans isomerase activity (PubMed:20676357, PubMed:23353830). {ECO:0000269|PubMed:11792325, ECO:0000269|PubMed:12032081, ECO:0000269|PubMed:15378033, ECO:0000269|PubMed:15931224, ECO:0000269|PubMed:20386726, ECO:0000269|PubMed:20676357, ECO:0000269|PubMed:22155184, ECO:0000269|PubMed:22194619, ECO:0000269|PubMed:22902403, ECO:0000269|PubMed:23353830, ECO:0000269|PubMed:7775481, ECO:0000303|PubMed:10078529}. |
P49792 | RANBP2 | S2493 | ochoa | E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (358 kDa nucleoporin) (Nuclear pore complex protein Nup358) (Nucleoporin Nup358) (Ran-binding protein 2) (RanBP2) (p270) | E3 SUMO-protein ligase which facilitates SUMO1 and SUMO2 conjugation by UBE2I (PubMed:11792325, PubMed:12032081, PubMed:15378033, PubMed:15931224, PubMed:22194619). Involved in transport factor (Ran-GTP, karyopherin)-mediated protein import via the F-G repeat-containing domain which acts as a docking site for substrates (PubMed:7775481). Binds single-stranded RNA (in vitro) (PubMed:7775481). May bind DNA (PubMed:7775481). Component of the nuclear export pathway (PubMed:10078529). Specific docking site for the nuclear export factor exportin-1 (PubMed:10078529). Inhibits EIF4E-dependent mRNA export (PubMed:22902403). Sumoylates PML at 'Lys-490' which is essential for the proper assembly of PML-NB (PubMed:22155184). Recruits BICD2 to the nuclear envelope and cytoplasmic stacks of nuclear pore complex known as annulate lamellae during G2 phase of cell cycle (PubMed:20386726). Probable inactive PPIase with no peptidyl-prolyl cis-trans isomerase activity (PubMed:20676357, PubMed:23353830). {ECO:0000269|PubMed:11792325, ECO:0000269|PubMed:12032081, ECO:0000269|PubMed:15378033, ECO:0000269|PubMed:15931224, ECO:0000269|PubMed:20386726, ECO:0000269|PubMed:20676357, ECO:0000269|PubMed:22155184, ECO:0000269|PubMed:22194619, ECO:0000269|PubMed:22902403, ECO:0000269|PubMed:23353830, ECO:0000269|PubMed:7775481, ECO:0000303|PubMed:10078529}. |
P50148 | GNAQ | S198 | ochoa | Guanine nucleotide-binding protein G(q) subunit alpha (EC 3.6.5.-) (Guanine nucleotide-binding protein alpha-q) | Guanine nucleotide-binding proteins (G proteins) function as transducers downstream of G protein-coupled receptors (GPCRs) in numerous signaling cascades (PubMed:37991948). The alpha chain contains the guanine nucleotide binding site and alternates between an active, GTP-bound state and an inactive, GDP-bound state (PubMed:37991948). Signaling by an activated GPCR promotes GDP release and GTP binding (PubMed:37991948). The alpha subunit has a low GTPase activity that converts bound GTP to GDP, thereby terminating the signal (PubMed:37991948). Both GDP release and GTP hydrolysis are modulated by numerous regulatory proteins (PubMed:37991948). Signaling is mediated via phospholipase C-beta-dependent inositol lipid hydrolysis for signal propagation: activates phospholipase C-beta: following GPCR activation, GNAQ activates PLC-beta (PLCB1, PLCB2, PLCB3 or PLCB4), leading to production of diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) (PubMed:37991948). Required for platelet activation (By similarity). Regulates B-cell selection and survival and is required to prevent B-cell-dependent autoimmunity (By similarity). Regulates chemotaxis of BM-derived neutrophils and dendritic cells (in vitro) (By similarity). Transduces FFAR4 signaling in response to long-chain fatty acids (LCFAs) (PubMed:27852822). Together with GNA11, required for heart development (By similarity). {ECO:0000250|UniProtKB:P21279, ECO:0000269|PubMed:27852822, ECO:0000269|PubMed:37991948}. |
P51114 | FXR1 | S494 | ochoa | RNA-binding protein FXR1 (FMR1 autosomal homolog 1) (hFXR1p) | mRNA-binding protein that acts as a regulator of mRNAs translation and/or stability, and which is required for various processes, such as neurogenesis, muscle development and spermatogenesis (PubMed:17382880, PubMed:20417602, PubMed:30067974, PubMed:34731628, PubMed:35989368, PubMed:36306353). Specifically binds to AU-rich elements (AREs) in the 3'-UTR of target mRNAs (PubMed:17382880, PubMed:34731628). Promotes formation of some phase-separated membraneless compartment by undergoing liquid-liquid phase separation upon binding to AREs-containing mRNAs, leading to assemble mRNAs into cytoplasmic ribonucleoprotein granules that concentrate mRNAs with associated regulatory factors (By similarity). Required to activate translation of stored mRNAs during late spermatogenesis: acts by undergoing liquid-liquid phase separation to assemble target mRNAs into cytoplasmic ribonucleoprotein granules that recruit translation initiation factor EIF4G3 to activate translation of stored mRNAs in late spermatids (By similarity). Promotes translation of MYC transcripts by recruiting the eIF4F complex to the translation start site (PubMed:34731628). Acts as a negative regulator of inflammation in response to IL19 by promoting destabilization of pro-inflammatory transcripts (PubMed:30067974). Also acts as an inhibitor of inflammation by binding to TNF mRNA, decreasing TNF protein production (By similarity). Acts as a negative regulator of AMPA receptor GRIA2/GluA2 synthesis during long-lasting synaptic potentiation of hippocampal neurons by binding to GRIA2/GluA2 mRNA, thereby inhibiting its translation (By similarity). Regulates proliferation of adult neural stem cells by binding to CDKN1A mRNA and promoting its expression (By similarity). Acts as a regulator of sleep and synaptic homeostasis by regulating translation of transcripts in neurons (By similarity). Required for embryonic and postnatal development of muscle tissue by undergoing liquid-liquid phase separation to assemble target mRNAs into cytoplasmic ribonucleoprotein granules (PubMed:30770808). Involved in the nuclear pore complex localization to the nuclear envelope by preventing cytoplasmic aggregation of nucleoporins: acts by preventing ectopic phase separation of nucleoporins in the cytoplasm via a microtubule-dependent mechanism (PubMed:32706158). Plays a role in the stabilization of PKP2 mRNA and therefore protein abundance, via its interaction with PKP3 (PubMed:25225333). May also do the same for PKP2, PKP3 and DSP via its interaction with PKP1 (PubMed:25225333). Forms a cytoplasmic messenger ribonucleoprotein (mRNP) network by packaging long mRNAs, serving as a scaffold that recruits proteins and signaling molecules. This network facilitates signaling reactions by maintaining proximity between kinases and substrates, crucial for processes like actomyosin reorganization (PubMed:39106863). {ECO:0000250|UniProtKB:Q61584, ECO:0000269|PubMed:17382880, ECO:0000269|PubMed:20417602, ECO:0000269|PubMed:25225333, ECO:0000269|PubMed:30067974, ECO:0000269|PubMed:30770808, ECO:0000269|PubMed:32706158, ECO:0000269|PubMed:34731628, ECO:0000269|PubMed:35989368, ECO:0000269|PubMed:36306353, ECO:0000269|PubMed:39106863}. |
P51116 | FXR2 | S533 | ochoa | RNA-binding protein FXR2 (FXR2P) (FMR1 autosomal homolog 2) | mRNA-binding protein that acts as a regulator of mRNAs translation and/or stability, and which is required for adult hippocampal neurogenesis (By similarity). Specifically binds to AU-rich elements (AREs) in the 3'-UTR of target mRNAs (By similarity). Promotes formation of some phase-separated membraneless compartment by undergoing liquid-liquid phase separation upon binding to AREs-containing mRNAs: mRNAs storage into membraneless compartments regulates their translation and/or stability (By similarity). Acts as a regulator of adult hippocampal neurogenesis by regulating translation and/or stability of NOG mRNA, thereby preventing NOG protein expression in the dentate gyrus (By similarity). {ECO:0000250|UniProtKB:Q61584, ECO:0000250|UniProtKB:Q9WVR4}. |
P52701 | MSH6 | S227 | ochoa|psp | DNA mismatch repair protein Msh6 (hMSH6) (G/T mismatch-binding protein) (GTBP) (GTMBP) (MutS protein homolog 6) (MutS-alpha 160 kDa subunit) (p160) | Component of the post-replicative DNA mismatch repair system (MMR). Heterodimerizes with MSH2 to form MutS alpha, which binds to DNA mismatches thereby initiating DNA repair. When bound, MutS alpha bends the DNA helix and shields approximately 20 base pairs, and recognizes single base mismatches and dinucleotide insertion-deletion loops (IDL) in the DNA. After mismatch binding, forms a ternary complex with the MutL alpha heterodimer, which is thought to be responsible for directing the downstream MMR events, including strand discrimination, excision, and resynthesis. ATP binding and hydrolysis play a pivotal role in mismatch repair functions. The ATPase activity associated with MutS alpha regulates binding similar to a molecular switch: mismatched DNA provokes ADP-->ATP exchange, resulting in a discernible conformational transition that converts MutS alpha into a sliding clamp capable of hydrolysis-independent diffusion along the DNA backbone. This transition is crucial for mismatch repair. MutS alpha may also play a role in DNA homologous recombination repair. Recruited on chromatin in G1 and early S phase via its PWWP domain that specifically binds trimethylated 'Lys-36' of histone H3 (H3K36me3): early recruitment to chromatin to be replicated allowing a quick identification of mismatch repair to initiate the DNA mismatch repair reaction. {ECO:0000269|PubMed:10078208, ECO:0000269|PubMed:10660545, ECO:0000269|PubMed:15064730, ECO:0000269|PubMed:21120944, ECO:0000269|PubMed:23622243, ECO:0000269|PubMed:9564049, ECO:0000269|PubMed:9822679, ECO:0000269|PubMed:9822680}. |
P52701 | MSH6 | S285 | ochoa | DNA mismatch repair protein Msh6 (hMSH6) (G/T mismatch-binding protein) (GTBP) (GTMBP) (MutS protein homolog 6) (MutS-alpha 160 kDa subunit) (p160) | Component of the post-replicative DNA mismatch repair system (MMR). Heterodimerizes with MSH2 to form MutS alpha, which binds to DNA mismatches thereby initiating DNA repair. When bound, MutS alpha bends the DNA helix and shields approximately 20 base pairs, and recognizes single base mismatches and dinucleotide insertion-deletion loops (IDL) in the DNA. After mismatch binding, forms a ternary complex with the MutL alpha heterodimer, which is thought to be responsible for directing the downstream MMR events, including strand discrimination, excision, and resynthesis. ATP binding and hydrolysis play a pivotal role in mismatch repair functions. The ATPase activity associated with MutS alpha regulates binding similar to a molecular switch: mismatched DNA provokes ADP-->ATP exchange, resulting in a discernible conformational transition that converts MutS alpha into a sliding clamp capable of hydrolysis-independent diffusion along the DNA backbone. This transition is crucial for mismatch repair. MutS alpha may also play a role in DNA homologous recombination repair. Recruited on chromatin in G1 and early S phase via its PWWP domain that specifically binds trimethylated 'Lys-36' of histone H3 (H3K36me3): early recruitment to chromatin to be replicated allowing a quick identification of mismatch repair to initiate the DNA mismatch repair reaction. {ECO:0000269|PubMed:10078208, ECO:0000269|PubMed:10660545, ECO:0000269|PubMed:15064730, ECO:0000269|PubMed:21120944, ECO:0000269|PubMed:23622243, ECO:0000269|PubMed:9564049, ECO:0000269|PubMed:9822679, ECO:0000269|PubMed:9822680}. |
P55060 | CSE1L | S366 | ochoa | Exportin-2 (Exp2) (Cellular apoptosis susceptibility protein) (Chromosome segregation 1-like protein) (Importin-alpha re-exporter) | Export receptor for importin-alpha. Mediates importin-alpha re-export from the nucleus to the cytoplasm after import substrates (cargos) have been released into the nucleoplasm. In the nucleus binds cooperatively to importin-alpha and to the GTPase Ran in its active GTP-bound form. Docking of this trimeric complex to the nuclear pore complex (NPC) is mediated through binding to nucleoporins. Upon transit of a nuclear export complex into the cytoplasm, disassembling of the complex and hydrolysis of Ran-GTP to Ran-GDP (induced by RANBP1 and RANGAP1, respectively) cause release of the importin-alpha from the export receptor. CSE1L/XPO2 then return to the nuclear compartment and mediate another round of transport. The directionality of nuclear export is thought to be conferred by an asymmetric distribution of the GTP- and GDP-bound forms of Ran between the cytoplasm and nucleus. {ECO:0000269|PubMed:9323134}. |
P67809 | YBX1 | S174 | ochoa|psp | Y-box-binding protein 1 (YB-1) (CCAAT-binding transcription factor I subunit A) (CBF-A) (DNA-binding protein B) (DBPB) (Enhancer factor I subunit A) (EFI-A) (Nuclease-sensitive element-binding protein 1) (Y-box transcription factor) | DNA- and RNA-binding protein involved in various processes, such as translational repression, RNA stabilization, mRNA splicing, DNA repair and transcription regulation (PubMed:10817758, PubMed:11698476, PubMed:14718551, PubMed:18809583, PubMed:31358969, PubMed:8188694). Predominantly acts as a RNA-binding protein: binds preferentially to the 5'-[CU]CUGCG-3' RNA motif and specifically recognizes mRNA transcripts modified by C5-methylcytosine (m5C) (PubMed:19561594, PubMed:31358969). Promotes mRNA stabilization: acts by binding to m5C-containing mRNAs and recruiting the mRNA stability maintainer ELAVL1, thereby preventing mRNA decay (PubMed:10817758, PubMed:11698476, PubMed:31358969). Component of the CRD-mediated complex that promotes MYC mRNA stability (PubMed:19029303). Contributes to the regulation of translation by modulating the interaction between the mRNA and eukaryotic initiation factors (By similarity). Plays a key role in RNA composition of extracellular exosomes by defining the sorting of small non-coding RNAs, such as tRNAs, Y RNAs, Vault RNAs and miRNAs (PubMed:27559612, PubMed:29073095). Probably sorts RNAs in exosomes by recognizing and binding C5-methylcytosine (m5C)-containing RNAs (PubMed:28341602, PubMed:29073095). Acts as a key effector of epidermal progenitors by preventing epidermal progenitor senescence: acts by regulating the translation of a senescence-associated subset of cytokine mRNAs, possibly by binding to m5C-containing mRNAs (PubMed:29712925). Also involved in pre-mRNA alternative splicing regulation: binds to splice sites in pre-mRNA and regulates splice site selection (PubMed:12604611). Binds to TSC22D1 transcripts, thereby inhibiting their translation and negatively regulating TGF-beta-mediated transcription of COL1A2 (By similarity). Also able to bind DNA: regulates transcription of the multidrug resistance gene MDR1 is enhanced in presence of the APEX1 acetylated form at 'Lys-6' and 'Lys-7' (PubMed:18809583). Binds to promoters that contain a Y-box (5'-CTGATTGGCCAA-3'), such as MDR1 and HLA class II genes (PubMed:18809583, PubMed:8188694). Promotes separation of DNA strands that contain mismatches or are modified by cisplatin (PubMed:14718551). Has endonucleolytic activity and can introduce nicks or breaks into double-stranded DNA, suggesting a role in DNA repair (PubMed:14718551). The secreted form acts as an extracellular mitogen and stimulates cell migration and proliferation (PubMed:19483673). {ECO:0000250|UniProtKB:P62960, ECO:0000250|UniProtKB:Q28618, ECO:0000269|PubMed:10817758, ECO:0000269|PubMed:11698476, ECO:0000269|PubMed:12604611, ECO:0000269|PubMed:14718551, ECO:0000269|PubMed:18809583, ECO:0000269|PubMed:19029303, ECO:0000269|PubMed:19483673, ECO:0000269|PubMed:19561594, ECO:0000269|PubMed:27559612, ECO:0000269|PubMed:28341602, ECO:0000269|PubMed:29073095, ECO:0000269|PubMed:29712925, ECO:0000269|PubMed:31358969, ECO:0000269|PubMed:8188694}. |
P78352 | DLG4 | S480 | ochoa | Disks large homolog 4 (Postsynaptic density protein 95) (PSD-95) (Synapse-associated protein 90) (SAP-90) (SAP90) | Postsynaptic scaffolding protein that plays a critical role in synaptogenesis and synaptic plasticity by providing a platform for the postsynaptic clustering of crucial synaptic proteins. Interacts with the cytoplasmic tail of NMDA receptor subunits and shaker-type potassium channels. Required for synaptic plasticity associated with NMDA receptor signaling. Overexpression or depletion of DLG4 changes the ratio of excitatory to inhibitory synapses in hippocampal neurons. May reduce the amplitude of ASIC3 acid-evoked currents by retaining the channel intracellularly. May regulate the intracellular trafficking of ADR1B. Also regulates AMPA-type glutamate receptor (AMPAR) immobilization at postsynaptic density keeping the channels in an activated state in the presence of glutamate and preventing synaptic depression (By similarity). Under basal conditions, cooperates with FYN to stabilize palmitoyltransferase ZDHHC5 at the synaptic membrane through FYN-mediated phosphorylation of ZDHHC5 and its subsequent inhibition of association with endocytic proteins (PubMed:26334723). {ECO:0000250|UniProtKB:Q62108, ECO:0000269|PubMed:26334723}. |
P78524 | DENND2B | S651 | ochoa | DENN domain-containing protein 2B (HeLa tumor suppression 1) (Suppression of tumorigenicity 5 protein) | [Isoform 1]: May be involved in cytoskeletal organization and tumorogenicity. Seems to be involved in a signaling transduction pathway leading to activation of MAPK1/ERK2. Plays a role in EGFR trafficking from recycling endosomes back to the cell membrane (PubMed:29030480). {ECO:0000269|PubMed:29030480, ECO:0000269|PubMed:9632734}.; FUNCTION: [Isoform 2]: Guanine nucleotide exchange factor (GEF) which may activate RAB9A and RAB9B. Promotes the exchange of GDP to GTP, converting inactive GDP-bound Rab proteins into their active GTP-bound form. {ECO:0000269|PubMed:20937701}.; FUNCTION: [Isoform 3]: May block ERK2 activation stimulated by ABL1 (Probable). May alter cell morphology and cell growth (Probable). {ECO:0000305|PubMed:10229203, ECO:0000305|PubMed:9632734}. |
Q00987 | MDM2 | S166 | ochoa|psp | E3 ubiquitin-protein ligase Mdm2 (EC 2.3.2.27) (Double minute 2 protein) (Hdm2) (Oncoprotein Mdm2) (RING-type E3 ubiquitin transferase Mdm2) (p53-binding protein Mdm2) | E3 ubiquitin-protein ligase that mediates ubiquitination of p53/TP53, leading to its degradation by the proteasome (PubMed:29681526). Inhibits p53/TP53- and p73/TP73-mediated cell cycle arrest and apoptosis by binding its transcriptional activation domain. Also acts as a ubiquitin ligase E3 toward itself and ARRB1. Permits the nuclear export of p53/TP53. Promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma RB1 protein. Inhibits DAXX-mediated apoptosis by inducing its ubiquitination and degradation. Component of the TRIM28/KAP1-MDM2-p53/TP53 complex involved in stabilizing p53/TP53. Also a component of the TRIM28/KAP1-ERBB4-MDM2 complex which links growth factor and DNA damage response pathways. Mediates ubiquitination and subsequent proteasome degradation of DYRK2 in nucleus. Ubiquitinates IGF1R and SNAI1 and promotes them to proteasomal degradation (PubMed:12821780, PubMed:15053880, PubMed:15195100, PubMed:15632057, PubMed:16337594, PubMed:17290220, PubMed:19098711, PubMed:19219073, PubMed:19837670, PubMed:19965871, PubMed:20173098, PubMed:20385133, PubMed:20858735, PubMed:22128911). Ubiquitinates DCX, leading to DCX degradation and reduction of the dendritic spine density of olfactory bulb granule cells (By similarity). Ubiquitinates DLG4, leading to proteasomal degradation of DLG4 which is required for AMPA receptor endocytosis (By similarity). Negatively regulates NDUFS1, leading to decreased mitochondrial respiration, marked oxidative stress, and commitment to the mitochondrial pathway of apoptosis (PubMed:30879903). Binds NDUFS1 leading to its cytosolic retention rather than mitochondrial localization resulting in decreased supercomplex assembly (interactions between complex I and complex III), decreased complex I activity, ROS production, and apoptosis (PubMed:30879903). {ECO:0000250|UniProtKB:P23804, ECO:0000269|PubMed:12821780, ECO:0000269|PubMed:15053880, ECO:0000269|PubMed:15195100, ECO:0000269|PubMed:15632057, ECO:0000269|PubMed:16337594, ECO:0000269|PubMed:17290220, ECO:0000269|PubMed:19098711, ECO:0000269|PubMed:19219073, ECO:0000269|PubMed:19837670, ECO:0000269|PubMed:19965871, ECO:0000269|PubMed:20173098, ECO:0000269|PubMed:20385133, ECO:0000269|PubMed:20858735, ECO:0000269|PubMed:22128911, ECO:0000269|PubMed:29681526, ECO:0000269|PubMed:30879903}. |
Q03701 | CEBPZ | S34 | ochoa | CCAAT/enhancer-binding protein zeta (CCAAT-box-binding transcription factor) (CBF) (CCAAT-binding factor) | Stimulates transcription from the HSP70 promoter. |
Q04837 | SSBP1 | S70 | ochoa | Single-stranded DNA-binding protein, mitochondrial (Mt-SSB) (MtSSB) (PWP1-interacting protein 17) | Binds preferentially and cooperatively to pyrimidine rich single-stranded DNA (ss-DNA) (PubMed:21953457, PubMed:23290262, PubMed:31550240). In vitro, required to maintain the copy number of mitochondrial DNA (mtDNA) and plays a crucial role during mtDNA replication by stimulating the activity of the replisome components POLG and TWNK at the replication fork (PubMed:12975372, PubMed:15167897, PubMed:21953457, PubMed:26446790, PubMed:31550240). Promotes the activity of the gamma complex polymerase POLG, largely by organizing the template DNA and eliminating secondary structures to favor ss-DNA conformations that facilitate POLG activity (PubMed:21953457, PubMed:26446790, PubMed:31550240). In addition it is able to promote the 5'-3' unwinding activity of the mtDNA helicase TWNK (PubMed:12975372). May also function in mtDNA repair (PubMed:23290262). {ECO:0000269|PubMed:12975372, ECO:0000269|PubMed:15167897, ECO:0000269|PubMed:21953457, ECO:0000269|PubMed:23290262, ECO:0000269|PubMed:26446790, ECO:0000269|PubMed:31550240}. |
Q07157 | TJP1 | S290 | ochoa | Tight junction protein 1 (Tight junction protein ZO-1) (Zona occludens protein 1) (Zonula occludens protein 1) | TJP1, TJP2, and TJP3 are closely related scaffolding proteins that link tight junction (TJ) transmembrane proteins such as claudins, junctional adhesion molecules, and occludin to the actin cytoskeleton (PubMed:7798316, PubMed:9792688). Forms a multistranded TJP1/ZO1 condensate which elongates to form a tight junction belt, the belt is anchored at the apical cell membrane via interaction with PATJ (By similarity). The tight junction acts to limit movement of substances through the paracellular space and as a boundary between the compositionally distinct apical and basolateral plasma membrane domains of epithelial and endothelial cells. Necessary for lumenogenesis, and particularly efficient epithelial polarization and barrier formation (By similarity). Plays a role in the regulation of cell migration by targeting CDC42BPB to the leading edge of migrating cells (PubMed:21240187). Plays an important role in podosome formation and associated function, thus regulating cell adhesion and matrix remodeling (PubMed:20930113). With TJP2 and TJP3, participates in the junctional retention and stability of the transcription factor DBPA, but is not involved in its shuttling to the nucleus (By similarity). May play a role in mediating cell morphology changes during ameloblast differentiation via its role in tight junctions (By similarity). {ECO:0000250|UniProtKB:O97758, ECO:0000250|UniProtKB:P39447, ECO:0000269|PubMed:20930113, ECO:0000269|PubMed:21240187}. |
Q12873 | CHD3 | S88 | ochoa | Chromodomain-helicase-DNA-binding protein 3 (CHD-3) (EC 3.6.4.-) (ATP-dependent helicase CHD3) (Mi-2 autoantigen 240 kDa protein) (Mi2-alpha) (Zinc finger helicase) (hZFH) | ATP-dependent chromatin-remodeling factor that binds and distorts nucleosomal DNA (PubMed:28977666). Acts as a component of the histone deacetylase NuRD complex which participates in the remodeling of chromatin (PubMed:16428440, PubMed:28977666, PubMed:30397230, PubMed:9804427). Involved in transcriptional repression as part of the NuRD complex (PubMed:27068747). Required for anchoring centrosomal pericentrin in both interphase and mitosis, for spindle organization and centrosome integrity (PubMed:17626165). {ECO:0000269|PubMed:16428440, ECO:0000269|PubMed:17626165, ECO:0000269|PubMed:27068747, ECO:0000269|PubMed:28977666, ECO:0000269|PubMed:30397230, ECO:0000269|PubMed:9804427}. |
Q13315 | ATM | S1891 | ochoa|psp | Serine-protein kinase ATM (EC 2.7.11.1) (Ataxia telangiectasia mutated) (A-T mutated) | Serine/threonine protein kinase which activates checkpoint signaling upon double strand breaks (DSBs), apoptosis and genotoxic stresses such as ionizing ultraviolet A light (UVA), thereby acting as a DNA damage sensor (PubMed:10550055, PubMed:10839545, PubMed:10910365, PubMed:12556884, PubMed:14871926, PubMed:15064416, PubMed:15448695, PubMed:15456891, PubMed:15790808, PubMed:15916964, PubMed:17923702, PubMed:21757780, PubMed:24534091, PubMed:35076389, PubMed:9733514). Recognizes the substrate consensus sequence [ST]-Q (PubMed:10550055, PubMed:10839545, PubMed:10910365, PubMed:12556884, PubMed:14871926, PubMed:15448695, PubMed:15456891, PubMed:15916964, PubMed:17923702, PubMed:24534091, PubMed:9733514). Phosphorylates 'Ser-139' of histone variant H2AX at double strand breaks (DSBs), thereby regulating DNA damage response mechanism (By similarity). Also plays a role in pre-B cell allelic exclusion, a process leading to expression of a single immunoglobulin heavy chain allele to enforce clonality and monospecific recognition by the B-cell antigen receptor (BCR) expressed on individual B-lymphocytes. After the introduction of DNA breaks by the RAG complex on one immunoglobulin allele, acts by mediating a repositioning of the second allele to pericentromeric heterochromatin, preventing accessibility to the RAG complex and recombination of the second allele. Also involved in signal transduction and cell cycle control. May function as a tumor suppressor. Necessary for activation of ABL1 and SAPK. Phosphorylates DYRK2, CHEK2, p53/TP53, FBXW7, FANCD2, NFKBIA, BRCA1, CREBBP/CBP, RBBP8/CTIP, FBXO46, MRE11, nibrin (NBN), RAD50, RAD17, PELI1, TERF1, UFL1, RAD9, UBQLN4 and DCLRE1C (PubMed:10550055, PubMed:10766245, PubMed:10802669, PubMed:10839545, PubMed:10910365, PubMed:10973490, PubMed:11375976, PubMed:12086603, PubMed:15456891, PubMed:19965871, PubMed:21757780, PubMed:24534091, PubMed:26240375, PubMed:26774286, PubMed:30171069, PubMed:30612738, PubMed:30886146, PubMed:30952868, PubMed:38128537, PubMed:9733515, PubMed:9843217). May play a role in vesicle and/or protein transport. Could play a role in T-cell development, gonad and neurological function. Plays a role in replication-dependent histone mRNA degradation. Binds DNA ends. Phosphorylation of DYRK2 in nucleus in response to genotoxic stress prevents its MDM2-mediated ubiquitination and subsequent proteasome degradation (PubMed:19965871). Phosphorylates ATF2 which stimulates its function in DNA damage response (PubMed:15916964). Phosphorylates ERCC6 which is essential for its chromatin remodeling activity at DNA double-strand breaks (PubMed:29203878). Phosphorylates TTC5/STRAP at 'Ser-203' in the cytoplasm in response to DNA damage, which promotes TTC5/STRAP nuclear localization (PubMed:15448695). Also involved in pexophagy by mediating phosphorylation of PEX5: translocated to peroxisomes in response to reactive oxygen species (ROS), and catalyzes phosphorylation of PEX5, promoting PEX5 ubiquitination and induction of pexophagy (PubMed:26344566). {ECO:0000250|UniProtKB:Q62388, ECO:0000269|PubMed:10550055, ECO:0000269|PubMed:10766245, ECO:0000269|PubMed:10802669, ECO:0000269|PubMed:10839545, ECO:0000269|PubMed:10910365, ECO:0000269|PubMed:10973490, ECO:0000269|PubMed:11375976, ECO:0000269|PubMed:12086603, ECO:0000269|PubMed:12556884, ECO:0000269|PubMed:14871926, ECO:0000269|PubMed:15448695, ECO:0000269|PubMed:15456891, ECO:0000269|PubMed:15916964, ECO:0000269|PubMed:16086026, ECO:0000269|PubMed:16858402, ECO:0000269|PubMed:17923702, ECO:0000269|PubMed:19431188, ECO:0000269|PubMed:19965871, ECO:0000269|PubMed:21757780, ECO:0000269|PubMed:24534091, ECO:0000269|PubMed:26240375, ECO:0000269|PubMed:26344566, ECO:0000269|PubMed:26774286, ECO:0000269|PubMed:29203878, ECO:0000269|PubMed:30171069, ECO:0000269|PubMed:30612738, ECO:0000269|PubMed:30886146, ECO:0000269|PubMed:30952868, ECO:0000269|PubMed:35076389, ECO:0000269|PubMed:38128537, ECO:0000269|PubMed:9733514, ECO:0000269|PubMed:9733515, ECO:0000269|PubMed:9843217}. |
Q13435 | SF3B2 | S778 | ochoa | Splicing factor 3B subunit 2 (Pre-mRNA-splicing factor SF3b 145 kDa subunit) (SF3b145) (Spliceosome-associated protein 145) (SAP 145) | Component of the 17S U2 SnRNP complex of the spliceosome, a large ribonucleoprotein complex that removes introns from transcribed pre-mRNAs (PubMed:12234937, PubMed:32494006, PubMed:34822310). The 17S U2 SnRNP complex (1) directly participates in early spliceosome assembly and (2) mediates recognition of the intron branch site during pre-mRNA splicing by promoting the selection of the pre-mRNA branch-site adenosine, the nucleophile for the first step of splicing (PubMed:12234937, PubMed:32494006, PubMed:34822310). Within the 17S U2 SnRNP complex, SF3B2 is part of the SF3B subcomplex, which is required for 'A' complex assembly formed by the stable binding of U2 snRNP to the branchpoint sequence in pre-mRNA (PubMed:12234937, PubMed:27720643). Sequence independent binding of SF3A and SF3B subcomplexes upstream of the branch site is essential, it may anchor U2 snRNP to the pre-mRNA (PubMed:12234937). May also be involved in the assembly of the 'E' complex (PubMed:10882114). Also acts as a component of the minor spliceosome, which is involved in the splicing of U12-type introns in pre-mRNAs (PubMed:15146077, PubMed:33509932). {ECO:0000269|PubMed:10882114, ECO:0000269|PubMed:12234937, ECO:0000269|PubMed:15146077, ECO:0000269|PubMed:27720643, ECO:0000269|PubMed:32494006, ECO:0000269|PubMed:33509932, ECO:0000269|PubMed:34822310}. |
Q13439 | GOLGA4 | S122 | ochoa | Golgin subfamily A member 4 (256 kDa golgin) (Golgin-245) (Protein 72.1) (Trans-Golgi p230) | Involved in vesicular trafficking at the Golgi apparatus level. May play a role in delivery of transport vesicles containing GPI-linked proteins from the trans-Golgi network through its interaction with MACF1. Involved in endosome-to-Golgi trafficking (PubMed:29084197). {ECO:0000269|PubMed:15265687, ECO:0000269|PubMed:29084197}. |
Q13459 | MYO9B | S1999 | ochoa | Unconventional myosin-IXb (Unconventional myosin-9b) | Myosins are actin-based motor molecules with ATPase activity. Unconventional myosins serve in intracellular movements. Binds actin with high affinity both in the absence and presence of ATP and its mechanochemical activity is inhibited by calcium ions (PubMed:9490638). Also acts as a GTPase activator for RHOA (PubMed:26529257, PubMed:9490638). Plays a role in the regulation of cell migration via its role as RHOA GTPase activator. This is regulated by its interaction with the SLIT2 receptor ROBO1; interaction with ROBO1 impairs interaction with RHOA and subsequent activation of RHOA GTPase activity, and thereby leads to increased levels of active, GTP-bound RHOA (PubMed:26529257). {ECO:0000269|PubMed:26529257, ECO:0000269|PubMed:9490638}. |
Q14188 | TFDP2 | S117 | ochoa | Transcription factor Dp-2 (E2F dimerization partner 2) | Can stimulate E2F-dependent transcription. Binds DNA cooperatively with E2F family members through the E2 recognition site, 5'-TTTC[CG]CGC-3', found in the promoter region of a number of genes whose products are involved in cell cycle regulation or in DNA replication. The TFDP2:E2F complex functions in the control of cell-cycle progression from G1 to S phase. The E2F1:DP complex appears to mediate both cell proliferation and apoptosis. Blocks adipocyte differentiation by repressing CEBPA binding to its target gene promoters (PubMed:20176812). {ECO:0000305|PubMed:20176812}. |
Q14684 | RRP1B | S460 | ochoa | Ribosomal RNA processing protein 1 homolog B (RRP1-like protein B) | Positively regulates DNA damage-induced apoptosis by acting as a transcriptional coactivator of proapoptotic target genes of the transcriptional activator E2F1 (PubMed:20040599). Likely to play a role in ribosome biogenesis by targeting serine/threonine protein phosphatase PP1 to the nucleolus (PubMed:20926688). Involved in regulation of mRNA splicing (By similarity). Inhibits SIPA1 GTPase activity (By similarity). Involved in regulating expression of extracellular matrix genes (By similarity). Associates with chromatin and may play a role in modulating chromatin structure (PubMed:19710015). {ECO:0000250|UniProtKB:Q91YK2, ECO:0000269|PubMed:19710015, ECO:0000269|PubMed:20040599, ECO:0000269|PubMed:20926688}.; FUNCTION: (Microbial infection) Following influenza A virus (IAV) infection, promotes viral mRNA transcription by facilitating the binding of IAV RNA-directed RNA polymerase to capped mRNA. {ECO:0000269|PubMed:26311876}. |
Q15746 | MYLK | S1091 | ochoa | Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form] | Calcium/calmodulin-dependent myosin light chain kinase implicated in smooth muscle contraction via phosphorylation of myosin light chains (MLC). Also regulates actin-myosin interaction through a non-kinase activity. Phosphorylates PTK2B/PYK2 and myosin light-chains. Involved in the inflammatory response (e.g. apoptosis, vascular permeability, leukocyte diapedesis), cell motility and morphology, airway hyperreactivity and other activities relevant to asthma. Required for tonic airway smooth muscle contraction that is necessary for physiological and asthmatic airway resistance. Necessary for gastrointestinal motility. Implicated in the regulation of endothelial as well as vascular permeability, probably via the regulation of cytoskeletal rearrangements. In the nervous system it has been shown to control the growth initiation of astrocytic processes in culture and to participate in transmitter release at synapses formed between cultured sympathetic ganglion cells. Critical participant in signaling sequences that result in fibroblast apoptosis. Plays a role in the regulation of epithelial cell survival. Required for epithelial wound healing, especially during actomyosin ring contraction during purse-string wound closure. Mediates RhoA-dependent membrane blebbing. Triggers TRPC5 channel activity in a calcium-dependent signaling, by inducing its subcellular localization at the plasma membrane. Promotes cell migration (including tumor cells) and tumor metastasis. PTK2B/PYK2 activation by phosphorylation mediates ITGB2 activation and is thus essential to trigger neutrophil transmigration during acute lung injury (ALI). May regulate optic nerve head astrocyte migration. Probably involved in mitotic cytoskeletal regulation. Regulates tight junction probably by modulating ZO-1 exchange in the perijunctional actomyosin ring. Mediates burn-induced microvascular barrier injury; triggers endothelial contraction in the development of microvascular hyperpermeability by phosphorylating MLC. Essential for intestinal barrier dysfunction. Mediates Giardia spp.-mediated reduced epithelial barrier function during giardiasis intestinal infection via reorganization of cytoskeletal F-actin and tight junctional ZO-1. Necessary for hypotonicity-induced Ca(2+) entry and subsequent activation of volume-sensitive organic osmolyte/anion channels (VSOAC) in cervical cancer cells. Responsible for high proliferative ability of breast cancer cells through anti-apoptosis. {ECO:0000269|PubMed:11113114, ECO:0000269|PubMed:11976941, ECO:0000269|PubMed:15020676, ECO:0000269|PubMed:15825080, ECO:0000269|PubMed:16284075, ECO:0000269|PubMed:16723733, ECO:0000269|PubMed:18587400, ECO:0000269|PubMed:18710790, ECO:0000269|PubMed:19826488, ECO:0000269|PubMed:20139351, ECO:0000269|PubMed:20181817, ECO:0000269|PubMed:20375339, ECO:0000269|PubMed:20453870}. |
Q16891 | IMMT | S518 | ochoa | MICOS complex subunit MIC60 (Cell proliferation-inducing gene 4/52 protein) (Mitochondrial inner membrane protein) (Mitofilin) (p87/89) | Component of the MICOS complex, a large protein complex of the mitochondrial inner membrane that plays crucial roles in the maintenance of crista junctions, inner membrane architecture, and formation of contact sites to the outer membrane (PubMed:22114354, PubMed:25781180, PubMed:32567732, PubMed:33130824). Plays an important role in the maintenance of the MICOS complex stability and the mitochondrial cristae morphology (PubMed:22114354, PubMed:25781180, PubMed:32567732, PubMed:33130824). {ECO:0000269|PubMed:22114354, ECO:0000269|PubMed:25781180, ECO:0000269|PubMed:32567732, ECO:0000269|PubMed:33130824}. |
Q1KMD3 | HNRNPUL2 | S185 | ochoa | Heterogeneous nuclear ribonucleoprotein U-like protein 2 (Scaffold-attachment factor A2) (SAF-A2) | None |
Q3L8U1 | CHD9 | S1468 | ochoa | Chromodomain-helicase-DNA-binding protein 9 (CHD-9) (EC 3.6.4.-) (ATP-dependent helicase CHD9) (Chromatin-related mesenchymal modulator) (CReMM) (Chromatin-remodeling factor CHROM1) (Kismet homolog 2) (PPAR-alpha-interacting complex protein 320 kDa) (Peroxisomal proliferator-activated receptor A-interacting complex 320 kDa protein) | Probable ATP-dependent chromatin-remodeling factor. Acts as a transcriptional coactivator for PPARA and possibly other nuclear receptors. Has DNA-dependent ATPase activity and binds to A/T-rich DNA. Associates with A/T-rich regulatory regions in promoters of genes that participate in the differentiation of progenitors during osteogenesis (By similarity). {ECO:0000250, ECO:0000269|PubMed:16095617, ECO:0000269|PubMed:16554032}. |
Q52LR7 | EPC2 | S119 | ochoa | Enhancer of polycomb homolog 2 (EPC-like) | May play a role in transcription or DNA repair. {ECO:0000250}. |
Q53GS9 | USP39 | S82 | ochoa | Ubiquitin carboxyl-terminal hydrolase 39 (EC 3.4.19.12) (SAD1 homolog) (U4/U6.U5 tri-snRNP-associated 65 kDa protein) | Deubiquitinating enzyme that plays a role in many cellular processes including cellular antiviral response, epithelial morphogenesis, DNA repair or B-cell development (PubMed:33127822, PubMed:34614178). Plays a role in pre-mRNA splicing as a component of the U4/U6-U5 tri-snRNP, one of the building blocks of the precatalytic spliceosome (PubMed:11350945, PubMed:26912367). Specifically regulates immunoglobulin gene rearrangement in a spliceosome-dependent manner, which involves modulating chromatin interactions at the Igh locus and therefore plays an essential role in B-cell development (By similarity). Regulates AURKB mRNA levels, and thereby plays a role in cytokinesis and in the spindle checkpoint (PubMed:18728397). Regulates apoptosis and G2/M cell cycle checkpoint in response to DNA damage by deubiquitinating and stabilizing CHK2 (PubMed:30771428). Also plays an important role in DNA repair by controlling the recruitment of XRCC4/LIG4 to DNA double-strand breaks for non-homologous end-joining repair (PubMed:34614178). Participates in antiviral activity by affecting the type I IFN signaling by stabilizing STAT1 and decreasing its 'Lys-6'-linked ubiquitination (PubMed:33127822). Contributes to non-canonical Wnt signaling during epidermal differentiation (By similarity). Acts as a negative regulator NF-kappa-B activation through deubiquitination of 'Lys-48'-linked ubiquitination of NFKBIA (PubMed:36651806). {ECO:0000250|UniProtKB:Q3TIX9, ECO:0000269|PubMed:11350945, ECO:0000269|PubMed:18728397, ECO:0000269|PubMed:26912367, ECO:0000269|PubMed:30771428, ECO:0000269|PubMed:33127822, ECO:0000269|PubMed:34614178, ECO:0000269|PubMed:36651806}. |
Q5BKX6 | SLC45A4 | S289 | ochoa | Solute carrier family 45 member 4 | Proton-associated sucrose transporter. May be able to transport also glucose and fructose. {ECO:0000250|UniProtKB:Q0P5V9}. |
Q5C9Z4 | NOM1 | S57 | ochoa | Nucleolar MIF4G domain-containing protein 1 (SGD1 homolog) | Plays a role in targeting PPP1CA to the nucleolus. {ECO:0000269|PubMed:17965019}. |
Q5JVF3 | PCID2 | S24 | ochoa | PCI domain-containing protein 2 (CSN12-like protein) | Required for B-cell survival through the regulation of the expression of cell-cycle checkpoint MAD2L1 protein during B cell differentiation (By similarity). As a component of the TREX-2 complex, involved in the export of mRNAs to the cytoplasm through the nuclear pores (PubMed:22307388). Binds and stabilizes BRCA2 and is thus involved in the control of R-loop-associated DNA damage and transcription-associated genomic instability (PubMed:24896180). Blocks the activity of the SRCAP chromatin remodeling complex by interacting with SRCAP complex member ZNHIT1 and inhibiting its interaction with the complex (By similarity). This prevents the deposition of histone variant H2AZ1/H2A.Z at the nucleosomes of key lymphoid fate regulator genes which suppresses their expression and restricts lymphoid lineage commitment (By similarity). {ECO:0000250|UniProtKB:Q8BFV2, ECO:0000269|PubMed:22307388, ECO:0000269|PubMed:24896180, ECO:0000305|PubMed:23591820}. |
Q5QJE6 | DNTTIP2 | S88 | ochoa | Deoxynucleotidyltransferase terminal-interacting protein 2 (Estrogen receptor-binding protein) (LPTS-interacting protein 2) (LPTS-RP2) (Terminal deoxynucleotidyltransferase-interacting factor 2) (TdIF2) (TdT-interacting factor 2) | Regulates the transcriptional activity of DNTT and ESR1. May function as a chromatin remodeling protein (PubMed:12786946, PubMed:15047147). Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and work in concert to generate RNA folding, modifications, rearrangements and cleavage as well as targeted degradation of pre-ribosomal RNA by the RNA exosome (PubMed:34516797). {ECO:0000269|PubMed:12786946, ECO:0000269|PubMed:15047147, ECO:0000269|PubMed:34516797}. |
Q5QJE6 | DNTTIP2 | S92 | ochoa | Deoxynucleotidyltransferase terminal-interacting protein 2 (Estrogen receptor-binding protein) (LPTS-interacting protein 2) (LPTS-RP2) (Terminal deoxynucleotidyltransferase-interacting factor 2) (TdIF2) (TdT-interacting factor 2) | Regulates the transcriptional activity of DNTT and ESR1. May function as a chromatin remodeling protein (PubMed:12786946, PubMed:15047147). Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and work in concert to generate RNA folding, modifications, rearrangements and cleavage as well as targeted degradation of pre-ribosomal RNA by the RNA exosome (PubMed:34516797). {ECO:0000269|PubMed:12786946, ECO:0000269|PubMed:15047147, ECO:0000269|PubMed:34516797}. |
Q5TCZ1 | SH3PXD2A | S567 | ochoa | SH3 and PX domain-containing protein 2A (Adapter protein TKS5) (Five SH3 domain-containing protein) (SH3 multiple domains protein 1) (Tyrosine kinase substrate with five SH3 domains) | Adapter protein involved in invadopodia and podosome formation, extracellular matrix degradation and invasiveness of some cancer cells (PubMed:27789576). Binds matrix metalloproteinases (ADAMs), NADPH oxidases (NOXs) and phosphoinositides. Acts as an organizer protein that allows NOX1- or NOX3-dependent reactive oxygen species (ROS) generation and ROS localization. In association with ADAM12, mediates the neurotoxic effect of amyloid-beta peptide. {ECO:0000269|PubMed:12615925, ECO:0000269|PubMed:15710328, ECO:0000269|PubMed:15710903, ECO:0000269|PubMed:19755710, ECO:0000269|PubMed:20609497, ECO:0000269|PubMed:27789576}. |
Q5THJ4 | VPS13D | S663 | ochoa | Intermembrane lipid transfer protein VPS13D (Vacuolar protein sorting-associated protein 13D) | Mediates the transfer of lipids between membranes at organelle contact sites (By similarity). Functions in promoting mitochondrial clearance by mitochondrial autophagy (mitophagy), also possibly by positively regulating mitochondrial fission (PubMed:29307555, PubMed:29604224). Mitophagy plays an important role in regulating cell health and mitochondrial size and homeostasis. {ECO:0000250|UniProtKB:Q07878, ECO:0000269|PubMed:29307555, ECO:0000269|PubMed:29604224}. |
Q5UIP0 | RIF1 | S1526 | ochoa | Telomere-associated protein RIF1 (Rap1-interacting factor 1 homolog) | Key regulator of TP53BP1 that plays a key role in the repair of double-strand DNA breaks (DSBs) in response to DNA damage: acts by promoting non-homologous end joining (NHEJ)-mediated repair of DSBs (PubMed:15342490, PubMed:28241136). In response to DNA damage, interacts with ATM-phosphorylated TP53BP1 (PubMed:23333306, PubMed:28241136). Interaction with TP53BP1 leads to dissociate the interaction between NUDT16L1/TIRR and TP53BP1, thereby unmasking the tandem Tudor-like domain of TP53BP1 and allowing recruitment to DNA DSBs (PubMed:28241136). Once recruited to DSBs, RIF1 and TP53BP1 act by promoting NHEJ-mediated repair of DSBs (PubMed:23333306). In the same time, RIF1 and TP53BP1 specifically counteract the function of BRCA1 by blocking DSBs resection via homologous recombination (HR) during G1 phase (PubMed:23333306). Also required for immunoglobulin class-switch recombination (CSR) during antibody genesis, a process that involves the generation of DNA DSBs (By similarity). Promotes NHEJ of dysfunctional telomeres (By similarity). {ECO:0000250|UniProtKB:Q6PR54, ECO:0000269|PubMed:15342490, ECO:0000269|PubMed:23333306, ECO:0000269|PubMed:28241136}. |
Q5UIP0 | RIF1 | S1552 | ochoa | Telomere-associated protein RIF1 (Rap1-interacting factor 1 homolog) | Key regulator of TP53BP1 that plays a key role in the repair of double-strand DNA breaks (DSBs) in response to DNA damage: acts by promoting non-homologous end joining (NHEJ)-mediated repair of DSBs (PubMed:15342490, PubMed:28241136). In response to DNA damage, interacts with ATM-phosphorylated TP53BP1 (PubMed:23333306, PubMed:28241136). Interaction with TP53BP1 leads to dissociate the interaction between NUDT16L1/TIRR and TP53BP1, thereby unmasking the tandem Tudor-like domain of TP53BP1 and allowing recruitment to DNA DSBs (PubMed:28241136). Once recruited to DSBs, RIF1 and TP53BP1 act by promoting NHEJ-mediated repair of DSBs (PubMed:23333306). In the same time, RIF1 and TP53BP1 specifically counteract the function of BRCA1 by blocking DSBs resection via homologous recombination (HR) during G1 phase (PubMed:23333306). Also required for immunoglobulin class-switch recombination (CSR) during antibody genesis, a process that involves the generation of DNA DSBs (By similarity). Promotes NHEJ of dysfunctional telomeres (By similarity). {ECO:0000250|UniProtKB:Q6PR54, ECO:0000269|PubMed:15342490, ECO:0000269|PubMed:23333306, ECO:0000269|PubMed:28241136}. |
Q5UIP0 | RIF1 | S1709 | ochoa | Telomere-associated protein RIF1 (Rap1-interacting factor 1 homolog) | Key regulator of TP53BP1 that plays a key role in the repair of double-strand DNA breaks (DSBs) in response to DNA damage: acts by promoting non-homologous end joining (NHEJ)-mediated repair of DSBs (PubMed:15342490, PubMed:28241136). In response to DNA damage, interacts with ATM-phosphorylated TP53BP1 (PubMed:23333306, PubMed:28241136). Interaction with TP53BP1 leads to dissociate the interaction between NUDT16L1/TIRR and TP53BP1, thereby unmasking the tandem Tudor-like domain of TP53BP1 and allowing recruitment to DNA DSBs (PubMed:28241136). Once recruited to DSBs, RIF1 and TP53BP1 act by promoting NHEJ-mediated repair of DSBs (PubMed:23333306). In the same time, RIF1 and TP53BP1 specifically counteract the function of BRCA1 by blocking DSBs resection via homologous recombination (HR) during G1 phase (PubMed:23333306). Also required for immunoglobulin class-switch recombination (CSR) during antibody genesis, a process that involves the generation of DNA DSBs (By similarity). Promotes NHEJ of dysfunctional telomeres (By similarity). {ECO:0000250|UniProtKB:Q6PR54, ECO:0000269|PubMed:15342490, ECO:0000269|PubMed:23333306, ECO:0000269|PubMed:28241136}. |
Q5W0B1 | OBI1 | S75 | ochoa | ORC ubiquitin ligase 1 (OBI1) (EC 2.3.2.27) (RING finger protein 219) | E3 ubiquitin ligase essential for DNA replication origin activation during S phase (PubMed:31160578). Acts as a replication origin selector which selects the origins to be fired and catalyzes the multi-mono-ubiquitination of a subset of chromatin-bound ORC3 and ORC5 during S-phase (PubMed:31160578). {ECO:0000269|PubMed:31160578}. |
Q6AZW8 | ZNF660 | S27 | ochoa | Zinc finger protein 660 | May be involved in transcriptional regulation. |
Q6F5E8 | CARMIL2 | S1253 | ochoa | Capping protein, Arp2/3 and myosin-I linker protein 2 (Capping protein regulator and myosin 1 linker 2) (F-actin-uncapping protein RLTPR) (Leucine-rich repeat-containing protein 16C) (RGD, leucine-rich repeat, tropomodulin and proline-rich-containing protein) | Cell membrane-cytoskeleton-associated protein that plays a role in the regulation of actin polymerization at the barbed end of actin filaments. Prevents F-actin heterodimeric capping protein (CP) activity at the leading edges of migrating cells, and hence generates uncapped barbed ends and enhances actin polymerization (PubMed:26466680). Plays a role in cell protrusion formations; involved in cell polarity, lamellipodial assembly, membrane ruffling and macropinosome formations (PubMed:19846667, PubMed:26466680, PubMed:26578515). Involved as well in cell migration and invadopodia formation during wound healing (PubMed:19846667, PubMed:26466680, PubMed:26578515). Required for CD28-mediated stimulation of NF-kappa-B signaling, involved in naive T cells activation, maturation into T memory cells, and differentiation into T helper and T regulatory cells (PubMed:27647348, PubMed:27647349, PubMed:28112205). {ECO:0000269|PubMed:19846667, ECO:0000269|PubMed:26466680, ECO:0000269|PubMed:26578515, ECO:0000269|PubMed:27647348, ECO:0000269|PubMed:27647349, ECO:0000269|PubMed:28112205}. |
Q6NWY9 | PRPF40B | S847 | ochoa | Pre-mRNA-processing factor 40 homolog B (Huntingtin yeast partner C) (Huntingtin-interacting protein C) | May be involved in pre-mRNA splicing. {ECO:0000269|PubMed:9700202}. |
Q6P2Q9 | PRPF8 | S2060 | ochoa | Pre-mRNA-processing-splicing factor 8 (220 kDa U5 snRNP-specific protein) (PRP8 homolog) (Splicing factor Prp8) (p220) | Plays a role in pre-mRNA splicing as core component of precatalytic, catalytic and postcatalytic spliceosomal complexes, both of the predominant U2-type spliceosome and the minor U12-type spliceosome (PubMed:10411133, PubMed:11971955, PubMed:28076346, PubMed:28502770, PubMed:28781166, PubMed:29301961, PubMed:29360106, PubMed:29361316, PubMed:30315277, PubMed:30705154, PubMed:30728453). Functions as a scaffold that mediates the ordered assembly of spliceosomal proteins and snRNAs. Required for the assembly of the U4/U6-U5 tri-snRNP complex, a building block of the spliceosome. Functions as a scaffold that positions spliceosomal U2, U5 and U6 snRNAs at splice sites on pre-mRNA substrates, so that splicing can occur. Interacts with both the 5' and the 3' splice site. {ECO:0000269|PubMed:10411133, ECO:0000269|PubMed:11971955, ECO:0000269|PubMed:20595234, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:28781166, ECO:0000269|PubMed:29301961, ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000269|PubMed:30315277, ECO:0000269|PubMed:30705154, ECO:0000269|PubMed:30728453, ECO:0000303|PubMed:15840809}. |
Q6P3W7 | SCYL2 | S660 | ochoa | SCY1-like protein 2 (Coated vesicle-associated kinase of 104 kDa) | Component of the AP2-containing clathrin coat that may regulate clathrin-dependent trafficking at plasma membrane, TGN and endosomal system (Probable). A possible serine/threonine-protein kinase toward the beta2-subunit of the plasma membrane adapter complex AP2 and other proteins in presence of poly-L-lysine has not been confirmed (PubMed:15809293, PubMed:16914521). By regulating the expression of excitatory receptors at synapses, plays an essential role in neuronal function and signaling and in brain development (By similarity). {ECO:0000250|UniProtKB:Q8CFE4, ECO:0000269|PubMed:15809293, ECO:0000269|PubMed:16914521, ECO:0000305|PubMed:15809293, ECO:0000305|PubMed:16914521}. |
Q6P4E1 | GOLM2 | S332 | ochoa | Protein GOLM2 (Cancer susceptibility candidate gene 4 protein) (CASC4) (Golgi membrane protein 2) | None |
Q6PH81 | C16orf87 | S47 | ochoa | UPF0547 protein C16orf87 | None |
Q6UN15 | FIP1L1 | S244 | ochoa | Pre-mRNA 3'-end-processing factor FIP1 (hFip1) (FIP1-like 1 protein) (Factor interacting with PAP) (Rearranged in hypereosinophilia) | Component of the cleavage and polyadenylation specificity factor (CPSF) complex that plays a key role in pre-mRNA 3'-end formation, recognizing the AAUAAA signal sequence and interacting with poly(A) polymerase and other factors to bring about cleavage and poly(A) addition. FIP1L1 contributes to poly(A) site recognition and stimulates poly(A) addition. Binds to U-rich RNA sequence elements surrounding the poly(A) site. May act to tether poly(A) polymerase to the CPSF complex. {ECO:0000269|PubMed:14749727}. |
Q6ZN30 | BNC2 | S367 | ochoa | Zinc finger protein basonuclin-2 | Probable transcription factor specific for skin keratinocytes. May play a role in the differentiation of spermatozoa and oocytes (PubMed:14988505). May also play an important role in early urinary-tract development (PubMed:31051115). {ECO:0000269|PubMed:14988505, ECO:0000269|PubMed:31051115}. |
Q6ZUJ8 | PIK3AP1 | S573 | ochoa | Phosphoinositide 3-kinase adapter protein 1 (B-cell adapter for phosphoinositide 3-kinase) (B-cell phosphoinositide 3-kinase adapter protein 1) | Signaling adapter that contributes to B-cell development by linking B-cell receptor (BCR) signaling to the phosphoinositide 3-kinase (PI3K)-Akt signaling pathway. Has a complementary role to the BCR coreceptor CD19, coupling BCR and PI3K activation by providing a docking site for the PI3K subunit PIK3R1. Alternatively, links Toll-like receptor (TLR) signaling to PI3K activation, a process preventing excessive inflammatory cytokine production. Also involved in the activation of PI3K in natural killer cells. May be involved in the survival of mature B-cells via activation of REL. {ECO:0000269|PubMed:15893754}. |
Q71F23 | CENPU | S116 | ochoa | Centromere protein U (CENP-U) (Centromere protein of 50 kDa) (CENP-50) (Interphase centromere complex protein 24) (KSHV latent nuclear antigen-interacting protein 1) (MLF1-interacting protein) (Polo-box-interacting protein 1) | Component of the CENPA-NAC (nucleosome-associated) complex, a complex that plays a central role in assembly of kinetochore proteins, mitotic progression and chromosome segregation. The CENPA-NAC complex recruits the CENPA-CAD (nucleosome distal) complex and may be involved in incorporation of newly synthesized CENPA into centromeres. Plays an important role in the correct PLK1 localization to the mitotic kinetochores. A scaffold protein responsible for the initial recruitment and maintenance of the kinetochore PLK1 population until its degradation. Involved in transcriptional repression. {ECO:0000269|PubMed:12941884, ECO:0000269|PubMed:16716197, ECO:0000269|PubMed:17081991}. |
Q71H61 | ILDR2 | S426 | ochoa | Immunoglobulin-like domain-containing receptor 2 (Angulin-3) | May be involved in ER stress pathways with effects on lipid homeostasis and insulin secretion. With ILDR1 and LSR, involved in the maintain of the epithelial barrier function through the recruitment of MARVELD2/tricellulin to tricellular tight junctions (By similarity). Also functions as a B7-like protein family member expressed on immune cells and inflamed tissue and with T-cell inhibitory activity (PubMed:29431694). In the inner ear, may regulate alternative pre-mRNA splicing via binding to TRA2A, TRA2B and SRSF1 (By similarity). {ECO:0000250|UniProtKB:B5TVM2, ECO:0000269|PubMed:29431694}. |
Q76FK4 | NOL8 | S304 | ochoa | Nucleolar protein 8 (Nucleolar protein Nop132) | Plays an essential role in the survival of diffuse-type gastric cancer cells. Acts as a nucleolar anchoring protein for DDX47. May be involved in regulation of gene expression at the post-transcriptional level or in ribosome biogenesis in cancer cells. {ECO:0000269|PubMed:14660641, ECO:0000269|PubMed:15132771, ECO:0000269|PubMed:16963496}. |
Q76G19 | PDZD4 | S236 | ochoa | PDZ domain-containing protein 4 (PDZ domain-containing RING finger protein 4-like protein) | None |
Q76N89 | HECW1 | S540 | ochoa | E3 ubiquitin-protein ligase HECW1 (EC 2.3.2.26) (HECT, C2 and WW domain-containing protein 1) (HECT-type E3 ubiquitin transferase HECW1) (NEDD4-like E3 ubiquitin-protein ligase 1) (hNEDL1) | E3 ubiquitin-protein ligase that mediates ubiquitination and subsequent degradation of DVL1. Also targets the mutant SOD1 protein involved in familial amyotrophic lateral sclerosis (FALS). Forms cytotoxic aggregates with DVL1, SSR3 and mutant SOD1 that lead to motor neuron death in FALS. {ECO:0000269|PubMed:14684739}. |
Q7L4I2 | RSRC2 | S105 | ochoa | Arginine/serine-rich coiled-coil protein 2 | None |
Q7Z3K6 | MIER3 | S156 | ochoa | Mesoderm induction early response protein 3 (Mi-er3) | Transcriptional repressor. {ECO:0000250}. |
Q7Z401 | DENND4A | S1128 | ochoa | C-myc promoter-binding protein (DENN domain-containing protein 4A) | Probable guanine nucleotide exchange factor (GEF) which may activate RAB10. Promotes the exchange of GDP to GTP, converting inactive GDP-bound Rab proteins into their active GTP-bound form. According to PubMed:8056341, it may bind to ISRE-like element (interferon-stimulated response element) of MYC P2 promoter. {ECO:0000269|PubMed:20937701, ECO:0000269|PubMed:8056341}. |
Q7Z5K2 | WAPL | S202 | ochoa | Wings apart-like protein homolog (Friend of EBNA2 protein) (WAPL cohesin release factor) | Regulator of sister chromatid cohesion in mitosis which negatively regulates cohesin association with chromatin (PubMed:26299517). Involved in both sister chromatid cohesion during interphase and sister-chromatid resolution during early stages of mitosis. Couples DNA replication to sister chromatid cohesion. Cohesion ensures that chromosome partitioning is accurate in both meiotic and mitotic cells and plays an important role in DNA repair. {ECO:0000269|PubMed:15150110, ECO:0000269|PubMed:17112726, ECO:0000269|PubMed:17113138, ECO:0000269|PubMed:19696148, ECO:0000269|PubMed:19907496, ECO:0000269|PubMed:21111234, ECO:0000269|PubMed:23776203, ECO:0000269|PubMed:26299517}. |
Q86US8 | SMG6 | S874 | ochoa | Telomerase-binding protein EST1A (EC 3.1.-.-) (Ever shorter telomeres 1A) (hEST1A) (Nonsense mediated mRNA decay factor SMG6) (Smg-6 homolog) (hSmg5/7a) | Component of the telomerase ribonucleoprotein (RNP) complex that is essential for the replication of chromosome termini (PubMed:19179534). May have a general role in telomere regulation (PubMed:12676087, PubMed:12699629). Promotes in vitro the ability of TERT to elongate telomeres (PubMed:12676087, PubMed:12699629). Overexpression induces telomere uncapping, chromosomal end-to-end fusions (telomeric DNA persists at the fusion points) and did not perturb TRF2 telomeric localization (PubMed:12676087, PubMed:12699629). Binds to the single-stranded 5'-(GTGTGG)(4)GTGT-3' telomeric DNA, but not to a telomerase RNA template component (TER) (PubMed:12676087, PubMed:12699629). {ECO:0000269|PubMed:12676087, ECO:0000269|PubMed:12699629, ECO:0000269|PubMed:19179534}.; FUNCTION: Plays a role in nonsense-mediated mRNA decay (PubMed:17053788, PubMed:18974281, PubMed:19060897, PubMed:20930030). Is thought to provide a link to the mRNA degradation machinery as it has endonuclease activity required to initiate NMD, and to serve as an adapter for UPF1 to protein phosphatase 2A (PP2A), thereby triggering UPF1 dephosphorylation (PubMed:17053788, PubMed:18974281, PubMed:19060897, PubMed:20930030). Degrades single-stranded RNA (ssRNA), but not ssDNA or dsRNA (PubMed:17053788, PubMed:18974281, PubMed:19060897, PubMed:20930030). {ECO:0000269|PubMed:17053788, ECO:0000269|PubMed:18974281, ECO:0000269|PubMed:19060897, ECO:0000269|PubMed:20930030}. |
Q86V48 | LUZP1 | S961 | ochoa | Leucine zipper protein 1 (Filamin mechanobinding actin cross-linking protein) (Fimbacin) | F-actin cross-linking protein (PubMed:30990684). Stabilizes actin and acts as a negative regulator of primary cilium formation (PubMed:32496561). Positively regulates the phosphorylation of both myosin II and protein phosphatase 1 regulatory subunit PPP1R12A/MYPT1 and promotes the assembly of myosin II stacks within actin stress fibers (PubMed:38832964). Inhibits the phosphorylation of myosin light chain MYL9 by DAPK3 and suppresses the constriction velocity of the contractile ring during cytokinesis (PubMed:38009294). Binds to microtubules and promotes epithelial cell apical constriction by up-regulating levels of diphosphorylated myosin light chain (MLC) through microtubule-dependent inhibition of MLC dephosphorylation by myosin phosphatase (By similarity). Involved in regulation of cell migration, nuclear size and centriole number, probably through regulation of the actin cytoskeleton (By similarity). Component of the CERF-1 and CERF-5 chromatin remodeling complexes in embryonic stem cells where it acts to stabilize the complexes (By similarity). Plays a role in embryonic brain and cardiovascular development (By similarity). {ECO:0000250|UniProtKB:Q8R4U7, ECO:0000269|PubMed:30990684, ECO:0000269|PubMed:32496561, ECO:0000269|PubMed:38009294, ECO:0000269|PubMed:38832964}. |
Q8IVT5 | KSR1 | S569 | ochoa | Kinase suppressor of Ras 1 (EC 2.7.11.1) | Part of a multiprotein signaling complex which promotes phosphorylation of Raf family members and activation of downstream MAP kinases (By similarity). Independently of its kinase activity, acts as MAP2K1/MEK1 and MAP2K2/MEK2-dependent allosteric activator of BRAF; upon binding to MAP2K1/MEK1 or MAP2K2/MEK2, dimerizes with BRAF and promotes BRAF-mediated phosphorylation of MAP2K1/MEK1 and/or MAP2K2/MEK2 (PubMed:29433126). Promotes activation of MAPK1 and/or MAPK3, both in response to EGF and to cAMP (By similarity). Its kinase activity is unsure (By similarity). Some protein kinase activity has been detected in vitro, however the physiological relevance of this activity is unknown (By similarity). {ECO:0000250|UniProtKB:Q61097, ECO:0000269|PubMed:29433126}. |
Q8IW35 | CEP97 | S728 | ochoa | Centrosomal protein of 97 kDa (Cep97) (Leucine-rich repeat and IQ domain-containing protein 2) | Acts as a key negative regulator of ciliogenesis in collaboration with CCP110 by capping the mother centriole thereby preventing cilia formation (PubMed:17719545, PubMed:30375385). Required for recruitment of CCP110 to the centrosome (PubMed:17719545). {ECO:0000269|PubMed:17719545, ECO:0000269|PubMed:30375385}. |
Q8IWU2 | LMTK2 | S1111 | ochoa | Serine/threonine-protein kinase LMTK2 (EC 2.7.11.1) (Apoptosis-associated tyrosine kinase 2) (Brain-enriched kinase) (hBREK) (CDK5/p35-regulated kinase) (CPRK) (Kinase/phosphatase/inhibitor 2) (Lemur tyrosine kinase 2) (Serine/threonine-protein kinase KPI-2) | Phosphorylates PPP1C, phosphorylase b and CFTR. |
Q8IX21 | SLF2 | S578 | ochoa | SMC5-SMC6 complex localization factor protein 2 (Smc5/6 localization factor 1) | Plays a role in the DNA damage response (DDR) pathway by regulating postreplication repair of UV-damaged DNA and genomic stability maintenance (PubMed:25931565). The SLF1-SLF2 complex acts to link RAD18 with the SMC5-SMC6 complex at replication-coupled interstrand cross-links (ICL) and DNA double-strand breaks (DSBs) sites on chromatin during DNA repair in response to stalled replication forks (PubMed:25931565). Promotes the recruitment of the SMC5-SMC6 complex to DNA lesions (PubMed:25931565). Plays a role in SMC5-SMC6 complex recruitment for viral restriction. Forms a complex with SIMC1 and this complex is required to recruit SMC5-SMC6 complex to PML nuclear bodies and sites of viral replication (PubMed:36373674). {ECO:0000269|PubMed:25931565, ECO:0000269|PubMed:36373674}. |
Q8IZ40 | RCOR2 | S213 | ochoa | REST corepressor 2 | May act as a component of a corepressor complex that represses transcription. {ECO:0000305}. |
Q8N3V7 | SYNPO | S718 | ochoa | Synaptopodin | Actin-associated protein that may play a role in modulating actin-based shape and motility of dendritic spines and renal podocyte foot processes. Seems to be essential for the formation of spine apparatuses in spines of telencephalic neurons, which is involved in synaptic plasticity (By similarity). {ECO:0000250}. |
Q8N8U2 | CDYL2 | S163 | ochoa | Chromodomain Y-like protein 2 (CDY-like 2) | None |
Q8NBJ4 | GOLM1 | S360 | ochoa | Golgi membrane protein 1 (Golgi membrane protein GP73) (Golgi phosphoprotein 2) | Unknown. Cellular response protein to viral infection. |
Q8NFC6 | BOD1L1 | S1124 | ochoa | Biorientation of chromosomes in cell division protein 1-like 1 | Component of the fork protection machinery required to protect stalled/damaged replication forks from uncontrolled DNA2-dependent resection. Acts by stabilizing RAD51 at stalled replication forks and protecting RAD51 nucleofilaments from the antirecombinogenic activities of FBH1 and BLM (PubMed:26166705, PubMed:29937342). Does not regulate spindle orientation (PubMed:26166705). {ECO:0000269|PubMed:26166705, ECO:0000269|PubMed:29937342}. |
Q8NFT8 | DNER | S688 | ochoa | Delta and Notch-like epidermal growth factor-related receptor | Activator of the NOTCH1 pathway. May mediate neuron-glia interaction during astrocytogenesis (By similarity). {ECO:0000250}. |
Q8TDJ6 | DMXL2 | S463 | ochoa | DmX-like protein 2 (Rabconnectin-3) | May serve as a scaffold protein for MADD and RAB3GA on synaptic vesicles (PubMed:11809763). Plays a role in the brain as a key controller of neuronal and endocrine homeostatic processes (By similarity). {ECO:0000250|UniProtKB:Q8BPN8, ECO:0000269|PubMed:11809763}. |
Q8TF44 | C2CD4C | S168 | ochoa | C2 calcium-dependent domain-containing protein 4C (Nuclear-localized factor 3) (Protein FAM148C) | None |
Q8WVM7 | STAG1 | S24 | ochoa | Cohesin subunit SA-1 (SCC3 homolog 1) (Stromal antigen 1) | Component of cohesin complex, a complex required for the cohesion of sister chromatids after DNA replication. The cohesin complex apparently forms a large proteinaceous ring within which sister chromatids can be trapped. At anaphase, the complex is cleaved and dissociates from chromatin, allowing sister chromatids to segregate. The cohesin complex may also play a role in spindle pole assembly during mitosis. |
Q8WVS4 | DYNC2I1 | S176 | ochoa | Cytoplasmic dynein 2 intermediate chain 1 (Dynein 2 intermediate chain 1) (WD repeat-containing protein 60) | Acts as one of several non-catalytic accessory components of the cytoplasmic dynein 2 complex (dynein-2 complex), a motor protein complex that drives the movement of cargos along microtubules within cilia and flagella in concert with the intraflagellar transport (IFT) system (PubMed:23910462, PubMed:25205765, PubMed:29742051, PubMed:31451806). DYNC2I1 plays a major role in retrograde ciliary protein trafficking in cilia and flagella (PubMed:29742051, PubMed:30320547, PubMed:30649997). Also requires to maintain a functional transition zone (PubMed:30320547). {ECO:0000269|PubMed:23910462, ECO:0000269|PubMed:25205765, ECO:0000269|PubMed:29742051, ECO:0000269|PubMed:30320547, ECO:0000269|PubMed:30649997, ECO:0000269|PubMed:31451806}. |
Q8WWI1 | LMO7 | S280 | ochoa | LIM domain only protein 7 (LMO-7) (F-box only protein 20) (LOMP) | None |
Q92614 | MYO18A | S1974 | ochoa | Unconventional myosin-XVIIIa (Molecule associated with JAK3 N-terminus) (MAJN) (Myosin containing a PDZ domain) (Surfactant protein receptor SP-R210) (SP-R210) | May link Golgi membranes to the cytoskeleton and participate in the tensile force required for vesicle budding from the Golgi. Thereby, may play a role in Golgi membrane trafficking and could indirectly give its flattened shape to the Golgi apparatus (PubMed:19837035, PubMed:23345592). Alternatively, in concert with LURAP1 and CDC42BPA/CDC42BPB, has been involved in modulating lamellar actomyosin retrograde flow that is crucial to cell protrusion and migration (PubMed:18854160). May be involved in the maintenance of the stromal cell architectures required for cell to cell contact (By similarity). Regulates trafficking, expression, and activation of innate immune receptors on macrophages. Plays a role to suppress inflammatory responsiveness of macrophages via a mechanism that modulates CD14 trafficking (PubMed:25965346). Acts as a receptor of surfactant-associated protein A (SFTPA1/SP-A) and plays an important role in internalization and clearance of SFTPA1-opsonized S.aureus by alveolar macrophages (PubMed:16087679, PubMed:21123169). Strongly enhances natural killer cell cytotoxicity (PubMed:27467939). {ECO:0000250|UniProtKB:Q9JMH9, ECO:0000269|PubMed:16087679, ECO:0000269|PubMed:18854160, ECO:0000269|PubMed:19837035, ECO:0000269|PubMed:21123169, ECO:0000269|PubMed:23345592, ECO:0000269|PubMed:25965346, ECO:0000269|PubMed:27467939}. |
Q92628 | KIAA0232 | S1082 | ochoa | Uncharacterized protein KIAA0232 | None |
Q92834 | RPGR | S895 | ochoa | X-linked retinitis pigmentosa GTPase regulator | Acts as a guanine-nucleotide releasing factor (GEF) for RAB8A and RAB37 by promoting the conversion of inactive RAB-GDP to the active form RAB-GTP (PubMed:20631154). GEF activity towards RAB8A may facilitate ciliary trafficking by modulating ciliary intracellular localization of RAB8A (PubMed:20631154). GEF activity towards RAB37 maintains autophagic homeostasis and retinal function (By similarity). Involved in photoreceptor integrity (By similarity). May control cilia formation by regulating actin stress filaments and cell contractility. May be involved in microtubule organization and regulation of transport in primary cilia (PubMed:21933838). May play a critical role in spermatogenesis and in intraflagellar transport processes (By similarity). {ECO:0000250|UniProtKB:Q9R0X5, ECO:0000269|PubMed:20631154, ECO:0000269|PubMed:21933838}. |
Q92997 | DVL3 | T133 | ochoa|psp | Segment polarity protein dishevelled homolog DVL-3 (Dishevelled-3) (DSH homolog 3) | Involved in the signal transduction pathway mediated by multiple Wnt genes. {ECO:0000250|UniProtKB:Q61062}. |
Q96AJ9 | VTI1A | S111 | ochoa | Vesicle transport through interaction with t-SNAREs homolog 1A (Vesicle transport v-SNARE protein Vti1-like 2) (Vti1-rp2) | V-SNARE that mediates vesicle transport pathways through interactions with t-SNAREs on the target membrane. These interactions are proposed to mediate aspects of the specificity of vesicle trafficking and to promote fusion of the lipid bilayers. Involved in vesicular transport from the late endosomes to the trans-Golgi network. Along with VAMP7, involved in an non-conventional RAB1-dependent traffic route to the cell surface used by KCNIP1 and KCND2. May be involved in increased cytokine secretion associated with cellular senescence. {ECO:0000269|PubMed:18195106, ECO:0000269|PubMed:19138172}. |
Q96B97 | SH3KBP1 | S86 | ochoa | SH3 domain-containing kinase-binding protein 1 (CD2-binding protein 3) (CD2BP3) (Cbl-interacting protein of 85 kDa) (Human Src family kinase-binding protein 1) (HSB-1) | Adapter protein involved in regulating diverse signal transduction pathways. Involved in the regulation of endocytosis and lysosomal degradation of ligand-induced receptor tyrosine kinases, including EGFR and MET/hepatocyte growth factor receptor, through an association with CBL and endophilins. The association with CBL, and thus the receptor internalization, may be inhibited by an interaction with PDCD6IP and/or SPRY2. Involved in regulation of ligand-dependent endocytosis of the IgE receptor. Attenuates phosphatidylinositol 3-kinase activity by interaction with its regulatory subunit (By similarity). May be involved in regulation of cell adhesion; promotes the interaction between TTK2B and PDCD6IP. May be involved in the regulation of cellular stress response via the MAPK pathways through its interaction with MAP3K4. Is involved in modulation of tumor necrosis factor mediated apoptosis. Plays a role in the regulation of cell morphology and cytoskeletal organization. Required in the control of cell shape and migration. Has an essential role in the stimulation of B cell activation (PubMed:29636373). {ECO:0000250, ECO:0000269|PubMed:11894095, ECO:0000269|PubMed:11894096, ECO:0000269|PubMed:12177062, ECO:0000269|PubMed:12734385, ECO:0000269|PubMed:12771190, ECO:0000269|PubMed:15090612, ECO:0000269|PubMed:15707590, ECO:0000269|PubMed:16177060, ECO:0000269|PubMed:16256071, ECO:0000269|PubMed:21275903, ECO:0000269|PubMed:21834987, ECO:0000269|PubMed:29636373}. |
Q96CC6 | RHBDF1 | S309 | ochoa | Inactive rhomboid protein 1 (iRhom1) (Epidermal growth factor receptor-related protein) (Rhomboid 5 homolog 1) (Rhomboid family member 1) (p100hRho) | Regulates ADAM17 protease, a sheddase of the epidermal growth factor (EGF) receptor ligands and TNF, thereby plays a role in sleep, cell survival, proliferation, migration and inflammation. Does not exhibit any protease activity on its own. {ECO:0000269|PubMed:15965977, ECO:0000269|PubMed:18524845, ECO:0000269|PubMed:18832597, ECO:0000269|PubMed:21439629}. |
Q96DR7 | ARHGEF26 | S296 | ochoa | Rho guanine nucleotide exchange factor 26 (SH3 domain-containing guanine exchange factor) | Activates RhoG GTPase by promoting the exchange of GDP by GTP. Required for the formation of membrane ruffles during macropinocytosis. Required for the formation of cup-like structures during trans-endothelial migration of leukocytes. In case of Salmonella enterica infection, activated by SopB, which induces cytoskeleton rearrangements and promotes bacterial entry. {ECO:0000269|PubMed:15133129, ECO:0000269|PubMed:17074883, ECO:0000269|PubMed:17875742}. |
Q96EI5 | TCEAL4 | S108 | ochoa | Transcription elongation factor A protein-like 4 (TCEA-like protein 4) (Transcription elongation factor S-II protein-like 4) | May be involved in transcriptional regulation. |
Q96I99 | SUCLG2 | S280 | ochoa | Succinate--CoA ligase [GDP-forming] subunit beta, mitochondrial (EC 6.2.1.4) (GTP-specific succinyl-CoA synthetase subunit beta) (G-SCS) (GTPSCS) (Succinyl-CoA synthetase beta-G chain) (SCS-betaG) | GTP-specific succinyl-CoA synthetase functions in the citric acid cycle (TCA), coupling the hydrolysis of succinyl-CoA to the synthesis of GTP and thus represents the only step of substrate-level phosphorylation in the TCA. The beta subunit provides nucleotide specificity of the enzyme and binds the substrate succinate, while the binding sites for coenzyme A and phosphate are found in the alpha subunit. {ECO:0000255|HAMAP-Rule:MF_03221}. |
Q96JQ2 | CLMN | S927 | ochoa | Calmin (Calponin-like transmembrane domain protein) | None |
Q96K76 | USP47 | S1017 | ochoa | Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47) | Ubiquitin-specific protease that specifically deubiquitinates monoubiquitinated DNA polymerase beta (POLB), stabilizing POLB thereby playing a role in base-excision repair (BER). Acts as a regulator of cell growth and genome integrity. May also indirectly regulate CDC25A expression at a transcriptional level. {ECO:0000269|PubMed:19966869, ECO:0000269|PubMed:21362556}. |
Q96L73 | NSD1 | S1143 | ochoa | Histone-lysine N-methyltransferase, H3 lysine-36 specific (EC 2.1.1.357) (Androgen receptor coactivator 267 kDa protein) (Androgen receptor-associated protein of 267 kDa) (H3-K36-HMTase) (Lysine N-methyltransferase 3B) (Nuclear receptor-binding SET domain-containing protein 1) (NR-binding SET domain-containing protein) | Histone methyltransferase that dimethylates Lys-36 of histone H3 (H3K36me2). Transcriptional intermediary factor capable of both negatively or positively influencing transcription, depending on the cellular context. {ECO:0000269|PubMed:21196496}. |
Q96M11 | HYLS1 | S83 | ochoa | Centriolar and ciliogenesis-associated protein HYLS1 (Hydrolethalus syndrome protein 1) | Plays a role in ciliogenesis. {ECO:0000250|UniProtKB:A0A1L8ER70, ECO:0000250|UniProtKB:Q95X94}. |
Q96PU5 | NEDD4L | S231 | ochoa | E3 ubiquitin-protein ligase NEDD4-like (EC 2.3.2.26) (EC 2.3.2.36) (HECT-type E3 ubiquitin transferase NED4L) (NEDD4.2) (Nedd4-2) | E3 ubiquitin-protein ligase that mediates the polyubiquitination of lysine and cysteine residues on target proteins and is thereby implicated in the regulation of various signaling pathways including autophagy, innate immunity or DNA repair (PubMed:20064473, PubMed:31959741, PubMed:33608556). Inhibits TGF-beta signaling by triggering SMAD2 and TGFBR1 ubiquitination and proteasome-dependent degradation (PubMed:15496141). Downregulates autophagy and cell growth by ubiquitinating and reducing cellular ULK1 or ASCT2 levels (PubMed:28820317, PubMed:31959741). Promotes ubiquitination and internalization of various plasma membrane channels such as ENaC, SCN2A/Nav1.2, SCN3A/Nav1.3, SCN5A/Nav1.5, SCN9A/Nav1.7, SCN10A/Nav1.8, KCNA3/Kv1.3, KCNH2, EAAT1, KCNQ2/Kv7.2, KCNQ3/Kv7.3 or CLC5 (PubMed:26363003, PubMed:27445338). Promotes ubiquitination and degradation of SGK1 and TNK2. Ubiquitinates BRAT1 and this ubiquitination is enhanced in the presence of NDFIP1 (PubMed:25631046). Plays a role in dendrite formation by melanocytes (PubMed:23999003). Involved in the regulation of TOR signaling (PubMed:27694961). Ubiquitinates and regulates protein levels of NTRK1 once this one is activated by NGF (PubMed:27445338). Plays a role in antiviral innate immunity by catalyzing 'Lys-29'-linked cysteine ubiquitination of TRAF3, resulting in enhanced 'Lys-48' and 'Lys-63'-linked ubiquitination of TRAF3 (PubMed:33608556). Ubiquitinates TTYH2 and TTYH3 and regulates protein levels of TTYH2 (PubMed:18577513). {ECO:0000250|UniProtKB:Q8CFI0, ECO:0000269|PubMed:12911626, ECO:0000269|PubMed:15040001, ECO:0000269|PubMed:15217910, ECO:0000269|PubMed:15489223, ECO:0000269|PubMed:15496141, ECO:0000269|PubMed:15576372, ECO:0000269|PubMed:18577513, ECO:0000269|PubMed:19144635, ECO:0000269|PubMed:23999003, ECO:0000269|PubMed:25631046, ECO:0000269|PubMed:26363003, ECO:0000269|PubMed:27445338, ECO:0000269|PubMed:27694961, ECO:0000269|PubMed:33608556}. |
Q96QE3 | ATAD5 | S306 | ochoa | ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein) | Has an important role in DNA replication and in maintaining genome integrity during replication stress (PubMed:15983387, PubMed:19755857). Involved in a RAD9A-related damage checkpoint, a pathway that is important in determining whether DNA damage is compatible with cell survival or whether it requires cell elimination by apoptosis (PubMed:15983387). Modulates the RAD9A interaction with BCL2 and thereby induces DNA damage-induced apoptosis (PubMed:15983387). Promotes PCNA deubiquitination by recruiting the ubiquitin-specific protease 1 (USP1) and WDR48 thereby down-regulating the error-prone damage bypass pathway (PubMed:20147293). As component of the ATAD5 RFC-like complex, regulates the function of the DNA polymerase processivity factor PCNA by unloading the ring-shaped PCNA homotrimer from DNA after replication during the S phase of the cell cycle (PubMed:23277426, PubMed:23937667). This seems to be dependent on its ATPase activity (PubMed:23277426). Plays important roles in restarting stalled replication forks under replication stress, by unloading the PCNA homotrimer from DNA and recruiting RAD51 possibly through an ATR-dependent manner (PubMed:31844045). Ultimately this enables replication fork regression, breakage, and eventual fork restart (PubMed:31844045). Both the PCNA unloading activity and the interaction with WDR48 are required to efficiently recruit RAD51 to stalled replication forks (PubMed:31844045). Promotes the generation of MUS81-mediated single-stranded DNA-associated breaks in response to replication stress, which is an alternative pathway to restart stalled/regressed replication forks (PubMed:31844045). {ECO:0000269|PubMed:15983387, ECO:0000269|PubMed:19755857, ECO:0000269|PubMed:20147293, ECO:0000269|PubMed:23277426, ECO:0000269|PubMed:23937667, ECO:0000269|PubMed:31844045}. |
Q96RS0 | TGS1 | S89 | ochoa | Trimethylguanosine synthase (EC 2.1.1.-) (CLL-associated antigen KW-2) (Cap-specific guanine-N(2) methyltransferase) (Hepatocellular carcinoma-associated antigen 137) (Nuclear receptor coactivator 6-interacting protein) (PRIP-interacting protein with methyltransferase motif) (PIMT) (PIPMT) | Catalyzes the 2 serial methylation steps for the conversion of the 7-monomethylguanosine (m(7)G) caps of snRNAs and snoRNAs to a 2,2,7-trimethylguanosine (m(2,2,7)G) cap structure. The enzyme is specific for guanine, and N7 methylation must precede N2 methylation. Hypermethylation of the m7G cap of U snRNAs leads to their concentration in nuclear foci, their colocalization with coilin and the formation of canonical Cajal bodies (CBs). Plays a role in transcriptional regulation. {ECO:0000269|PubMed:11517327, ECO:0000269|PubMed:11912212, ECO:0000269|PubMed:16687569, ECO:0000269|PubMed:18775984}. |
Q96T23 | RSF1 | S1221 | ochoa | Remodeling and spacing factor 1 (Rsf-1) (HBV pX-associated protein 8) (Hepatitis B virus X-associated protein) (p325 subunit of RSF chromatin-remodeling complex) | Regulatory subunit of the ATP-dependent RSF-1 and RSF-5 ISWI chromatin-remodeling complexes, which form ordered nucleosome arrays on chromatin and facilitate access to DNA during DNA-templated processes such as DNA replication, transcription, and repair (PubMed:12972596, PubMed:28801535). Binds to core histones together with SMARCA5, and is required for the assembly of regular nucleosome arrays by the RSF-5 ISWI chromatin-remodeling complex (PubMed:12972596). Directly stimulates the ATPase activity of SMARCA1 and SMARCA5 in the RSF-1 and RSF-5 ISWI chromatin-remodeling complexes, respectively (PubMed:28801535). The RSF-1 ISWI chromatin remodeling complex has a lower ATP hydrolysis rate than the RSF-5 ISWI chromatin-remodeling complex (PubMed:28801535). The complexes do not have the ability to slide mononucleosomes to the center of a DNA template (PubMed:28801535). Facilitates transcription of hepatitis B virus (HBV) genes by the pX transcription activator. In case of infection by HBV, together with pX, it represses TNF-alpha induced NF-kappa-B transcription activation. Represses transcription when artificially recruited to chromatin by fusion to a heterogeneous DNA binding domain (PubMed:11788598, PubMed:11944984). {ECO:0000269|PubMed:11788598, ECO:0000269|PubMed:11944984, ECO:0000269|PubMed:12972596, ECO:0000269|PubMed:28801535}. |
Q99700 | ATXN2 | S788 | ochoa | Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein) | Involved in EGFR trafficking, acting as negative regulator of endocytic EGFR internalization at the plasma membrane. {ECO:0000269|PubMed:18602463}. |
Q99714 | HSD17B10 | S67 | ochoa | 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-estradiol 17-dehydrogenase) (EC 1.1.1.62) (2-methyl-3-hydroxybutyryl-CoA dehydrogenase) (MHBD) (3-alpha-(17-beta)-hydroxysteroid dehydrogenase (NAD(+))) (EC 1.1.1.239) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (3alpha(or 20beta)-hydroxysteroid dehydrogenase) (EC 1.1.1.53) (7-alpha-hydroxysteroid dehydrogenase) (EC 1.1.1.159) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) | Mitochondrial dehydrogenase involved in pathways of fatty acid, branched-chain amino acid and steroid metabolism (PubMed:10600649, PubMed:12917011, PubMed:18996107, PubMed:19706438, PubMed:20077426, PubMed:25925575, PubMed:26950678, PubMed:28888424, PubMed:9553139). Acts as (S)-3-hydroxyacyl-CoA dehydrogenase in mitochondrial fatty acid beta-oxidation, a major degradation pathway of fatty acids. Catalyzes the third step in the beta-oxidation cycle, namely the reversible conversion of (S)-3-hydroxyacyl-CoA to 3-ketoacyl-CoA. Preferentially accepts straight medium- and short-chain acyl-CoA substrates with highest efficiency for (3S)-hydroxybutanoyl-CoA (PubMed:10600649, PubMed:12917011, PubMed:25925575, PubMed:26950678, PubMed:9553139). Acts as 3-hydroxy-2-methylbutyryl-CoA dehydrogenase in branched-chain amino acid catabolic pathway. Catalyzes the oxidation of 3-hydroxy-2-methylbutanoyl-CoA into 2-methyl-3-oxobutanoyl-CoA, a step in isoleucine degradation pathway (PubMed:18996107, PubMed:19706438, PubMed:20077426). Has hydroxysteroid dehydrogenase activity toward steroid hormones and bile acids. Catalyzes the oxidation of 3alpha-, 17beta-, 20beta- and 21-hydroxysteroids and 7alpha- and 7beta-hydroxy bile acids (PubMed:10600649, PubMed:12917011). Oxidizes allopregnanolone/brexanolone at the 3alpha-hydroxyl group, which is known to be critical for the activation of gamma-aminobutyric acid receptors (GABAARs) chloride channel (PubMed:19706438, PubMed:28888424). Has phospholipase C-like activity toward cardiolipin and its oxidized species. Likely oxidizes the 2'-hydroxyl in the head group of cardiolipin to form a ketone intermediate that undergoes nucleophilic attack by water and fragments into diacylglycerol, dihydroxyacetone and orthophosphate. Has higher affinity for cardiolipin with oxidized fatty acids and may degrade these species during the oxidative stress response to protect cells from apoptosis (PubMed:26338420). By interacting with intracellular amyloid-beta, it may contribute to the neuronal dysfunction associated with Alzheimer disease (AD) (PubMed:9338779). Essential for structural and functional integrity of mitochondria (PubMed:20077426). {ECO:0000269|PubMed:10600649, ECO:0000269|PubMed:12917011, ECO:0000269|PubMed:18996107, ECO:0000269|PubMed:19706438, ECO:0000269|PubMed:20077426, ECO:0000269|PubMed:25925575, ECO:0000269|PubMed:26338420, ECO:0000269|PubMed:26950678, ECO:0000269|PubMed:28888424, ECO:0000269|PubMed:9553139}.; FUNCTION: In addition to mitochondrial dehydrogenase activity, moonlights as a component of mitochondrial ribonuclease P, a complex that cleaves tRNA molecules in their 5'-ends (PubMed:18984158, PubMed:24549042, PubMed:25925575, PubMed:26950678, PubMed:28888424). Together with TRMT10C/MRPP1, forms a subcomplex of the mitochondrial ribonuclease P, named MRPP1-MRPP2 subcomplex, which displays functions that are independent of the ribonuclease P activity (PubMed:23042678, PubMed:29040705). The MRPP1-MRPP2 subcomplex catalyzes the formation of N(1)-methylguanine and N(1)-methyladenine at position 9 (m1G9 and m1A9, respectively) in tRNAs; HSD17B10/MRPP2 acting as a non-catalytic subunit (PubMed:23042678, PubMed:25925575, PubMed:28888424). The MRPP1-MRPP2 subcomplex also acts as a tRNA maturation platform: following 5'-end cleavage by the mitochondrial ribonuclease P complex, the MRPP1-MRPP2 subcomplex enhances the efficiency of 3'-processing catalyzed by ELAC2, retains the tRNA product after ELAC2 processing and presents the nascent tRNA to the mitochondrial CCA tRNA nucleotidyltransferase TRNT1 enzyme (PubMed:29040705). Associates with mitochondrial DNA complexes at the nucleoids to initiate RNA processing and ribosome assembly. {ECO:0000269|PubMed:18984158, ECO:0000269|PubMed:23042678, ECO:0000269|PubMed:24549042, ECO:0000269|PubMed:24703694, ECO:0000269|PubMed:25925575, ECO:0000269|PubMed:26950678, ECO:0000269|PubMed:28888424, ECO:0000269|PubMed:29040705}. |
Q99733 | NAP1L4 | S309 | ochoa | Nucleosome assembly protein 1-like 4 (Nucleosome assembly protein 2) (NAP-2) | Acts as a histone chaperone in nucleosome assembly. {ECO:0000269|PubMed:9325046}. |
Q9BV36 | MLPH | S318 | ochoa | Melanophilin (Exophilin-3) (Slp homolog lacking C2 domains a) (SlaC2-a) (Synaptotagmin-like protein 2a) | Rab effector protein involved in melanosome transport. Serves as link between melanosome-bound RAB27A and the motor protein MYO5A. {ECO:0000269|PubMed:12062444}. |
Q9C099 | LRRCC1 | S333 | ochoa | Leucine-rich repeat and coiled-coil domain-containing protein 1 (Centrosomal leucine-rich repeat and coiled-coil domain-containing protein) | Required for the organization of the mitotic spindle. Maintains the structural integrity of centrosomes during mitosis. {ECO:0000269|PubMed:18728398}. |
Q9H0W5 | CCDC8 | S401 | ochoa | Coiled-coil domain-containing protein 8 | Core component of the 3M complex, a complex required to regulate microtubule dynamics and genome integrity. It is unclear how the 3M complex regulates microtubules, it could act by controlling the level of a microtubule stabilizer (PubMed:24793695, PubMed:24793696). Required for localization of CUL7 to the centrosome (PubMed:24793695). {ECO:0000269|PubMed:24793695, ECO:0000269|PubMed:24793696}. |
Q9H2F5 | EPC1 | S119 | ochoa | Enhancer of polycomb homolog 1 | Component of the NuA4 histone acetyltransferase (HAT) complex, a multiprotein complex involved in transcriptional activation of select genes principally by acetylation of nucleosomal histones H4 and H2A (PubMed:14966270). The NuA4 complex plays a direct role in repair of DNA double-strand breaks (DSBs) by promoting homologous recombination (HR) (PubMed:27153538). The NuA4 complex is also required for spermatid development by promoting acetylation of histones: histone acetylation is required for histone replacement during the transition from round to elongating spermatids (By similarity). In the NuA4 complex, EPC1 is required to recruit MBTD1 into the complex (PubMed:32209463). {ECO:0000250|UniProtKB:Q8C9X6, ECO:0000269|PubMed:14966270, ECO:0000269|PubMed:27153538, ECO:0000269|PubMed:32209463}. |
Q9H8E8 | KAT14 | S428 | ochoa | Cysteine-rich protein 2-binding protein (CSRP2-binding protein) (ADA2A-containing complex subunit 2) (ATAC2) (CRP2-binding partner) (CRP2BP) (Lysine acetyltransferase 14) | Component of the ATAC complex, a complex with histone acetyltransferase activity on histones H3 and H4. May function as a scaffold for the ATAC complex to promote ATAC complex stability. Has also weak histone acetyltransferase activity toward histone H4. Required for the normal progression through G1 and G2/M phases of the cell cycle. {ECO:0000269|PubMed:19103755}. |
Q9H9A7 | RMI1 | S265 | ochoa | RecQ-mediated genome instability protein 1 (BLM-associated protein of 75 kDa) (BLAP75) (FAAP75) | Essential component of the RMI complex, a complex that plays an important role in the processing of homologous recombination intermediates to limit DNA crossover formation in cells. Promotes TOP3A binding to double Holliday junctions (DHJ) and hence stimulates TOP3A-mediated dissolution. Required for BLM phosphorylation during mitosis. Within the BLM complex, required for BLM and TOP3A stability. {ECO:0000269|PubMed:15775963, ECO:0000269|PubMed:16537486, ECO:0000269|PubMed:16595695}. |
Q9HAU0 | PLEKHA5 | S351 | ochoa | Pleckstrin homology domain-containing family A member 5 (PH domain-containing family A member 5) (Phosphoinositol 3-phosphate-binding protein 2) (PEPP-2) | None |
Q9HCG8 | CWC22 | S831 | ochoa | Pre-mRNA-splicing factor CWC22 homolog (Nucampholin homolog) (fSAPb) | Required for pre-mRNA splicing as component of the spliceosome (PubMed:11991638, PubMed:12226669, PubMed:22961380, PubMed:28076346, PubMed:28502770, PubMed:29301961, PubMed:29360106). As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). Promotes exon-junction complex (EJC) assembly (PubMed:22959432, PubMed:22961380). Hinders EIF4A3 from non-specifically binding RNA and escorts it to the splicing machinery to promote EJC assembly on mature mRNAs. Through its role in EJC assembly, required for nonsense-mediated mRNA decay. {ECO:0000269|PubMed:11991638, ECO:0000269|PubMed:12226669, ECO:0000269|PubMed:22959432, ECO:0000269|PubMed:22961380, ECO:0000269|PubMed:23236153, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:29301961, ECO:0000269|PubMed:29360106, ECO:0000305|PubMed:33509932}. |
Q9HCK8 | CHD8 | S1424 | ochoa | Chromodomain-helicase-DNA-binding protein 8 (CHD-8) (EC 3.6.4.-) (ATP-dependent helicase CHD8) (Helicase with SNF2 domain 1) | ATP-dependent chromatin-remodeling factor, it slides nucleosomes along DNA; nucleosome sliding requires ATP (PubMed:28533432). Acts as a transcription repressor by remodeling chromatin structure and recruiting histone H1 to target genes. Suppresses p53/TP53-mediated apoptosis by recruiting histone H1 and preventing p53/TP53 transactivation activity. Acts as a negative regulator of Wnt signaling pathway by regulating beta-catenin (CTNNB1) activity. Negatively regulates CTNNB1-targeted gene expression by being recruited specifically to the promoter regions of several CTNNB1 responsive genes. Involved in both enhancer blocking and epigenetic remodeling at chromatin boundary via its interaction with CTCF. Acts as a suppressor of STAT3 activity by suppressing the LIF-induced STAT3 transcriptional activity. Also acts as a transcription activator via its interaction with ZNF143 by participating in efficient U6 RNA polymerase III transcription. Regulates alternative splicing of a core group of genes involved in neuronal differentiation, cell cycle and DNA repair. Enables H3K36me3-coupled transcription elongation and co-transcriptional RNA processing likely via interaction with HNRNPL. {ECO:0000255|HAMAP-Rule:MF_03071, ECO:0000269|PubMed:17938208, ECO:0000269|PubMed:18378692, ECO:0000269|PubMed:28533432, ECO:0000269|PubMed:36537238}. |
Q9NRL2 | BAZ1A | T731 | ochoa | Bromodomain adjacent to zinc finger domain protein 1A (ATP-dependent chromatin-remodeling protein) (ATP-utilizing chromatin assembly and remodeling factor 1) (hACF1) (CHRAC subunit ACF1) (Williams syndrome transcription factor-related chromatin-remodeling factor 180) (WCRF180) (hWALp1) | Regulatory subunit of the ATP-dependent ACF-1 and ACF-5 ISWI chromatin remodeling complexes, which form ordered nucleosome arrays on chromatin and slide edge- and center-positioned histone octamers away from their original location on the DNA template to facilitate access to DNA during DNA-templated processes such as DNA replication, transcription, and repair (PubMed:17099699, PubMed:28801535). Both complexes regulate the spacing of nucleosomes along the chromatin and have the ability to slide mononucleosomes to the center of a DNA template in an ATP-dependent manner (PubMed:14759371, PubMed:17099699, PubMed:28801535). The ACF-1 ISWI chromatin remodeling complex has a lower ATP hydrolysis rate than the ACF-5 ISWI chromatin remodeling complex (PubMed:28801535). Has a role in sensing the length of DNA which flank nucleosomes, which modulates the nucleosome spacing activity of the ACF-5 ISWI chromatin remodeling complex (PubMed:17099699). Involved in DNA replication and together with SMARCA5/SNF2H is required for replication of pericentric heterochromatin in S-phase (PubMed:12434153). May have a role in nuclear receptor-mediated transcription repression (PubMed:17519354). {ECO:0000269|PubMed:12434153, ECO:0000269|PubMed:14759371, ECO:0000269|PubMed:17099699, ECO:0000269|PubMed:17519354, ECO:0000269|PubMed:28801535}. |
Q9NVA4 | TMEM184C | S344 | ochoa | Transmembrane protein 184C (Transmembrane protein 34) | Possible tumor suppressor which may play a role in cell growth. {ECO:0000269|PubMed:17072649}. |
Q9NX94 | WBP1L | S228 | ochoa | WW domain binding protein 1-like (Outcome predictor in acute leukemia 1) | None |
Q9NY61 | AATF | S321 | ochoa|psp | Protein AATF (Apoptosis-antagonizing transcription factor) (Rb-binding protein Che-1) | Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and work in concert to generate RNA folding, modifications, rearrangements and cleavage as well as targeted degradation of pre-ribosomal RNA by the RNA exosome (PubMed:34516797). May function as a general inhibitor of the histone deacetylase HDAC1. Binding to the pocket region of RB1 may displace HDAC1 from RB1/E2F complexes, leading to activation of E2F target genes and cell cycle progression. Conversely, displacement of HDAC1 from SP1 bound to the CDKN1A promoter leads to increased expression of this CDK inhibitor and blocks cell cycle progression. Also antagonizes PAWR mediated induction of aberrant amyloid peptide production in Alzheimer disease (presenile and senile dementia), although the molecular basis for this phenomenon has not been described to date. {ECO:0000269|PubMed:12450794, ECO:0000269|PubMed:12847090, ECO:0000269|PubMed:14627703, ECO:0000269|PubMed:15207272, ECO:0000269|PubMed:34516797}. |
Q9NZM1 | MYOF | S174 | ochoa | Myoferlin (Fer-1-like protein 3) | Calcium/phospholipid-binding protein that plays a role in the plasmalemma repair mechanism of endothelial cells that permits rapid resealing of membranes disrupted by mechanical stress. Involved in endocytic recycling. Implicated in VEGF signal transduction by regulating the levels of the receptor KDR (By similarity). {ECO:0000250}. |
Q9UBL3 | ASH2L | S92 | ochoa | Set1/Ash2 histone methyltransferase complex subunit ASH2 (ASH2-like protein) | Transcriptional regulator (PubMed:12670868). Component or associated component of some histone methyltransferase complexes which regulates transcription through recruitment of those complexes to gene promoters (PubMed:19131338). Component of the Set1/Ash2 histone methyltransferase (HMT) complex, a complex that specifically methylates 'Lys-4' of histone H3, but not if the neighboring 'Lys-9' residue is already methylated (PubMed:19556245). As part of the MLL1/MLL complex it is involved in methylation and dimethylation at 'Lys-4' of histone H3 (PubMed:19556245). May play a role in hematopoiesis (PubMed:12670868). In association with RBBP5 and WDR5, stimulates the histone methyltransferase activities of KMT2A, KMT2B, KMT2C, KMT2D, SETD1A and SETD1B (PubMed:21220120, PubMed:22266653). {ECO:0000269|PubMed:12670868, ECO:0000269|PubMed:19131338, ECO:0000269|PubMed:19556245, ECO:0000269|PubMed:21220120, ECO:0000269|PubMed:22266653}. |
Q9UIB8 | CD84 | S317 | ochoa | SLAM family member 5 (Cell surface antigen MAX.3) (Hly9-beta) (Leukocyte differentiation antigen CD84) (Signaling lymphocytic activation molecule 5) (CD antigen CD84) | Self-ligand receptor of the signaling lymphocytic activation molecule (SLAM) family. SLAM receptors triggered by homo- or heterotypic cell-cell interactions are modulating the activation and differentiation of a wide variety of immune cells and thus are involved in the regulation and interconnection of both innate and adaptive immune response. Activities are controlled by presence or absence of small cytoplasmic adapter proteins, SH2D1A/SAP and/or SH2D1B/EAT-2. Can mediate natural killer (NK) cell cytotoxicity dependent on SH2D1A and SH2D1B (By similarity). Increases proliferative responses of activated T-cells and SH2D1A/SAP does not seem be required for this process. Homophilic interactions enhance interferon gamma/IFNG secretion in lymphocytes and induce platelet stimulation via a SH2D1A-dependent pathway. May serve as a marker for hematopoietic progenitor cells (PubMed:11564780, PubMed:12115647, PubMed:12928397, PubMed:12962726, PubMed:16037392) Required for a prolonged T-cell:B-cell contact, optimal T follicular helper function, and germinal center formation. In germinal centers involved in maintaining B-cell tolerance and in preventing autoimmunity (By similarity). In mast cells negatively regulates high affinity immunoglobulin epsilon receptor signaling; independent of SH2D1A and SH2D1B but implicating FES and PTPN6/SHP-1 (PubMed:22068234). In macrophages enhances LPS-induced MAPK phosphorylation and NF-kappaB activation and modulates LPS-induced cytokine secretion; involving ITSM 2 (By similarity). Positively regulates macroautophagy in primary dendritic cells via stabilization of IRF8; inhibits TRIM21-mediated proteasomal degradation of IRF8 (PubMed:29434592). {ECO:0000250|UniProtKB:Q18PI6, ECO:0000269|PubMed:11564780, ECO:0000269|PubMed:12115647, ECO:0000269|PubMed:12928397, ECO:0000269|PubMed:12962726, ECO:0000269|PubMed:16037392, ECO:0000269|PubMed:22068234, ECO:0000269|PubMed:29434592, ECO:0000305}. |
Q9UIS9 | MBD1 | S391 | ochoa | Methyl-CpG-binding domain protein 1 (CXXC-type zinc finger protein 3) (Methyl-CpG-binding protein MBD1) (Protein containing methyl-CpG-binding domain 1) | Transcriptional repressor that binds CpG islands in promoters where the DNA is methylated at position 5 of cytosine within CpG dinucleotides. Binding is abolished by the presence of 7-mG that is produced by DNA damage by methylmethanesulfonate (MMS). Acts as transcriptional repressor and plays a role in gene silencing by recruiting ATF7IP, which in turn recruits factors such as the histone methyltransferase SETDB1. Probably forms a complex with SETDB1 and ATF7IP that represses transcription and couples DNA methylation and histone 'Lys-9' trimethylation. Isoform 1 and isoform 2 can also repress transcription from unmethylated promoters. {ECO:0000269|PubMed:10454587, ECO:0000269|PubMed:10648624, ECO:0000269|PubMed:12665582, ECO:0000269|PubMed:12697822, ECO:0000269|PubMed:12711603, ECO:0000269|PubMed:14555760, ECO:0000269|PubMed:14610093, ECO:0000269|PubMed:9207790, ECO:0000269|PubMed:9774669}. |
Q9UKG1 | APPL1 | S491 | ochoa | DCC-interacting protein 13-alpha (Dip13-alpha) (Adapter protein containing PH domain, PTB domain and leucine zipper motif 1) | Multifunctional adapter protein that binds to various membrane receptors, nuclear factors and signaling proteins to regulate many processes, such as cell proliferation, immune response, endosomal trafficking and cell metabolism (PubMed:10490823, PubMed:15016378, PubMed:19661063, PubMed:26073777, PubMed:26583432). Regulates signaling pathway leading to cell proliferation through interaction with RAB5A and subunits of the NuRD/MeCP1 complex (PubMed:15016378). Functions as a positive regulator of innate immune response via activation of AKT1 signaling pathway by forming a complex with APPL1 and PIK3R1 (By similarity). Inhibits Fc-gamma receptor-mediated phagocytosis through PI3K/Akt signaling in macrophages (By similarity). Regulates TLR4 signaling in activated macrophages (By similarity). Involved in trafficking of the TGFBR1 from the endosomes to the nucleus via microtubules in a TRAF6-dependent manner (PubMed:26583432). Plays a role in cell metabolism by regulating adiponecting and insulin signaling pathways (PubMed:19661063, PubMed:24879834, PubMed:26073777). Required for fibroblast migration through HGF cell signaling (By similarity). Positive regulator of beta-catenin/TCF-dependent transcription through direct interaction with RUVBL2/reptin resulting in the relief of RUVBL2-mediated repression of beta-catenin/TCF target genes by modulating the interactions within the beta-catenin-reptin-HDAC complex (PubMed:19433865). {ECO:0000250|UniProtKB:Q8K3H0, ECO:0000269|PubMed:10490823, ECO:0000269|PubMed:15016378, ECO:0000269|PubMed:19433865, ECO:0000269|PubMed:19661063, ECO:0000269|PubMed:24879834, ECO:0000269|PubMed:26073777, ECO:0000269|PubMed:26583432}. |
Q9UKI8 | TLK1 | S109 | ochoa | Serine/threonine-protein kinase tousled-like 1 (EC 2.7.11.1) (PKU-beta) (Tousled-like kinase 1) | Rapidly and transiently inhibited by phosphorylation following the generation of DNA double-stranded breaks during S-phase. This is cell cycle checkpoint and ATM-pathway dependent and appears to regulate processes involved in chromatin assembly. Isoform 3 phosphorylates and enhances the stability of the t-SNARE SNAP23, augmenting its assembly with syntaxin. Isoform 3 protects the cells from the ionizing radiation by facilitating the repair of DSBs. In vitro, phosphorylates histone H3 at 'Ser-10'. {ECO:0000269|PubMed:10523312, ECO:0000269|PubMed:10588641, ECO:0000269|PubMed:11314006, ECO:0000269|PubMed:11470414, ECO:0000269|PubMed:12660173, ECO:0000269|PubMed:9427565}. |
Q9UKK3 | PARP4 | S1529 | ochoa | Protein mono-ADP-ribosyltransferase PARP4 (EC 2.4.2.-) (193 kDa vault protein) (ADP-ribosyltransferase diphtheria toxin-like 4) (ARTD4) (PARP-related/IalphaI-related H5/proline-rich) (PH5P) (Poly [ADP-ribose] polymerase 4) (PARP-4) (Vault poly(ADP-ribose) polymerase) (VPARP) | Mono-ADP-ribosyltransferase that mediates mono-ADP-ribosylation of target proteins. {ECO:0000269|PubMed:25043379}. |
Q9UKV8 | AGO2 | S672 | psp | Protein argonaute-2 (Argonaute2) (hAgo2) (EC 3.1.26.n2) (Argonaute RISC catalytic component 2) (Eukaryotic translation initiation factor 2C 2) (eIF-2C 2) (eIF2C 2) (PAZ Piwi domain protein) (PPD) (Protein slicer) | Required for RNA-mediated gene silencing (RNAi) by the RNA-induced silencing complex (RISC). The 'minimal RISC' appears to include AGO2 bound to a short guide RNA such as a microRNA (miRNA) or short interfering RNA (siRNA). These guide RNAs direct RISC to complementary mRNAs that are targets for RISC-mediated gene silencing. The precise mechanism of gene silencing depends on the degree of complementarity between the miRNA or siRNA and its target. Binding of RISC to a perfectly complementary mRNA generally results in silencing due to endonucleolytic cleavage of the mRNA specifically by AGO2. Binding of RISC to a partially complementary mRNA results in silencing through inhibition of translation, and this is independent of endonuclease activity. May inhibit translation initiation by binding to the 7-methylguanosine cap, thereby preventing the recruitment of the translation initiation factor eIF4-E. May also inhibit translation initiation via interaction with EIF6, which itself binds to the 60S ribosomal subunit and prevents its association with the 40S ribosomal subunit. The inhibition of translational initiation leads to the accumulation of the affected mRNA in cytoplasmic processing bodies (P-bodies), where mRNA degradation may subsequently occur. In some cases RISC-mediated translational repression is also observed for miRNAs that perfectly match the 3' untranslated region (3'-UTR). Can also up-regulate the translation of specific mRNAs under certain growth conditions. Binds to the AU element of the 3'-UTR of the TNF (TNF-alpha) mRNA and up-regulates translation under conditions of serum starvation. Also required for transcriptional gene silencing (TGS), in which short RNAs known as antigene RNAs or agRNAs direct the transcriptional repression of complementary promoter regions. {ECO:0000250|UniProtKB:Q8CJG0, ECO:0000255|HAMAP-Rule:MF_03031, ECO:0000269|PubMed:15105377, ECO:0000269|PubMed:15260970, ECO:0000269|PubMed:15284456, ECO:0000269|PubMed:15337849, ECO:0000269|PubMed:15800637, ECO:0000269|PubMed:16081698, ECO:0000269|PubMed:16142218, ECO:0000269|PubMed:16271387, ECO:0000269|PubMed:16289642, ECO:0000269|PubMed:16357216, ECO:0000269|PubMed:16756390, ECO:0000269|PubMed:16936728, ECO:0000269|PubMed:17382880, ECO:0000269|PubMed:17507929, ECO:0000269|PubMed:17524464, ECO:0000269|PubMed:17531811, ECO:0000269|PubMed:17932509, ECO:0000269|PubMed:18048652, ECO:0000269|PubMed:18178619, ECO:0000269|PubMed:18690212, ECO:0000269|PubMed:18771919, ECO:0000269|PubMed:19167051, ECO:0000269|PubMed:23746446, ECO:0000269|PubMed:37328606}.; FUNCTION: (Microbial infection) Upon Sars-CoV-2 infection, associates with viral miRNA-like small RNA, CoV2-miR-O7a, and may repress mRNAs, such as BATF2, to evade the IFN response. {ECO:0000269|PubMed:34903581}. |
Q9UKX2 | MYH2 | S1834 | ochoa | Myosin-2 (Myosin heavy chain 2) (Myosin heavy chain 2a) (MyHC-2a) (Myosin heavy chain IIa) (MyHC-IIa) (Myosin heavy chain, skeletal muscle, adult 2) | Myosins are actin-based motor molecules with ATPase activity essential for muscle contraction. {ECO:0000250|UniProtKB:P12883}. |
Q9ULU4 | ZMYND8 | S533 | ochoa | MYND-type zinc finger-containing chromatin reader ZMYND8 (Cutaneous T-cell lymphoma-associated antigen se14-3) (CTCL-associated antigen se14-3) (Protein kinase C-binding protein 1) (Rack7) (Transcription coregulator ZMYND8) (Zinc finger MYND domain-containing protein 8) | Chromatin reader that recognizes dual histone modifications such as histone H3.1 dimethylated at 'Lys-36' and histone H4 acetylated at 'Lys-16' (H3.1K36me2-H4K16ac) and histone H3 methylated at 'Lys-4' and histone H4 acetylated at 'Lys-14' (H3K4me1-H3K14ac) (PubMed:26655721, PubMed:27477906, PubMed:31965980, PubMed:36064715). May act as a transcriptional corepressor for KDM5D by recognizing the dual histone signature H3K4me1-H3K14ac (PubMed:27477906). May also act as a transcriptional corepressor for KDM5C and EZH2 (PubMed:33323928). Recognizes acetylated histone H4 and recruits the NuRD chromatin remodeling complex to damaged chromatin for transcriptional repression and double-strand break repair by homologous recombination (PubMed:25593309, PubMed:27732854, PubMed:30134174). Also activates transcription elongation by RNA polymerase II through recruiting the P-TEFb complex to target promoters (PubMed:26655721, PubMed:30134174). Localizes to H3.1K36me2-H4K16ac marks at all-trans-retinoic acid (ATRA)-responsive genes and positively regulates their expression (PubMed:26655721). Promotes neuronal differentiation by associating with regulatory regions within the MAPT gene, to enhance transcription of a protein-coding MAPT isoform and suppress the non-coding MAPT213 isoform (PubMed:30134174, PubMed:35916866, PubMed:36064715). Suppresses breast cancer, and prostate cancer cell invasion and metastasis (PubMed:27477906, PubMed:31965980, PubMed:33323928). {ECO:0000269|PubMed:25593309, ECO:0000269|PubMed:26655721, ECO:0000269|PubMed:27477906, ECO:0000269|PubMed:27732854, ECO:0000269|PubMed:30134174, ECO:0000269|PubMed:31965980, ECO:0000269|PubMed:33323928, ECO:0000269|PubMed:35916866, ECO:0000269|PubMed:36064715}. |
Q9UM54 | MYO6 | S1019 | ochoa | Unconventional myosin-VI (Unconventional myosin-6) | Myosins are actin-based motor molecules with ATPase activity (By similarity). Unconventional myosins serve in intracellular movements (By similarity). Myosin 6 is a reverse-direction motor protein that moves towards the minus-end of actin filaments (PubMed:10519557). Has slow rate of actin-activated ADP release due to weak ATP binding (By similarity). Functions in a variety of intracellular processes such as vesicular membrane trafficking and cell migration (By similarity). Required for the structural integrity of the Golgi apparatus via the p53-dependent pro-survival pathway (PubMed:16507995). Appears to be involved in a very early step of clathrin-mediated endocytosis in polarized epithelial cells (PubMed:11447109). Together with TOM1, mediates delivery of endocytic cargo to autophagosomes thereby promoting autophagosome maturation and driving fusion with lysosomes (PubMed:23023224). Links TOM1 with autophagy receptors, such as TAX1BP1; CALCOCO2/NDP52 and OPTN (PubMed:31371777). May act as a regulator of F-actin dynamics (By similarity). As part of the DISP complex, may regulate the association of septins with actin and thereby regulate the actin cytoskeleton (PubMed:29467281). May play a role in transporting DAB2 from the plasma membrane to specific cellular targets (By similarity). May play a role in the extension and network organization of neurites (By similarity). Required for structural integrity of inner ear hair cells (By similarity). Required for the correct localization of CLIC5 and RDX at the stereocilium base (By similarity). Modulates RNA polymerase II-dependent transcription (PubMed:16949370). {ECO:0000250|UniProtKB:Q29122, ECO:0000250|UniProtKB:Q64331, ECO:0000269|PubMed:10519557, ECO:0000269|PubMed:11447109, ECO:0000269|PubMed:16507995, ECO:0000269|PubMed:16949370, ECO:0000269|PubMed:23023224, ECO:0000269|PubMed:29467281, ECO:0000269|PubMed:31371777}. |
Q9UPQ7 | PDZRN3 | S584 | ochoa | E3 ubiquitin-protein ligase PDZRN3 (EC 2.3.2.27) (Ligand of Numb protein X 3) (PDZ domain-containing RING finger protein 3) (RING-type E3 ubiquitin transferase PDZRN3) (Semaphorin cytoplasmic domain-associated protein 3) (Protein SEMACAP3) | E3 ubiquitin-protein ligase. Plays an important role in regulating the surface level of MUSK on myotubes. Mediates the ubiquitination of MUSK, promoting its endocytosis and lysosomal degradation. Might contribute to terminal myogenic differentiation. {ECO:0000250|UniProtKB:Q69ZS0}. |
Q9UQ80 | PA2G4 | S345 | ochoa | Proliferation-associated protein 2G4 (Cell cycle protein p38-2G4 homolog) (hG4-1) (ErbB3-binding protein 1) | May play a role in a ERBB3-regulated signal transduction pathway. Seems be involved in growth regulation. Acts a corepressor of the androgen receptor (AR) and is regulated by the ERBB3 ligand neuregulin-1/heregulin (HRG). Inhibits transcription of some E2F1-regulated promoters, probably by recruiting histone acetylase (HAT) activity. Binds RNA. Associates with 28S, 18S and 5.8S mature rRNAs, several rRNA precursors and probably U3 small nucleolar RNA. May be involved in regulation of intermediate and late steps of rRNA processing. May be involved in ribosome assembly. Mediates cap-independent translation of specific viral IRESs (internal ribosomal entry site) (By similarity). Regulates cell proliferation, differentiation, and survival. Isoform 1 suppresses apoptosis whereas isoform 2 promotes cell differentiation (By similarity). {ECO:0000250|UniProtKB:P50580, ECO:0000250|UniProtKB:Q6AYD3, ECO:0000269|PubMed:11268000, ECO:0000269|PubMed:12682367, ECO:0000269|PubMed:15064750, ECO:0000269|PubMed:15583694, ECO:0000269|PubMed:16832058}. |
Q9Y266 | NUDC | S281 | ochoa | Nuclear migration protein nudC (Nuclear distribution protein C homolog) | Plays a role in neurogenesis and neuronal migration (By similarity). Necessary for correct formation of mitotic spindles and chromosome separation during mitosis (PubMed:12679384, PubMed:12852857, PubMed:25789526). Necessary for cytokinesis and cell proliferation (PubMed:12679384, PubMed:12852857). {ECO:0000250|UniProtKB:O35685, ECO:0000269|PubMed:12679384, ECO:0000269|PubMed:12852857, ECO:0000269|PubMed:25789526}. |
Q9Y4J8 | DTNA | S641 | ochoa | Dystrobrevin alpha (DTN-A) (Alpha-dystrobrevin) (Dystrophin-related protein 3) | May be involved in the formation and stability of synapses as well as being involved in the clustering of nicotinic acetylcholine receptors. |
Q9Y5Q9 | GTF3C3 | S51 | ochoa | General transcription factor 3C polypeptide 3 (Transcription factor IIIC 102 kDa subunit) (TFIIIC 102 kDa subunit) (TFIIIC102) (Transcription factor IIIC subunit gamma) (TF3C-gamma) | Involved in RNA polymerase III-mediated transcription. Integral, tightly associated component of the DNA-binding TFIIIC2 subcomplex that directly binds tRNA and virus-associated RNA promoters. |
Q9Y6X4 | FAM169A | S637 | ochoa | Soluble lamin-associated protein of 75 kDa (SLAP75) (Protein FAM169A) | None |
P07814 | EPRS1 | S1122 | Sugiyama | Bifunctional glutamate/proline--tRNA ligase (Bifunctional aminoacyl-tRNA synthetase) (Cell proliferation-inducing gene 32 protein) (Glutamatyl-prolyl-tRNA synthetase) [Includes: Glutamate--tRNA ligase (EC 6.1.1.17) (Glutamyl-tRNA synthetase) (GluRS); Proline--tRNA ligase (EC 6.1.1.15) (Prolyl-tRNA synthetase)] | Multifunctional protein which primarily functions within the aminoacyl-tRNA synthetase multienzyme complex, also known as multisynthetase complex. Within the complex it catalyzes the attachment of both L-glutamate and L-proline to their cognate tRNAs in a two-step reaction where the amino acid is first activated by ATP to form a covalent intermediate with AMP. Subsequently, the activated amino acid is transferred to the acceptor end of the cognate tRNA to form L-glutamyl-tRNA(Glu) and L-prolyl-tRNA(Pro) (PubMed:23263184, PubMed:24100331, PubMed:29576217, PubMed:3290852, PubMed:37212275). Upon interferon-gamma stimulation, EPRS1 undergoes phosphorylation, causing its dissociation from the aminoacyl-tRNA synthetase multienzyme complex. It is recruited to form the GAIT complex, which binds to stem loop-containing GAIT elements found in the 3'-UTR of various inflammatory mRNAs, such as ceruloplasmin. The GAIT complex inhibits the translation of these mRNAs, allowing interferon-gamma to redirect the function of EPRS1 from protein synthesis to translation inhibition in specific cell contexts (PubMed:15479637, PubMed:23071094). Furthermore, it can function as a downstream effector in the mTORC1 signaling pathway, by promoting the translocation of SLC27A1 from the cytoplasm to the plasma membrane where it mediates the uptake of long-chain fatty acid by adipocytes. Thereby, EPRS1 also plays a role in fat metabolism and more indirectly influences lifespan (PubMed:28178239). {ECO:0000269|PubMed:15479637, ECO:0000269|PubMed:23071094, ECO:0000269|PubMed:23263184, ECO:0000269|PubMed:24100331, ECO:0000269|PubMed:28178239, ECO:0000269|PubMed:29576217, ECO:0000269|PubMed:3290852, ECO:0000269|PubMed:37212275}. |
P53621 | COPA | S268 | Sugiyama | Coatomer subunit alpha (Alpha-coat protein) (Alpha-COP) (HEP-COP) (HEPCOP) [Cleaved into: Xenin (Xenopsin-related peptide); Proxenin] | The coatomer is a cytosolic protein complex that binds to dilysine motifs and reversibly associates with Golgi non-clathrin-coated vesicles, which further mediate biosynthetic protein transport from the ER, via the Golgi up to the trans Golgi network. Coatomer complex is required for budding from Golgi membranes, and is essential for the retrograde Golgi-to-ER transport of dilysine-tagged proteins. In mammals, the coatomer can only be recruited by membranes associated to ADP-ribosylation factors (ARFs), which are small GTP-binding proteins; the complex also influences the Golgi structural integrity, as well as the processing, activity, and endocytic recycling of LDL receptors (By similarity). {ECO:0000250}.; FUNCTION: Xenin stimulates exocrine pancreatic secretion. It inhibits pentagastrin-stimulated secretion of acid, to induce exocrine pancreatic secretion and to affect small and large intestinal motility. In the gut, xenin interacts with the neurotensin receptor. |
P52907 | CAPZA1 | S244 | Sugiyama | F-actin-capping protein subunit alpha-1 (CapZ alpha-1) | F-actin-capping proteins bind in a Ca(2+)-independent manner to the fast growing ends of actin filaments (barbed end) thereby blocking the exchange of subunits at these ends. Unlike other capping proteins (such as gelsolin and severin), these proteins do not sever actin filaments. May play a role in the formation of epithelial cell junctions (PubMed:22891260). Forms, with CAPZB, the barbed end of the fast growing ends of actin filaments in the dynactin complex and stabilizes dynactin structure. The dynactin multiprotein complex activates the molecular motor dynein for ultra-processive transport along microtubules (By similarity). {ECO:0000250|UniProtKB:A0PFK5, ECO:0000269|PubMed:22891260}. |
P50416 | CPT1A | S371 | Sugiyama | Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A) (Succinyltransferase CPT1A) (EC 2.3.1.-) | Catalyzes the transfer of the acyl group of long-chain fatty acid-CoA conjugates onto carnitine, an essential step for the mitochondrial uptake of long-chain fatty acids and their subsequent beta-oxidation in the mitochondrion (PubMed:11350182, PubMed:14517221, PubMed:16651524, PubMed:9691089). Also possesses a lysine succinyltransferase activity that can regulate enzymatic activity of substrate proteins such as ENO1 and metabolism independent of its classical carnitine O-palmitoyltransferase activity (PubMed:29425493). Plays an important role in hepatic triglyceride metabolism (By similarity). Also plays a role in inducible regulatory T-cell (iTreg) differentiation once activated by butyryl-CoA that antagonizes malonyl-CoA-mediated CPT1A repression (By similarity). Sustains the IFN-I response by recruiting ZDHCC4 to palmitoylate MAVS at the mitochondria leading to MAVS stabilization and activation (PubMed:38016475). Promotes ROS-induced oxidative stress in liver injury via modulation of NFE2L2 and NLRP3-mediated signaling pathways (By similarity). {ECO:0000250|UniProtKB:P32198, ECO:0000269|PubMed:11350182, ECO:0000269|PubMed:14517221, ECO:0000269|PubMed:16651524, ECO:0000269|PubMed:29425493, ECO:0000269|PubMed:38016475, ECO:0000269|PubMed:9691089}. |
P47755 | CAPZA2 | S244 | Sugiyama | F-actin-capping protein subunit alpha-2 (CapZ alpha-2) | F-actin-capping proteins bind in a Ca(2+)-independent manner to the fast growing ends of actin filaments (barbed end) thereby blocking the exchange of subunits at these ends. Unlike other capping proteins (such as gelsolin and severin), these proteins do not sever actin filaments. |
Q8WTQ7 | GRK7 | S490 | SIGNOR|Sugiyama | Rhodopsin kinase GRK7 (EC 2.7.11.14) (G protein-coupled receptor kinase 7) (G protein-coupled receptor kinase GRK7) | Retina-specific kinase involved in the shutoff of the photoresponse and adaptation to changing light conditions via cone opsin phosphorylation, including rhodopsin (RHO). {ECO:0000269|PubMed:15946941}. |
Q9HAU0 | PLEKHA5 | S832 | Sugiyama | Pleckstrin homology domain-containing family A member 5 (PH domain-containing family A member 5) (Phosphoinositol 3-phosphate-binding protein 2) (PEPP-2) | None |
Q96JH7 | VCPIP1 | S1079 | Sugiyama | Deubiquitinating protein VCPIP1 (EC 3.4.19.12) (Valosin-containing protein p97/p47 complex-interacting protein 1) (Valosin-containing protein p97/p47 complex-interacting protein p135) (VCP/p47 complex-interacting 135-kDa protein) | Deubiquitinating enzyme involved in DNA repair and reassembly of the Golgi apparatus and the endoplasmic reticulum following mitosis (PubMed:32649882). Necessary for VCP-mediated reassembly of Golgi stacks after mitosis (By similarity). Plays a role in VCP-mediated formation of transitional endoplasmic reticulum (tER) (By similarity). Mediates dissociation of the ternary complex containing STX5A, NSFL1C and VCP (By similarity). Also involved in DNA repair following phosphorylation by ATM or ATR: acts by catalyzing deubiquitination of SPRTN, thereby promoting SPRTN recruitment to chromatin and subsequent proteolytic cleavage of covalent DNA-protein cross-links (DPCs) (PubMed:32649882). Hydrolyzes 'Lys-11'- and 'Lys-48'-linked polyubiquitin chains (PubMed:23827681). {ECO:0000250|UniProtKB:Q8CF97, ECO:0000269|PubMed:23827681, ECO:0000269|PubMed:32649882}.; FUNCTION: (Microbial infection) Regulates the duration of C.botulinum neurotoxin type A (BoNT/A) intoxication by catalyzing deubiquitination of Botulinum neurotoxin A light chain (LC), thereby preventing LC degradation by the proteasome, and accelerating botulinum neurotoxin intoxication in patients. {ECO:0000269|PubMed:28584101}. |
Download
reactome_id | name | p | -log10_p |
---|---|---|---|
R-HSA-9933387 | RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | 0.000067 | 4.176 |
R-HSA-9834899 | Specification of the neural plate border | 0.000184 | 3.735 |
R-HSA-2173793 | Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | 0.000916 | 3.038 |
R-HSA-9772755 | Formation of WDR5-containing histone-modifying complexes | 0.001473 | 2.832 |
R-HSA-170834 | Signaling by TGF-beta Receptor Complex | 0.001638 | 2.786 |
R-HSA-447038 | NrCAM interactions | 0.003018 | 2.520 |
R-HSA-8935964 | RUNX1 regulates expression of components of tight junctions | 0.003913 | 2.407 |
R-HSA-1592230 | Mitochondrial biogenesis | 0.004214 | 2.375 |
R-HSA-2151201 | Transcriptional activation of mitochondrial biogenesis | 0.003794 | 2.421 |
R-HSA-9006936 | Signaling by TGFB family members | 0.004677 | 2.330 |
R-HSA-9670621 | Defective Inhibition of DNA Recombination at Telomere | 0.022595 | 1.646 |
R-HSA-9006821 | Alternative Lengthening of Telomeres (ALT) | 0.022595 | 1.646 |
R-HSA-9673013 | Diseases of Telomere Maintenance | 0.022595 | 1.646 |
R-HSA-9670615 | Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | 0.022595 | 1.646 |
R-HSA-9670613 | Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | 0.022595 | 1.646 |
R-HSA-5632968 | Defective Mismatch Repair Associated With MSH6 | 0.022595 | 1.646 |
R-HSA-2470946 | Cohesin Loading onto Chromatin | 0.006024 | 2.220 |
R-HSA-9673766 | Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | 0.055539 | 1.255 |
R-HSA-5368598 | Negative regulation of TCF-dependent signaling by DVL-interacting proteins | 0.055539 | 1.255 |
R-HSA-9944997 | Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | 0.055539 | 1.255 |
R-HSA-8941237 | Invadopodia formation | 0.055539 | 1.255 |
R-HSA-9944971 | Loss of Function of KMT2D in Kabuki Syndrome | 0.055539 | 1.255 |
R-HSA-1306955 | GRB7 events in ERBB2 signaling | 0.066273 | 1.179 |
R-HSA-2468052 | Establishment of Sister Chromatid Cohesion | 0.009955 | 2.002 |
R-HSA-9673768 | Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | 0.076886 | 1.114 |
R-HSA-8985586 | SLIT2:ROBO1 increases RHOA activity | 0.087379 | 1.059 |
R-HSA-9017802 | Noncanonical activation of NOTCH3 | 0.087379 | 1.059 |
R-HSA-9022537 | Loss of MECP2 binding ability to the NCoR/SMRT complex | 0.087379 | 1.059 |
R-HSA-426486 | Small interfering RNA (siRNA) biogenesis | 0.097753 | 1.010 |
R-HSA-9732724 | IFNG signaling activates MAPKs | 0.108010 | 0.967 |
R-HSA-9768778 | Regulation of NPAS4 mRNA translation | 0.118150 | 0.928 |
R-HSA-9709603 | Impaired BRCA2 binding to PALB2 | 0.031273 | 1.505 |
R-HSA-9020958 | Interleukin-21 signaling | 0.128177 | 0.892 |
R-HSA-201688 | WNT mediated activation of DVL | 0.128177 | 0.892 |
R-HSA-9701193 | Defective homologous recombination repair (HRR) due to PALB2 loss of function | 0.033684 | 1.473 |
R-HSA-9704646 | Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of... | 0.033684 | 1.473 |
R-HSA-9704331 | Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of... | 0.033684 | 1.473 |
R-HSA-9701192 | Defective homologous recombination repair (HRR) due to BRCA1 loss of function | 0.033684 | 1.473 |
R-HSA-451308 | Activation of Ca-permeable Kainate Receptor | 0.138089 | 0.860 |
R-HSA-9759811 | Regulation of CDH11 mRNA translation by microRNAs | 0.147890 | 0.830 |
R-HSA-5693554 | Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SD... | 0.049561 | 1.305 |
R-HSA-9661069 | Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | 0.176632 | 0.753 |
R-HSA-9709570 | Impaired BRCA2 binding to RAD51 | 0.061357 | 1.212 |
R-HSA-72165 | mRNA Splicing - Minor Pathway | 0.024592 | 1.609 |
R-HSA-8847993 | ERBB2 Activates PTK6 Signaling | 0.185997 | 0.730 |
R-HSA-8948700 | Competing endogenous RNAs (ceRNAs) regulate PTEN translation | 0.195256 | 0.709 |
R-HSA-6785631 | ERBB2 Regulates Cell Motility | 0.195256 | 0.709 |
R-HSA-1362300 | Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL... | 0.204410 | 0.689 |
R-HSA-77595 | Processing of Intronless Pre-mRNAs | 0.213460 | 0.671 |
R-HSA-159231 | Transport of Mature mRNA Derived from an Intronless Transcript | 0.097858 | 1.009 |
R-HSA-159234 | Transport of Mature mRNAs Derived from Intronless Transcripts | 0.101425 | 0.994 |
R-HSA-6802952 | Signaling by BRAF and RAF1 fusions | 0.052054 | 1.284 |
R-HSA-9909620 | Regulation of PD-L1(CD274) translation | 0.248650 | 0.604 |
R-HSA-1362277 | Transcription of E2F targets under negative control by DREAM complex | 0.248650 | 0.604 |
R-HSA-202040 | G-protein activation | 0.257199 | 0.590 |
R-HSA-606279 | Deposition of new CENPA-containing nucleosomes at the centromere | 0.123534 | 0.908 |
R-HSA-774815 | Nucleosome assembly | 0.123534 | 0.908 |
R-HSA-438066 | Unblocking of NMDA receptors, glutamate binding and activation | 0.265652 | 0.576 |
R-HSA-76066 | RNA Polymerase III Transcription Initiation From Type 2 Promoter | 0.265652 | 0.576 |
R-HSA-442982 | Ras activation upon Ca2+ influx through NMDA receptor | 0.265652 | 0.576 |
R-HSA-912526 | Interleukin receptor SHC signaling | 0.282273 | 0.549 |
R-HSA-72163 | mRNA Splicing - Major Pathway | 0.011835 | 1.927 |
R-HSA-141444 | Amplification of signal from unattached kinetochores via a MAD2 inhibitory si... | 0.093885 | 1.027 |
R-HSA-141424 | Amplification of signal from the kinetochores | 0.093885 | 1.027 |
R-HSA-72172 | mRNA Splicing | 0.015193 | 1.818 |
R-HSA-445095 | Interaction between L1 and Ankyrins | 0.314399 | 0.503 |
R-HSA-1989781 | PPARA activates gene expression | 0.049619 | 1.304 |
R-HSA-5619107 | Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC... | 0.337551 | 0.472 |
R-HSA-8957275 | Post-translational protein phosphorylation | 0.129948 | 0.886 |
R-HSA-5578749 | Transcriptional regulation by small RNAs | 0.232607 | 0.633 |
R-HSA-400206 | Regulation of lipid metabolism by PPARalpha | 0.051634 | 1.287 |
R-HSA-72203 | Processing of Capped Intron-Containing Pre-mRNA | 0.007904 | 2.102 |
R-HSA-72202 | Transport of Mature Transcript to Cytoplasm | 0.274708 | 0.561 |
R-HSA-8943723 | Regulation of PTEN mRNA translation | 0.282273 | 0.549 |
R-HSA-5693607 | Processing of DNA double-strand break ends | 0.270494 | 0.568 |
R-HSA-4641258 | Degradation of DVL | 0.090836 | 1.042 |
R-HSA-9656223 | Signaling by RAF1 mutants | 0.108665 | 0.964 |
R-HSA-9664873 | Pexophagy | 0.138089 | 0.860 |
R-HSA-8854691 | Interleukin-20 family signaling | 0.282273 | 0.549 |
R-HSA-8983432 | Interleukin-15 signaling | 0.167160 | 0.777 |
R-HSA-9917777 | Epigenetic regulation by WDR5-containing histone modifying complexes | 0.048630 | 1.313 |
R-HSA-912694 | Regulation of IFNA/IFNB signaling | 0.274010 | 0.562 |
R-HSA-76061 | RNA Polymerase III Transcription Initiation From Type 1 Promoter | 0.274010 | 0.562 |
R-HSA-6804757 | Regulation of TP53 Degradation | 0.013591 | 1.867 |
R-HSA-191650 | Regulation of gap junction activity | 0.066273 | 1.179 |
R-HSA-6788467 | IL-6-type cytokine receptor ligand interactions | 0.176632 | 0.753 |
R-HSA-9649948 | Signaling downstream of RAS mutants | 0.127325 | 0.895 |
R-HSA-6802955 | Paradoxical activation of RAF signaling by kinase inactive BRAF | 0.127325 | 0.895 |
R-HSA-6802946 | Signaling by moderate kinase activity BRAF mutants | 0.127325 | 0.895 |
R-HSA-9674555 | Signaling by CSF3 (G-CSF) | 0.329922 | 0.482 |
R-HSA-6783589 | Interleukin-6 family signaling | 0.290442 | 0.537 |
R-HSA-9931509 | Expression of BMAL (ARNTL), CLOCK, and NPAS2 | 0.016232 | 1.790 |
R-HSA-1059683 | Interleukin-6 signaling | 0.176632 | 0.753 |
R-HSA-5358565 | Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | 0.222408 | 0.653 |
R-HSA-5693537 | Resolution of D-Loop Structures | 0.077277 | 1.112 |
R-HSA-426496 | Post-transcriptional silencing by small RNAs | 0.076886 | 1.114 |
R-HSA-9764562 | Regulation of CDH1 mRNA translation by microRNAs | 0.185997 | 0.730 |
R-HSA-5693568 | Resolution of D-loop Structures through Holliday Junction Intermediates | 0.073997 | 1.131 |
R-HSA-5685938 | HDR through Single Strand Annealing (SSA) | 0.073997 | 1.131 |
R-HSA-9664420 | Killing mechanisms | 0.204410 | 0.689 |
R-HSA-9673324 | WNT5:FZD7-mediated leishmania damping | 0.204410 | 0.689 |
R-HSA-434316 | Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | 0.204410 | 0.689 |
R-HSA-6802948 | Signaling by high-kinase activity BRAF mutants | 0.090836 | 1.042 |
R-HSA-8953750 | Transcriptional Regulation by E2F6 | 0.097858 | 1.009 |
R-HSA-5674135 | MAP2K and MAPK activation | 0.108665 | 0.964 |
R-HSA-1250196 | SHC1 events in ERBB2 signaling | 0.337551 | 0.472 |
R-HSA-6806003 | Regulation of TP53 Expression and Degradation | 0.016232 | 1.790 |
R-HSA-6802957 | Oncogenic MAPK signaling | 0.091649 | 1.038 |
R-HSA-9020558 | Interleukin-2 signaling | 0.147890 | 0.830 |
R-HSA-1500620 | Meiosis | 0.287343 | 0.542 |
R-HSA-2500257 | Resolution of Sister Chromatid Cohesion | 0.020131 | 1.696 |
R-HSA-76046 | RNA Polymerase III Transcription Initiation | 0.337551 | 0.472 |
R-HSA-5693532 | DNA Double-Strand Break Repair | 0.310784 | 0.508 |
R-HSA-9703465 | Signaling by FLT3 fusion proteins | 0.306504 | 0.514 |
R-HSA-9675126 | Diseases of mitotic cell cycle | 0.070763 | 1.150 |
R-HSA-3214815 | HDACs deacetylate histones | 0.036286 | 1.440 |
R-HSA-69541 | Stabilization of p53 | 0.097858 | 1.009 |
R-HSA-6807878 | COPI-mediated anterograde transport | 0.035234 | 1.453 |
R-HSA-5685942 | HDR through Homologous Recombination (HRR) | 0.211699 | 0.674 |
R-HSA-8984722 | Interleukin-35 Signalling | 0.167160 | 0.777 |
R-HSA-399997 | Acetylcholine regulates insulin secretion | 0.213460 | 0.671 |
R-HSA-418592 | ADP signalling through P2Y purinoceptor 1 | 0.290442 | 0.537 |
R-HSA-4641262 | Disassembly of the destruction complex and recruitment of AXIN to the membrane | 0.314399 | 0.503 |
R-HSA-69618 | Mitotic Spindle Checkpoint | 0.135084 | 0.869 |
R-HSA-9675136 | Diseases of DNA Double-Strand Break Repair | 0.080603 | 1.094 |
R-HSA-6802949 | Signaling by RAS mutants | 0.127325 | 0.895 |
R-HSA-9705462 | Inactivation of CSF3 (G-CSF) signaling | 0.265652 | 0.576 |
R-HSA-6811440 | Retrograde transport at the Trans-Golgi-Network | 0.025772 | 1.589 |
R-HSA-8985947 | Interleukin-9 signaling | 0.118150 | 0.928 |
R-HSA-212165 | Epigenetic regulation of gene expression | 0.200587 | 0.698 |
R-HSA-5632928 | Defective Mismatch Repair Associated With MSH2 | 0.033702 | 1.472 |
R-HSA-9705677 | SARS-CoV-2 targets PDZ proteins in cell-cell junction | 0.066273 | 1.179 |
R-HSA-8866376 | Reelin signalling pathway | 0.076886 | 1.114 |
R-HSA-68884 | Mitotic Telophase/Cytokinesis | 0.013057 | 1.884 |
R-HSA-8875656 | MET receptor recycling | 0.118150 | 0.928 |
R-HSA-190873 | Gap junction degradation | 0.128177 | 0.892 |
R-HSA-9014325 | TICAM1,TRAF6-dependent induction of TAK1 complex | 0.138089 | 0.860 |
R-HSA-451306 | Ionotropic activity of kainate receptors | 0.147890 | 0.830 |
R-HSA-1358803 | Downregulation of ERBB2:ERBB3 signaling | 0.167160 | 0.777 |
R-HSA-877312 | Regulation of IFNG signaling | 0.167160 | 0.777 |
R-HSA-9659787 | Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | 0.176632 | 0.753 |
R-HSA-937072 | TRAF6-mediated induction of TAK1 complex within TLR4 complex | 0.195256 | 0.709 |
R-HSA-9701190 | Defective homologous recombination repair (HRR) due to BRCA2 loss of function | 0.080603 | 1.094 |
R-HSA-350054 | Notch-HLH transcription pathway | 0.274010 | 0.562 |
R-HSA-400451 | Free fatty acids regulate insulin secretion | 0.282273 | 0.549 |
R-HSA-75067 | Processing of Capped Intronless Pre-mRNA | 0.290442 | 0.537 |
R-HSA-9839394 | TGFBR3 expression | 0.298519 | 0.525 |
R-HSA-8949613 | Cristae formation | 0.314399 | 0.503 |
R-HSA-191859 | snRNP Assembly | 0.178714 | 0.748 |
R-HSA-194441 | Metabolism of non-coding RNA | 0.178714 | 0.748 |
R-HSA-9925563 | Developmental Lineage of Pancreatic Ductal Cells | 0.220042 | 0.657 |
R-HSA-2219530 | Constitutive Signaling by Aberrant PI3K in Cancer | 0.333378 | 0.477 |
R-HSA-9664565 | Signaling by ERBB2 KD Mutants | 0.329922 | 0.482 |
R-HSA-9665686 | Signaling by ERBB2 TMD/JMD mutants | 0.290442 | 0.537 |
R-HSA-9020956 | Interleukin-27 signaling | 0.138089 | 0.860 |
R-HSA-8856688 | Golgi-to-ER retrograde transport | 0.240054 | 0.620 |
R-HSA-68877 | Mitotic Prometaphase | 0.097365 | 1.012 |
R-HSA-447043 | Neurofascin interactions | 0.097753 | 1.010 |
R-HSA-1839117 | Signaling by cytosolic FGFR1 fusion mutants | 0.231255 | 0.636 |
R-HSA-9620244 | Long-term potentiation | 0.298519 | 0.525 |
R-HSA-8863795 | Downregulation of ERBB2 signaling | 0.337551 | 0.472 |
R-HSA-6811442 | Intra-Golgi and retrograde Golgi-to-ER traffic | 0.041038 | 1.387 |
R-HSA-5358508 | Mismatch Repair | 0.231255 | 0.636 |
R-HSA-69563 | p53-Dependent G1 DNA Damage Response | 0.138858 | 0.857 |
R-HSA-69580 | p53-Dependent G1/S DNA damage checkpoint | 0.138858 | 0.857 |
R-HSA-1912408 | Pre-NOTCH Transcription and Translation | 0.316712 | 0.499 |
R-HSA-111448 | Activation of NOXA and translocation to mitochondria | 0.066273 | 1.179 |
R-HSA-139915 | Activation of PUMA and translocation to mitochondria | 0.108010 | 0.967 |
R-HSA-937042 | IRAK2 mediated activation of TAK1 complex | 0.128177 | 0.892 |
R-HSA-975163 | IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | 0.185997 | 0.730 |
R-HSA-5693579 | Homologous DNA Pairing and Strand Exchange | 0.094328 | 1.025 |
R-HSA-9707616 | Heme signaling | 0.047025 | 1.328 |
R-HSA-9648025 | EML4 and NUDC in mitotic spindle formation | 0.161752 | 0.791 |
R-HSA-1266695 | Interleukin-7 signaling | 0.298519 | 0.525 |
R-HSA-418889 | Caspase activation via Dependence Receptors in the absence of ligand | 0.128177 | 0.892 |
R-HSA-8849932 | Synaptic adhesion-like molecules | 0.231255 | 0.636 |
R-HSA-428930 | Thromboxane signalling through TP receptor | 0.290442 | 0.537 |
R-HSA-203927 | MicroRNA (miRNA) biogenesis | 0.298519 | 0.525 |
R-HSA-2467813 | Separation of Sister Chromatids | 0.059058 | 1.229 |
R-HSA-983695 | Antigen activates B Cell Receptor (BCR) leading to generation of second messenge... | 0.329222 | 0.483 |
R-HSA-5423599 | Diseases of Mismatch Repair (MMR) | 0.055539 | 1.255 |
R-HSA-9675151 | Disorders of Developmental Biology | 0.024479 | 1.611 |
R-HSA-112411 | MAPK1 (ERK2) activation | 0.128177 | 0.892 |
R-HSA-5693548 | Sensing of DNA Double Strand Breaks | 0.157580 | 0.802 |
R-HSA-9623433 | NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | 0.157580 | 0.802 |
R-HSA-113501 | Inhibition of replication initiation of damaged DNA by RB1/E2F1 | 0.157580 | 0.802 |
R-HSA-9913635 | Strand-asynchronous mitochondrial DNA replication | 0.240002 | 0.620 |
R-HSA-450321 | JNK (c-Jun kinases) phosphorylation and activation mediated by activated human ... | 0.257199 | 0.590 |
R-HSA-451326 | Activation of kainate receptors upon glutamate binding | 0.322205 | 0.492 |
R-HSA-9687139 | Aberrant regulation of mitotic cell cycle due to RB1 defects | 0.337551 | 0.472 |
R-HSA-9843745 | Adipogenesis | 0.089281 | 1.049 |
R-HSA-8934593 | Regulation of RUNX1 Expression and Activity | 0.306504 | 0.514 |
R-HSA-381340 | Transcriptional regulation of white adipocyte differentiation | 0.124885 | 0.903 |
R-HSA-5633007 | Regulation of TP53 Activity | 0.054745 | 1.262 |
R-HSA-5693571 | Nonhomologous End-Joining (NHEJ) | 0.134988 | 0.870 |
R-HSA-201681 | TCF dependent signaling in response to WNT | 0.083447 | 1.079 |
R-HSA-1257604 | PIP3 activates AKT signaling | 0.292666 | 0.534 |
R-HSA-9022692 | Regulation of MECP2 expression and activity | 0.073997 | 1.131 |
R-HSA-5693616 | Presynaptic phase of homologous DNA pairing and strand exchange | 0.083972 | 1.076 |
R-HSA-1963642 | PI3K events in ERBB2 signaling | 0.222408 | 0.653 |
R-HSA-6811436 | COPI-independent Golgi-to-ER retrograde traffic | 0.162546 | 0.789 |
R-HSA-193648 | NRAGE signals death through JNK | 0.166563 | 0.778 |
R-HSA-5684996 | MAPK1/MAPK3 signaling | 0.294870 | 0.530 |
R-HSA-5673001 | RAF/MAP kinase cascade | 0.279505 | 0.554 |
R-HSA-69615 | G1/S DNA Damage Checkpoints | 0.195116 | 0.710 |
R-HSA-199991 | Membrane Trafficking | 0.044539 | 1.351 |
R-HSA-2559585 | Oncogene Induced Senescence | 0.083972 | 1.076 |
R-HSA-447115 | Interleukin-12 family signaling | 0.098424 | 1.007 |
R-HSA-69620 | Cell Cycle Checkpoints | 0.100962 | 0.996 |
R-HSA-879415 | Advanced glycosylation endproduct receptor signaling | 0.014746 | 1.831 |
R-HSA-399719 | Trafficking of AMPA receptors | 0.009098 | 2.041 |
R-HSA-110056 | MAPK3 (ERK1) activation | 0.138089 | 0.860 |
R-HSA-2173796 | SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | 0.014442 | 1.840 |
R-HSA-8875360 | InlB-mediated entry of Listeria monocytogenes into host cell | 0.195256 | 0.709 |
R-HSA-113510 | E2F mediated regulation of DNA replication | 0.240002 | 0.620 |
R-HSA-9617324 | Negative regulation of NMDA receptor-mediated neuronal transmission | 0.265652 | 0.576 |
R-HSA-9029569 | NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflu... | 0.174648 | 0.758 |
R-HSA-69473 | G2/M DNA damage checkpoint | 0.241009 | 0.618 |
R-HSA-983705 | Signaling by the B Cell Receptor (BCR) | 0.326329 | 0.486 |
R-HSA-1640170 | Cell Cycle | 0.076234 | 1.118 |
R-HSA-5653656 | Vesicle-mediated transport | 0.155605 | 0.808 |
R-HSA-3214841 | PKMTs methylate histone lysines | 0.105028 | 0.979 |
R-HSA-1227990 | Signaling by ERBB2 in Cancer | 0.337551 | 0.472 |
R-HSA-6787450 | tRNA modification in the mitochondrion | 0.213460 | 0.671 |
R-HSA-8953854 | Metabolism of RNA | 0.182606 | 0.738 |
R-HSA-3858494 | Beta-catenin independent WNT signaling | 0.255241 | 0.593 |
R-HSA-2173788 | Downregulation of TGF-beta receptor signaling | 0.041332 | 1.384 |
R-HSA-114452 | Activation of BH3-only proteins | 0.337551 | 0.472 |
R-HSA-73886 | Chromosome Maintenance | 0.201420 | 0.696 |
R-HSA-157858 | Gap junction trafficking and regulation | 0.138858 | 0.857 |
R-HSA-9675135 | Diseases of DNA repair | 0.024592 | 1.609 |
R-HSA-5683057 | MAPK family signaling cascades | 0.244264 | 0.612 |
R-HSA-195721 | Signaling by WNT | 0.074086 | 1.130 |
R-HSA-447041 | CHL1 interactions | 0.108010 | 0.967 |
R-HSA-9645460 | Alpha-protein kinase 1 signaling pathway | 0.147890 | 0.830 |
R-HSA-5682910 | LGI-ADAM interactions | 0.147890 | 0.830 |
R-HSA-9005891 | Loss of function of MECP2 in Rett syndrome | 0.167160 | 0.777 |
R-HSA-9005895 | Pervasive developmental disorders | 0.167160 | 0.777 |
R-HSA-9697154 | Disorders of Nervous System Development | 0.167160 | 0.777 |
R-HSA-1483148 | Synthesis of PG | 0.213460 | 0.671 |
R-HSA-9824594 | Regulation of MITF-M-dependent genes involved in apoptosis | 0.257199 | 0.590 |
R-HSA-450302 | activated TAK1 mediates p38 MAPK activation | 0.265652 | 0.576 |
R-HSA-5357956 | TNFR1-induced NF-kappa-B signaling pathway | 0.314399 | 0.503 |
R-HSA-9837999 | Mitochondrial protein degradation | 0.117429 | 0.930 |
R-HSA-3214847 | HATs acetylate histones | 0.132507 | 0.878 |
R-HSA-9024446 | NR1H2 and NR1H3-mediated signaling | 0.253636 | 0.596 |
R-HSA-456926 | Thrombin signalling through proteinase activated receptors (PARs) | 0.337551 | 0.472 |
R-HSA-1169408 | ISG15 antiviral mechanism | 0.245215 | 0.610 |
R-HSA-2173795 | Downregulation of SMAD2/3:SMAD4 transcriptional activity | 0.070763 | 1.150 |
R-HSA-4086398 | Ca2+ pathway | 0.236806 | 0.626 |
R-HSA-6804114 | TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | 0.213460 | 0.671 |
R-HSA-9768759 | Regulation of NPAS4 gene expression | 0.222408 | 0.653 |
R-HSA-9909396 | Circadian clock | 0.028385 | 1.547 |
R-HSA-199977 | ER to Golgi Anterograde Transport | 0.121829 | 0.914 |
R-HSA-6796648 | TP53 Regulates Transcription of DNA Repair Genes | 0.076649 | 1.115 |
R-HSA-5357769 | Caspase activation via extrinsic apoptotic signalling pathway | 0.306504 | 0.514 |
R-HSA-1852241 | Organelle biogenesis and maintenance | 0.042778 | 1.369 |
R-HSA-6804760 | Regulation of TP53 Activity through Methylation | 0.028934 | 1.539 |
R-HSA-9671555 | Signaling by PDGFR in disease | 0.038715 | 1.412 |
R-HSA-6807004 | Negative regulation of MET activity | 0.248650 | 0.604 |
R-HSA-112409 | RAF-independent MAPK1/3 activation | 0.274010 | 0.562 |
R-HSA-8876384 | Listeria monocytogenes entry into host cells | 0.265652 | 0.576 |
R-HSA-1236394 | Signaling by ERBB4 | 0.068613 | 1.164 |
R-HSA-6804756 | Regulation of TP53 Activity through Phosphorylation | 0.096144 | 1.017 |
R-HSA-201722 | Formation of the beta-catenin:TCF transactivating complex | 0.174648 | 0.758 |
R-HSA-8878171 | Transcriptional regulation by RUNX1 | 0.310160 | 0.508 |
R-HSA-3700989 | Transcriptional Regulation by TP53 | 0.106948 | 0.971 |
R-HSA-5663202 | Diseases of signal transduction by growth factor receptors and second messengers | 0.009099 | 2.041 |
R-HSA-9830674 | Formation of the ureteric bud | 0.044013 | 1.356 |
R-HSA-3769402 | Deactivation of the beta-catenin transactivating complex | 0.014442 | 1.840 |
R-HSA-9931295 | PD-L1(CD274) glycosylation and translocation to plasma membrane | 0.257199 | 0.590 |
R-HSA-9759475 | Regulation of CDH11 Expression and Function | 0.329922 | 0.482 |
R-HSA-9662360 | Sensory processing of sound by inner hair cells of the cochlea | 0.215867 | 0.666 |
R-HSA-8876198 | RAB GEFs exchange GTP for GDP on RABs | 0.291550 | 0.535 |
R-HSA-9679191 | Potential therapeutics for SARS | 0.127692 | 0.894 |
R-HSA-2173789 | TGF-beta receptor signaling activates SMADs | 0.116038 | 0.935 |
R-HSA-9018519 | Estrogen-dependent gene expression | 0.032056 | 1.494 |
R-HSA-9856649 | Transcriptional and post-translational regulation of MITF-M expression and activ... | 0.228413 | 0.641 |
R-HSA-9013507 | NOTCH3 Activation and Transmission of Signal to the Nucleus | 0.274010 | 0.562 |
R-HSA-3247509 | Chromatin modifying enzymes | 0.009322 | 2.030 |
R-HSA-157118 | Signaling by NOTCH | 0.178464 | 0.748 |
R-HSA-204998 | Cell death signalling via NRAGE, NRIF and NADE | 0.236806 | 0.626 |
R-HSA-948021 | Transport to the Golgi and subsequent modification | 0.247122 | 0.607 |
R-HSA-9007101 | Rab regulation of trafficking | 0.189848 | 0.722 |
R-HSA-399721 | Glutamate binding, activation of AMPA receptors and synaptic plasticity | 0.010480 | 1.980 |
R-HSA-198323 | AKT phosphorylates targets in the cytosol | 0.167160 | 0.777 |
R-HSA-9683610 | Maturation of nucleoprotein | 0.176632 | 0.753 |
R-HSA-9006931 | Signaling by Nuclear Receptors | 0.274822 | 0.561 |
R-HSA-9705671 | SARS-CoV-2 activates/modulates innate and adaptive immune responses | 0.276717 | 0.558 |
R-HSA-4839726 | Chromatin organization | 0.012801 | 1.893 |
R-HSA-9705683 | SARS-CoV-2-host interactions | 0.315288 | 0.501 |
R-HSA-140875 | Common Pathway of Fibrin Clot Formation | 0.248650 | 0.604 |
R-HSA-351906 | Apoptotic cleavage of cell adhesion proteins | 0.118150 | 0.928 |
R-HSA-200425 | Carnitine shuttle | 0.282273 | 0.549 |
R-HSA-162582 | Signal Transduction | 0.106784 | 0.971 |
R-HSA-9725370 | Signaling by ALK fusions and activated point mutants | 0.048636 | 1.313 |
R-HSA-2122948 | Activated NOTCH1 Transmits Signal to the Nucleus | 0.306504 | 0.514 |
R-HSA-2219528 | PI3K/AKT Signaling in Cancer | 0.192725 | 0.715 |
R-HSA-68882 | Mitotic Anaphase | 0.135156 | 0.869 |
R-HSA-2555396 | Mitotic Metaphase and Anaphase | 0.136857 | 0.864 |
R-HSA-8986944 | Transcriptional Regulation by MECP2 | 0.316712 | 0.499 |
R-HSA-69242 | S Phase | 0.295266 | 0.530 |
R-HSA-9020591 | Interleukin-12 signaling | 0.072581 | 1.139 |
R-HSA-9634815 | Transcriptional Regulation by NPAS4 | 0.032121 | 1.493 |
R-HSA-9700206 | Signaling by ALK in cancer | 0.048636 | 1.313 |
R-HSA-8939211 | ESR-mediated signaling | 0.172783 | 0.762 |
R-HSA-373753 | Nephrin family interactions | 0.248650 | 0.604 |
R-HSA-1980143 | Signaling by NOTCH1 | 0.249425 | 0.603 |
R-HSA-9659379 | Sensory processing of sound | 0.262064 | 0.582 |
R-HSA-9694631 | Maturation of nucleoprotein | 0.240002 | 0.620 |
R-HSA-2426168 | Activation of gene expression by SREBF (SREBP) | 0.195116 | 0.710 |
R-HSA-381426 | Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-l... | 0.178458 | 0.748 |
R-HSA-1660499 | Synthesis of PIPs at the plasma membrane | 0.190997 | 0.719 |
R-HSA-9730414 | MITF-M-regulated melanocyte development | 0.277081 | 0.557 |
R-HSA-6803207 | TP53 Regulates Transcription of Caspase Activators and Caspases | 0.204410 | 0.689 |
R-HSA-449836 | Other interleukin signaling | 0.240002 | 0.620 |
R-HSA-6806834 | Signaling by MET | 0.266279 | 0.575 |
R-HSA-1655829 | Regulation of cholesterol biosynthesis by SREBP (SREBF) | 0.262064 | 0.582 |
R-HSA-9768919 | NPAS4 regulates expression of target genes | 0.080603 | 1.094 |
R-HSA-1368108 | BMAL1:CLOCK,NPAS2 activates circadian expression | 0.080603 | 1.094 |
R-HSA-5674400 | Constitutive Signaling by AKT1 E17K in Cancer | 0.282273 | 0.549 |
R-HSA-9707564 | Cytoprotection by HMOX1 | 0.087246 | 1.059 |
R-HSA-3371497 | HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of lig... | 0.215867 | 0.666 |
R-HSA-6803204 | TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | 0.314399 | 0.503 |
R-HSA-9830369 | Kidney development | 0.211699 | 0.674 |
R-HSA-9758941 | Gastrulation | 0.125724 | 0.901 |
R-HSA-2028269 | Signaling by Hippo | 0.222408 | 0.653 |
R-HSA-8950505 | Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulati... | 0.203388 | 0.692 |
R-HSA-73887 | Death Receptor Signaling | 0.313892 | 0.503 |
R-HSA-9679506 | SARS-CoV Infections | 0.338067 | 0.471 |
R-HSA-109581 | Apoptosis | 0.338766 | 0.470 |
R-HSA-1855196 | IP3 and IP4 transport between cytosol and nucleus | 0.345095 | 0.462 |
R-HSA-1855229 | IP6 and IP7 transport between cytosol and nucleus | 0.345095 | 0.462 |
R-HSA-162588 | Budding and maturation of HIV virion | 0.345095 | 0.462 |
R-HSA-182971 | EGFR downregulation | 0.345095 | 0.462 |
R-HSA-9913351 | Formation of the dystrophin-glycoprotein complex (DGC) | 0.345095 | 0.462 |
R-HSA-9833109 | Evasion by RSV of host interferon responses | 0.345095 | 0.462 |
R-HSA-1538133 | G0 and Early G1 | 0.352553 | 0.453 |
R-HSA-111465 | Apoptotic cleavage of cellular proteins | 0.352553 | 0.453 |
R-HSA-422356 | Regulation of insulin secretion | 0.354044 | 0.451 |
R-HSA-69278 | Cell Cycle, Mitotic | 0.356937 | 0.447 |
R-HSA-193704 | p75 NTR receptor-mediated signalling | 0.358151 | 0.446 |
R-HSA-1855170 | IPs transport between nucleus and cytosol | 0.359926 | 0.444 |
R-HSA-159227 | Transport of the SLBP independent Mature mRNA | 0.359926 | 0.444 |
R-HSA-442742 | CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | 0.359926 | 0.444 |
R-HSA-1839124 | FGFR1 mutant receptor activation | 0.359926 | 0.444 |
R-HSA-9764260 | Regulation of Expression and Function of Type II Classical Cadherins | 0.359926 | 0.444 |
R-HSA-6804758 | Regulation of TP53 Activity through Acetylation | 0.359926 | 0.444 |
R-HSA-69273 | Cyclin A/B1/B2 associated events during G2/M transition | 0.359926 | 0.444 |
R-HSA-72306 | tRNA processing | 0.366685 | 0.436 |
R-HSA-159230 | Transport of the SLBP Dependant Mature mRNA | 0.367216 | 0.435 |
R-HSA-170822 | Regulation of Glucokinase by Glucokinase Regulatory Protein | 0.367216 | 0.435 |
R-HSA-2559580 | Oxidative Stress Induced Senescence | 0.370415 | 0.431 |
R-HSA-3371453 | Regulation of HSF1-mediated heat shock response | 0.370415 | 0.431 |
R-HSA-1483255 | PI Metabolism | 0.370415 | 0.431 |
R-HSA-9909648 | Regulation of PD-L1(CD274) expression | 0.372867 | 0.428 |
R-HSA-5673000 | RAF activation | 0.374423 | 0.427 |
R-HSA-392518 | Signal amplification | 0.374423 | 0.427 |
R-HSA-180746 | Nuclear import of Rev protein | 0.374423 | 0.427 |
R-HSA-168638 | NOD1/2 Signaling Pathway | 0.374423 | 0.427 |
R-HSA-349425 | Autodegradation of the E3 ubiquitin ligase COP1 | 0.374423 | 0.427 |
R-HSA-6814122 | Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | 0.374423 | 0.427 |
R-HSA-5689880 | Ub-specific processing proteases | 0.375954 | 0.425 |
R-HSA-8856825 | Cargo recognition for clathrin-mediated endocytosis | 0.378540 | 0.422 |
R-HSA-3301854 | Nuclear Pore Complex (NPC) Disassembly | 0.381549 | 0.418 |
R-HSA-9860927 | Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZ... | 0.381549 | 0.418 |
R-HSA-5619507 | Activation of HOX genes during differentiation | 0.382586 | 0.417 |
R-HSA-5617472 | Activation of anterior HOX genes in hindbrain development during early embryogen... | 0.382586 | 0.417 |
R-HSA-5688426 | Deubiquitination | 0.384877 | 0.415 |
R-HSA-69205 | G1/S-Specific Transcription | 0.388594 | 0.411 |
R-HSA-74158 | RNA Polymerase III Transcription | 0.388594 | 0.411 |
R-HSA-749476 | RNA Polymerase III Abortive And Retractive Initiation | 0.388594 | 0.411 |
R-HSA-9682385 | FLT3 signaling in disease | 0.388594 | 0.411 |
R-HSA-140877 | Formation of Fibrin Clot (Clotting Cascade) | 0.388594 | 0.411 |
R-HSA-211000 | Gene Silencing by RNA | 0.394657 | 0.404 |
R-HSA-180910 | Vpr-mediated nuclear import of PICs | 0.395559 | 0.403 |
R-HSA-5689896 | Ovarian tumor domain proteases | 0.395559 | 0.403 |
R-HSA-2559583 | Cellular Senescence | 0.397470 | 0.401 |
R-HSA-9006925 | Intracellular signaling by second messengers | 0.398081 | 0.400 |
R-HSA-6785470 | tRNA processing in the mitochondrion | 0.402445 | 0.395 |
R-HSA-165054 | Rev-mediated nuclear export of HIV RNA | 0.402445 | 0.395 |
R-HSA-168276 | NS1 Mediated Effects on Host Pathways | 0.409254 | 0.388 |
R-HSA-9694516 | SARS-CoV-2 Infection | 0.413834 | 0.383 |
R-HSA-9670095 | Inhibition of DNA recombination at telomere | 0.415985 | 0.381 |
R-HSA-451927 | Interleukin-2 family signaling | 0.415985 | 0.381 |
R-HSA-427389 | ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | 0.415985 | 0.381 |
R-HSA-9844594 | Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | 0.415985 | 0.381 |
R-HSA-9843743 | Transcriptional regulation of brown and beige adipocyte differentiation | 0.415985 | 0.381 |
R-HSA-177243 | Interactions of Rev with host cellular proteins | 0.415985 | 0.381 |
R-HSA-176033 | Interactions of Vpr with host cellular proteins | 0.415985 | 0.381 |
R-HSA-8941858 | Regulation of RUNX3 expression and activity | 0.415985 | 0.381 |
R-HSA-1251985 | Nuclear signaling by ERBB4 | 0.415985 | 0.381 |
R-HSA-8868766 | rRNA processing in the mitochondrion | 0.415985 | 0.381 |
R-HSA-1912422 | Pre-NOTCH Expression and Processing | 0.418470 | 0.378 |
R-HSA-74160 | Gene expression (Transcription) | 0.421600 | 0.375 |
R-HSA-5693567 | HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | 0.422394 | 0.374 |
R-HSA-9820841 | M-decay: degradation of maternal mRNAs by maternally stored factors | 0.422639 | 0.374 |
R-HSA-168271 | Transport of Ribonucleoproteins into the Host Nucleus | 0.422639 | 0.374 |
R-HSA-5655302 | Signaling by FGFR1 in disease | 0.429219 | 0.367 |
R-HSA-5675221 | Negative regulation of MAPK pathway | 0.429219 | 0.367 |
R-HSA-9609736 | Assembly and cell surface presentation of NMDA receptors | 0.429219 | 0.367 |
R-HSA-6811438 | Intra-Golgi traffic | 0.429219 | 0.367 |
R-HSA-9683701 | Translation of Structural Proteins | 0.429219 | 0.367 |
R-HSA-6785807 | Interleukin-4 and Interleukin-13 signaling | 0.433863 | 0.363 |
R-HSA-212436 | Generic Transcription Pathway | 0.435090 | 0.361 |
R-HSA-379716 | Cytosolic tRNA aminoacylation | 0.435724 | 0.361 |
R-HSA-73762 | RNA Polymerase I Transcription Initiation | 0.435724 | 0.361 |
R-HSA-512988 | Interleukin-3, Interleukin-5 and GM-CSF signaling | 0.435724 | 0.361 |
R-HSA-381676 | Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | 0.435724 | 0.361 |
R-HSA-373760 | L1CAM interactions | 0.437950 | 0.359 |
R-HSA-8854214 | TBC/RABGAPs | 0.442155 | 0.354 |
R-HSA-5693538 | Homology Directed Repair | 0.445643 | 0.351 |
R-HSA-69236 | G1 Phase | 0.448513 | 0.348 |
R-HSA-69231 | Cyclin D associated events in G1 | 0.448513 | 0.348 |
R-HSA-190828 | Gap junction trafficking | 0.448513 | 0.348 |
R-HSA-168333 | NEP/NS2 Interacts with the Cellular Export Machinery | 0.454799 | 0.342 |
R-HSA-9824585 | Regulation of MITF-M-dependent genes involved in pigmentation | 0.454799 | 0.342 |
R-HSA-3371556 | Cellular response to heat stress | 0.457073 | 0.340 |
R-HSA-389948 | Co-inhibition by PD-1 | 0.457681 | 0.339 |
R-HSA-168274 | Export of Viral Ribonucleoproteins from Nucleus | 0.461014 | 0.336 |
R-HSA-9839373 | Signaling by TGFBR3 | 0.461014 | 0.336 |
R-HSA-2514859 | Inactivation, recovery and regulation of the phototransduction cascade | 0.461014 | 0.336 |
R-HSA-75153 | Apoptotic execution phase | 0.461014 | 0.336 |
R-HSA-6811558 | PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | 0.464618 | 0.333 |
R-HSA-2132295 | MHC class II antigen presentation | 0.464618 | 0.333 |
R-HSA-445989 | TAK1-dependent IKK and NF-kappa-B activation | 0.467158 | 0.331 |
R-HSA-5620924 | Intraflagellar transport | 0.473232 | 0.325 |
R-HSA-9725371 | Nuclear events stimulated by ALK signaling in cancer | 0.473232 | 0.325 |
R-HSA-5357801 | Programmed Cell Death | 0.475268 | 0.323 |
R-HSA-9841922 | MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesi... | 0.475819 | 0.323 |
R-HSA-9851695 | Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | 0.475819 | 0.323 |
R-HSA-9818564 | Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | 0.475819 | 0.323 |
R-HSA-9766229 | Degradation of CDH1 | 0.479238 | 0.319 |
R-HSA-2122947 | NOTCH1 Intracellular Domain Regulates Transcription | 0.479238 | 0.319 |
R-HSA-69481 | G2/M Checkpoints | 0.483207 | 0.316 |
R-HSA-68886 | M Phase | 0.489112 | 0.311 |
R-HSA-912446 | Meiotic recombination | 0.491046 | 0.309 |
R-HSA-1169091 | Activation of NF-kappaB in B cells | 0.491046 | 0.309 |
R-HSA-70895 | Branched-chain amino acid catabolism | 0.491046 | 0.309 |
R-HSA-2514856 | The phototransduction cascade | 0.491046 | 0.309 |
R-HSA-199418 | Negative regulation of the PI3K/AKT network | 0.494169 | 0.306 |
R-HSA-112314 | Neurotransmitter receptors and postsynaptic signal transmission | 0.495452 | 0.305 |
R-HSA-73857 | RNA Polymerase II Transcription | 0.496591 | 0.304 |
R-HSA-72187 | mRNA 3'-end processing | 0.496850 | 0.304 |
R-HSA-6794361 | Neurexins and neuroligins | 0.496850 | 0.304 |
R-HSA-1474165 | Reproduction | 0.497791 | 0.303 |
R-HSA-1221632 | Meiotic synapsis | 0.502588 | 0.299 |
R-HSA-432722 | Golgi Associated Vesicle Biogenesis | 0.502588 | 0.299 |
R-HSA-445355 | Smooth Muscle Contraction | 0.502588 | 0.299 |
R-HSA-9012852 | Signaling by NOTCH3 | 0.513869 | 0.289 |
R-HSA-177929 | Signaling by EGFR | 0.519414 | 0.284 |
R-HSA-109606 | Intrinsic Pathway for Apoptosis | 0.519414 | 0.284 |
R-HSA-75893 | TNF signaling | 0.519414 | 0.284 |
R-HSA-163685 | Integration of energy metabolism | 0.522675 | 0.282 |
R-HSA-9764561 | Regulation of CDH1 Function | 0.524896 | 0.280 |
R-HSA-2980766 | Nuclear Envelope Breakdown | 0.524896 | 0.280 |
R-HSA-6791312 | TP53 Regulates Transcription of Cell Cycle Genes | 0.524896 | 0.280 |
R-HSA-6807070 | PTEN Regulation | 0.533086 | 0.273 |
R-HSA-5693565 | Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at... | 0.535674 | 0.271 |
R-HSA-9664407 | Parasite infection | 0.536521 | 0.270 |
R-HSA-9664422 | FCGR3A-mediated phagocytosis | 0.536521 | 0.270 |
R-HSA-9664417 | Leishmania phagocytosis | 0.536521 | 0.270 |
R-HSA-2029482 | Regulation of actin dynamics for phagocytic cup formation | 0.539940 | 0.268 |
R-HSA-9845323 | Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | 0.540972 | 0.267 |
R-HSA-1227986 | Signaling by ERBB2 | 0.540972 | 0.267 |
R-HSA-8873719 | RAB geranylgeranylation | 0.540972 | 0.267 |
R-HSA-379724 | tRNA Aminoacylation | 0.540972 | 0.267 |
R-HSA-8943724 | Regulation of PTEN gene transcription | 0.540972 | 0.267 |
R-HSA-2894858 | Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | 0.540972 | 0.267 |
R-HSA-2644602 | Signaling by NOTCH1 PEST Domain Mutants in Cancer | 0.540972 | 0.267 |
R-HSA-2894862 | Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | 0.540972 | 0.267 |
R-HSA-2644606 | Constitutive Signaling by NOTCH1 PEST Domain Mutants | 0.540972 | 0.267 |
R-HSA-2644603 | Signaling by NOTCH1 in Cancer | 0.540972 | 0.267 |
R-HSA-73856 | RNA Polymerase II Transcription Termination | 0.546209 | 0.263 |
R-HSA-168325 | Viral Messenger RNA Synthesis | 0.546209 | 0.263 |
R-HSA-112043 | PLC beta mediated events | 0.546209 | 0.263 |
R-HSA-450294 | MAP kinase activation | 0.546209 | 0.263 |
R-HSA-162599 | Late Phase of HIV Life Cycle | 0.546725 | 0.262 |
R-HSA-8856828 | Clathrin-mediated endocytosis | 0.550091 | 0.260 |
R-HSA-2559586 | DNA Damage/Telomere Stress Induced Senescence | 0.551387 | 0.259 |
R-HSA-6784531 | tRNA processing in the nucleus | 0.551387 | 0.259 |
R-HSA-9616222 | Transcriptional regulation of granulopoiesis | 0.551387 | 0.259 |
R-HSA-9006927 | Signaling by Non-Receptor Tyrosine Kinases | 0.556506 | 0.255 |
R-HSA-8848021 | Signaling by PTK6 | 0.556506 | 0.255 |
R-HSA-168643 | Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signali... | 0.561567 | 0.251 |
R-HSA-9909649 | Regulation of PD-L1(CD274) transcription | 0.571518 | 0.243 |
R-HSA-6782315 | tRNA modification in the nucleus and cytosol | 0.571518 | 0.243 |
R-HSA-9856651 | MITF-M-dependent gene expression | 0.573165 | 0.242 |
R-HSA-5693606 | DNA Double Strand Break Response | 0.576408 | 0.239 |
R-HSA-112040 | G-protein mediated events | 0.576408 | 0.239 |
R-HSA-196807 | Nicotinate metabolism | 0.576408 | 0.239 |
R-HSA-9820448 | Developmental Cell Lineages of the Exocrine Pancreas | 0.579598 | 0.237 |
R-HSA-8936459 | RUNX1 regulates genes involved in megakaryocyte differentiation and platelet fun... | 0.581243 | 0.236 |
R-HSA-1169410 | Antiviral mechanism by IFN-stimulated genes | 0.585961 | 0.232 |
R-HSA-9843940 | Regulation of endogenous retroelements by KRAB-ZFP proteins | 0.590750 | 0.229 |
R-HSA-1168372 | Downstream signaling events of B Cell Receptor (BCR) | 0.590750 | 0.229 |
R-HSA-448424 | Interleukin-17 signaling | 0.590750 | 0.229 |
R-HSA-69202 | Cyclin E associated events during G1/S transition | 0.590750 | 0.229 |
R-HSA-162587 | HIV Life Cycle | 0.595372 | 0.225 |
R-HSA-5250913 | Positive epigenetic regulation of rRNA expression | 0.595422 | 0.225 |
R-HSA-199992 | trans-Golgi Network Vesicle Budding | 0.600041 | 0.222 |
R-HSA-69656 | Cyclin A:Cdk2-associated events at S phase entry | 0.600041 | 0.222 |
R-HSA-877300 | Interferon gamma signaling | 0.601557 | 0.221 |
R-HSA-159236 | Transport of Mature mRNA derived from an Intron-Containing Transcript | 0.604608 | 0.219 |
R-HSA-1445148 | Translocation of SLC2A4 (GLUT4) to the plasma membrane | 0.604608 | 0.219 |
R-HSA-1226099 | Signaling by FGFR in disease | 0.609123 | 0.215 |
R-HSA-388841 | Regulation of T cell activation by CD28 family | 0.612467 | 0.213 |
R-HSA-3000171 | Non-integrin membrane-ECM interactions | 0.613587 | 0.212 |
R-HSA-71403 | Citric acid cycle (TCA cycle) | 0.613587 | 0.212 |
R-HSA-5633008 | TP53 Regulates Transcription of Cell Death Genes | 0.613587 | 0.212 |
R-HSA-73854 | RNA Polymerase I Promoter Clearance | 0.617999 | 0.209 |
R-HSA-9694635 | Translation of Structural Proteins | 0.622362 | 0.206 |
R-HSA-383280 | Nuclear Receptor transcription pathway | 0.626676 | 0.203 |
R-HSA-6783783 | Interleukin-10 signaling | 0.626676 | 0.203 |
R-HSA-4086400 | PCP/CE pathway | 0.626676 | 0.203 |
R-HSA-73864 | RNA Polymerase I Transcription | 0.626676 | 0.203 |
R-HSA-416482 | G alpha (12/13) signalling events | 0.626676 | 0.203 |
R-HSA-73894 | DNA Repair | 0.633205 | 0.198 |
R-HSA-9856530 | High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR... | 0.635156 | 0.197 |
R-HSA-9711123 | Cellular response to chemical stress | 0.641074 | 0.193 |
R-HSA-9764274 | Regulation of Expression and Function of Type I Classical Cadherins | 0.645686 | 0.190 |
R-HSA-9764265 | Regulation of CDH1 Expression and Function | 0.645686 | 0.190 |
R-HSA-2029480 | Fcgamma receptor (FCGR) dependent phagocytosis | 0.648487 | 0.188 |
R-HSA-597592 | Post-translational protein modification | 0.648765 | 0.188 |
R-HSA-983231 | Factors involved in megakaryocyte development and platelet production | 0.651270 | 0.186 |
R-HSA-2565942 | Regulation of PLK1 Activity at G2/M Transition | 0.651545 | 0.186 |
R-HSA-6794362 | Protein-protein interactions at synapses | 0.655527 | 0.183 |
R-HSA-5687128 | MAPK6/MAPK4 signaling | 0.655527 | 0.183 |
R-HSA-9909615 | Regulation of PD-L1(CD274) Post-translational modification | 0.659463 | 0.181 |
R-HSA-1266738 | Developmental Biology | 0.664245 | 0.178 |
R-HSA-438064 | Post NMDA receptor activation events | 0.667203 | 0.176 |
R-HSA-390466 | Chaperonin-mediated protein folding | 0.667203 | 0.176 |
R-HSA-9658195 | Leishmania infection | 0.670368 | 0.174 |
R-HSA-9824443 | Parasitic Infection Pathways | 0.670368 | 0.174 |
R-HSA-9663891 | Selective autophagy | 0.671006 | 0.173 |
R-HSA-5620912 | Anchoring of the basal body to the plasma membrane | 0.678484 | 0.168 |
R-HSA-202424 | Downstream TCR signaling | 0.678484 | 0.168 |
R-HSA-69275 | G2/M Transition | 0.680746 | 0.167 |
R-HSA-453274 | Mitotic G2-G2/M phases | 0.685882 | 0.164 |
R-HSA-391251 | Protein folding | 0.689386 | 0.162 |
R-HSA-9772573 | Late SARS-CoV-2 Infection Events | 0.689386 | 0.162 |
R-HSA-5617833 | Cilium Assembly | 0.690951 | 0.161 |
R-HSA-1483257 | Phospholipid metabolism | 0.699931 | 0.155 |
R-HSA-9609690 | HCMV Early Events | 0.705758 | 0.151 |
R-HSA-9759476 | Regulation of Homotypic Cell-Cell Adhesion | 0.705758 | 0.151 |
R-HSA-6811434 | COPI-dependent Golgi-to-ER retrograde traffic | 0.706744 | 0.151 |
R-HSA-5607764 | CLEC7A (Dectin-1) signaling | 0.706744 | 0.151 |
R-HSA-157579 | Telomere Maintenance | 0.710098 | 0.149 |
R-HSA-8878159 | Transcriptional regulation by RUNX3 | 0.710098 | 0.149 |
R-HSA-975871 | MyD88 cascade initiated on plasma membrane | 0.713414 | 0.147 |
R-HSA-168142 | Toll Like Receptor 10 (TLR10) Cascade | 0.713414 | 0.147 |
R-HSA-168176 | Toll Like Receptor 5 (TLR5) Cascade | 0.713414 | 0.147 |
R-HSA-70171 | Glycolysis | 0.719933 | 0.143 |
R-HSA-1643685 | Disease | 0.721406 | 0.142 |
R-HSA-9020702 | Interleukin-1 signaling | 0.723137 | 0.141 |
R-HSA-442755 | Activation of NMDA receptors and postsynaptic events | 0.726305 | 0.139 |
R-HSA-9842860 | Regulation of endogenous retroelements | 0.726305 | 0.139 |
R-HSA-111885 | Opioid Signalling | 0.732532 | 0.135 |
R-HSA-9860931 | Response of endothelial cells to shear stress | 0.732532 | 0.135 |
R-HSA-9833110 | RSV-host interactions | 0.735593 | 0.133 |
R-HSA-168164 | Toll Like Receptor 3 (TLR3) Cascade | 0.738618 | 0.132 |
R-HSA-1500931 | Cell-Cell communication | 0.740460 | 0.130 |
R-HSA-446203 | Asparagine N-linked glycosylation | 0.747491 | 0.126 |
R-HSA-975138 | TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | 0.747491 | 0.126 |
R-HSA-2672351 | Stimuli-sensing channels | 0.747491 | 0.126 |
R-HSA-975155 | MyD88 dependent cascade initiated on endosome | 0.750381 | 0.125 |
R-HSA-449147 | Signaling by Interleukins | 0.750884 | 0.124 |
R-HSA-112315 | Transmission across Chemical Synapses | 0.752973 | 0.123 |
R-HSA-937061 | TRIF (TICAM1)-mediated TLR4 signaling | 0.753239 | 0.123 |
R-HSA-166166 | MyD88-independent TLR4 cascade | 0.753239 | 0.123 |
R-HSA-202403 | TCR signaling | 0.753239 | 0.123 |
R-HSA-418990 | Adherens junctions interactions | 0.757146 | 0.121 |
R-HSA-975957 | Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | 0.758856 | 0.120 |
R-HSA-927802 | Nonsense-Mediated Decay (NMD) | 0.758856 | 0.120 |
R-HSA-1483249 | Inositol phosphate metabolism | 0.758856 | 0.120 |
R-HSA-168181 | Toll Like Receptor 7/8 (TLR7/8) Cascade | 0.761617 | 0.118 |
R-HSA-8951664 | Neddylation | 0.763248 | 0.117 |
R-HSA-9855142 | Cellular responses to mechanical stimuli | 0.764347 | 0.117 |
R-HSA-168138 | Toll Like Receptor 9 (TLR9) Cascade | 0.769713 | 0.114 |
R-HSA-5628897 | TP53 Regulates Metabolic Genes | 0.769713 | 0.114 |
R-HSA-909733 | Interferon alpha/beta signaling | 0.772350 | 0.112 |
R-HSA-162906 | HIV Infection | 0.775056 | 0.111 |
R-HSA-70326 | Glucose metabolism | 0.777535 | 0.109 |
R-HSA-166058 | MyD88:MAL(TIRAP) cascade initiated on plasma membrane | 0.782602 | 0.106 |
R-HSA-168188 | Toll Like Receptor TLR6:TLR2 Cascade | 0.782602 | 0.106 |
R-HSA-1280218 | Adaptive Immune System | 0.783067 | 0.106 |
R-HSA-68875 | Mitotic Prophase | 0.785093 | 0.105 |
R-HSA-168179 | Toll Like Receptor TLR1:TLR2 Cascade | 0.789989 | 0.102 |
R-HSA-181438 | Toll Like Receptor 2 (TLR2) Cascade | 0.789989 | 0.102 |
R-HSA-9816359 | Maternal to zygotic transition (MZT) | 0.792395 | 0.101 |
R-HSA-162909 | Host Interactions of HIV factors | 0.794774 | 0.100 |
R-HSA-6798695 | Neutrophil degranulation | 0.798202 | 0.098 |
R-HSA-69206 | G1/S Transition | 0.799451 | 0.097 |
R-HSA-114608 | Platelet degranulation | 0.804022 | 0.095 |
R-HSA-9609646 | HCMV Infection | 0.815692 | 0.088 |
R-HSA-421270 | Cell-cell junction organization | 0.817301 | 0.088 |
R-HSA-76005 | Response to elevated platelet cytosolic Ca2+ | 0.819218 | 0.087 |
R-HSA-9820952 | Respiratory Syncytial Virus Infection Pathway | 0.829350 | 0.081 |
R-HSA-9734767 | Developmental Cell Lineages | 0.835656 | 0.078 |
R-HSA-1632852 | Macroautophagy | 0.837047 | 0.077 |
R-HSA-913531 | Interferon Signaling | 0.842570 | 0.074 |
R-HSA-2871837 | FCERI mediated NF-kB activation | 0.844399 | 0.073 |
R-HSA-2262752 | Cellular responses to stress | 0.845161 | 0.073 |
R-HSA-453279 | Mitotic G1 phase and G1/S transition | 0.847950 | 0.072 |
R-HSA-2187338 | Visual phototransduction | 0.849695 | 0.071 |
R-HSA-76002 | Platelet activation, signaling and aggregation | 0.851008 | 0.070 |
R-HSA-9824446 | Viral Infection Pathways | 0.851416 | 0.070 |
R-HSA-166016 | Toll Like Receptor 4 (TLR4) Cascade | 0.851420 | 0.070 |
R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases | 0.853458 | 0.069 |
R-HSA-446728 | Cell junction organization | 0.856261 | 0.067 |
R-HSA-446652 | Interleukin-1 family signaling | 0.858127 | 0.066 |
R-HSA-69306 | DNA Replication | 0.859756 | 0.066 |
R-HSA-983168 | Antigen processing: Ubiquitination & Proteasome degradation | 0.861345 | 0.065 |
R-HSA-392499 | Metabolism of proteins | 0.862176 | 0.064 |
R-HSA-168273 | Influenza Viral RNA Transcription and Replication | 0.862958 | 0.064 |
R-HSA-8953897 | Cellular responses to stimuli | 0.864067 | 0.063 |
R-HSA-9612973 | Autophagy | 0.864532 | 0.063 |
R-HSA-9610379 | HCMV Late Events | 0.866088 | 0.062 |
R-HSA-2408522 | Selenoamino acid metabolism | 0.876493 | 0.057 |
R-HSA-5619102 | SLC transporter disorders | 0.880702 | 0.055 |
R-HSA-5621481 | C-type lectin receptors (CLRs) | 0.887402 | 0.052 |
R-HSA-422475 | Axon guidance | 0.890185 | 0.051 |
R-HSA-9678108 | SARS-CoV-1 Infection | 0.892492 | 0.049 |
R-HSA-168255 | Influenza Infection | 0.897353 | 0.047 |
R-HSA-8957322 | Metabolism of steroids | 0.905632 | 0.043 |
R-HSA-983712 | Ion channel transport | 0.908570 | 0.042 |
R-HSA-168898 | Toll-like Receptor Cascades | 0.910663 | 0.041 |
R-HSA-1474244 | Extracellular matrix organization | 0.911592 | 0.040 |
R-HSA-9675108 | Nervous system development | 0.916387 | 0.038 |
R-HSA-112316 | Neuronal System | 0.920079 | 0.036 |
R-HSA-2454202 | Fc epsilon receptor (FCERI) signaling | 0.922255 | 0.035 |
R-HSA-376176 | Signaling by ROBO receptors | 0.922255 | 0.035 |
R-HSA-1483206 | Glycerophospholipid biosynthesis | 0.922255 | 0.035 |
R-HSA-397014 | Muscle contraction | 0.930763 | 0.031 |
R-HSA-1280215 | Cytokine Signaling in Immune system | 0.937204 | 0.028 |
R-HSA-196849 | Metabolism of water-soluble vitamins and cofactors | 0.943810 | 0.025 |
R-HSA-72312 | rRNA processing | 0.945099 | 0.025 |
R-HSA-983169 | Class I MHC mediated antigen processing & presentation | 0.946527 | 0.024 |
R-HSA-202733 | Cell surface interactions at the vascular wall | 0.948196 | 0.023 |
R-HSA-5619115 | Disorders of transmembrane transporters | 0.953877 | 0.021 |
R-HSA-109582 | Hemostasis | 0.955281 | 0.020 |
R-HSA-5663205 | Infectious disease | 0.960934 | 0.017 |
R-HSA-416476 | G alpha (q) signalling events | 0.962148 | 0.017 |
R-HSA-168249 | Innate Immune System | 0.974909 | 0.011 |
R-HSA-1428517 | Aerobic respiration and respiratory electron transport | 0.984577 | 0.007 |
R-HSA-196854 | Metabolism of vitamins and cofactors | 0.988215 | 0.005 |
R-HSA-168256 | Immune System | 0.989965 | 0.004 |
R-HSA-9824439 | Bacterial Infection Pathways | 0.991411 | 0.004 |
R-HSA-418594 | G alpha (i) signalling events | 0.992964 | 0.003 |
R-HSA-8978868 | Fatty acid metabolism | 0.992964 | 0.003 |
R-HSA-72766 | Translation | 0.994566 | 0.002 |
R-HSA-71291 | Metabolism of amino acids and derivatives | 0.994999 | 0.002 |
R-HSA-71387 | Metabolism of carbohydrates and carbohydrate derivatives | 0.995998 | 0.002 |
R-HSA-556833 | Metabolism of lipids | 0.996620 | 0.001 |
R-HSA-388396 | GPCR downstream signalling | 0.999050 | 0.000 |
R-HSA-372790 | Signaling by GPCR | 0.999616 | 0.000 |
R-HSA-9709957 | Sensory Perception | 0.999957 | 0.000 |
R-HSA-382551 | Transport of small molecules | 0.999993 | 0.000 |
R-HSA-1430728 | Metabolism | 1.000000 | 0.000 |
Download
kinase | JSD_mean | pearson_surrounding | kinase_max_IC_position | max_position_JSD |
---|---|---|---|---|
BMPR1B |
0.795 | 0.402 | 1 | 0.459 |
CK2A2 |
0.795 | 0.381 | 1 | 0.368 |
CDC7 |
0.792 | 0.477 | 1 | 0.493 |
BMPR1A |
0.792 | 0.450 | 1 | 0.515 |
MOS |
0.786 | 0.445 | 1 | 0.415 |
COT |
0.784 | 0.080 | 2 | 0.888 |
GRK7 |
0.780 | 0.263 | 1 | 0.295 |
CK2A1 |
0.779 | 0.316 | 1 | 0.338 |
GRK6 |
0.778 | 0.294 | 1 | 0.341 |
GRK1 |
0.777 | 0.227 | -2 | 0.738 |
ALK2 |
0.777 | 0.400 | -2 | 0.840 |
ACVR2B |
0.776 | 0.321 | -2 | 0.838 |
TGFBR1 |
0.774 | 0.214 | -2 | 0.836 |
DSTYK |
0.772 | 0.042 | 2 | 0.877 |
FAM20C |
0.772 | 0.135 | 2 | 0.530 |
IKKA |
0.772 | 0.081 | -2 | 0.742 |
IKKB |
0.770 | -0.007 | -2 | 0.734 |
ACVR2A |
0.769 | 0.247 | -2 | 0.831 |
GCN2 |
0.767 | -0.055 | 2 | 0.812 |
GRK5 |
0.766 | 0.192 | -3 | 0.739 |
KIS |
0.766 | 0.005 | 1 | 0.168 |
GRK4 |
0.766 | 0.122 | -2 | 0.802 |
CLK3 |
0.763 | 0.063 | 1 | 0.283 |
IKKE |
0.763 | -0.099 | 1 | 0.184 |
PRPK |
0.762 | -0.015 | -1 | 0.793 |
ATM |
0.762 | 0.035 | 1 | 0.247 |
RAF1 |
0.761 | -0.024 | 1 | 0.274 |
TBK1 |
0.761 | -0.118 | 1 | 0.185 |
CAMK2G |
0.761 | 0.033 | 2 | 0.809 |
BMPR2 |
0.761 | 0.066 | -2 | 0.875 |
ALK4 |
0.761 | 0.151 | -2 | 0.852 |
NEK6 |
0.759 | -0.044 | -2 | 0.861 |
PIM3 |
0.757 | 0.025 | -3 | 0.681 |
MTOR |
0.756 | -0.135 | 1 | 0.197 |
PLK3 |
0.756 | 0.095 | 2 | 0.775 |
ULK2 |
0.754 | -0.149 | 2 | 0.805 |
NEK7 |
0.754 | -0.125 | -3 | 0.691 |
PLK1 |
0.754 | 0.034 | -2 | 0.823 |
TGFBR2 |
0.753 | -0.010 | -2 | 0.819 |
PDHK4 |
0.752 | -0.189 | 1 | 0.241 |
JNK3 |
0.752 | -0.004 | 1 | 0.153 |
ATR |
0.751 | -0.077 | 1 | 0.224 |
PDHK1 |
0.751 | -0.139 | 1 | 0.234 |
ULK1 |
0.749 | -0.123 | -3 | 0.681 |
TTBK2 |
0.749 | -0.025 | 2 | 0.723 |
NDR2 |
0.749 | -0.034 | -3 | 0.678 |
CAMK1B |
0.749 | -0.063 | -3 | 0.683 |
ERK5 |
0.748 | -0.103 | 1 | 0.184 |
MLK1 |
0.748 | -0.097 | 2 | 0.818 |
CDK8 |
0.748 | -0.063 | 1 | 0.152 |
CAMK2B |
0.748 | 0.069 | 2 | 0.768 |
MAPKAPK2 |
0.748 | 0.021 | -3 | 0.553 |
CDK1 |
0.747 | -0.033 | 1 | 0.140 |
JNK2 |
0.747 | -0.019 | 1 | 0.135 |
HUNK |
0.747 | -0.099 | 2 | 0.847 |
BCKDK |
0.746 | -0.106 | -1 | 0.774 |
TLK2 |
0.746 | 0.009 | 1 | 0.202 |
NLK |
0.745 | -0.137 | 1 | 0.203 |
PLK2 |
0.745 | 0.119 | -3 | 0.792 |
P38G |
0.744 | -0.035 | 1 | 0.108 |
DLK |
0.744 | -0.089 | 1 | 0.240 |
PRKD1 |
0.744 | -0.070 | -3 | 0.625 |
CDKL1 |
0.743 | -0.067 | -3 | 0.639 |
PKN3 |
0.742 | -0.094 | -3 | 0.648 |
MARK4 |
0.742 | -0.041 | 4 | 0.838 |
LATS1 |
0.741 | 0.069 | -3 | 0.727 |
GRK2 |
0.741 | 0.009 | -2 | 0.702 |
TSSK2 |
0.741 | -0.000 | -5 | 0.774 |
P38D |
0.740 | -0.019 | 1 | 0.123 |
CDK19 |
0.740 | -0.075 | 1 | 0.138 |
RSK2 |
0.739 | -0.033 | -3 | 0.600 |
CHAK2 |
0.739 | -0.094 | -1 | 0.739 |
YSK4 |
0.739 | -0.079 | 1 | 0.208 |
GRK3 |
0.739 | 0.046 | -2 | 0.655 |
LATS2 |
0.738 | -0.039 | -5 | 0.707 |
AMPKA1 |
0.738 | -0.066 | -3 | 0.655 |
NIK |
0.738 | -0.162 | -3 | 0.709 |
PIM1 |
0.738 | -0.019 | -3 | 0.607 |
BRAF |
0.737 | 0.078 | -4 | 0.794 |
ANKRD3 |
0.737 | -0.143 | 1 | 0.223 |
MLK3 |
0.737 | -0.064 | 2 | 0.750 |
TLK1 |
0.737 | 0.006 | -2 | 0.844 |
NEK9 |
0.736 | -0.209 | 2 | 0.848 |
CAMK2A |
0.736 | 0.030 | 2 | 0.796 |
P38B |
0.736 | -0.048 | 1 | 0.124 |
JNK1 |
0.736 | -0.010 | 1 | 0.138 |
HIPK4 |
0.736 | -0.090 | 1 | 0.188 |
CDK3 |
0.736 | -0.035 | 1 | 0.125 |
DAPK2 |
0.736 | -0.072 | -3 | 0.689 |
MLK4 |
0.735 | -0.055 | 2 | 0.726 |
RIPK3 |
0.735 | -0.202 | 3 | 0.539 |
CAMK2D |
0.735 | -0.090 | -3 | 0.637 |
MST4 |
0.734 | -0.139 | 2 | 0.842 |
CAMLCK |
0.734 | -0.111 | -2 | 0.755 |
SRPK1 |
0.734 | -0.069 | -3 | 0.593 |
NUAK2 |
0.734 | -0.107 | -3 | 0.646 |
DNAPK |
0.733 | -0.080 | 1 | 0.154 |
NDR1 |
0.733 | -0.117 | -3 | 0.661 |
MAPKAPK3 |
0.733 | -0.086 | -3 | 0.577 |
MASTL |
0.733 | -0.237 | -2 | 0.767 |
DYRK2 |
0.733 | -0.074 | 1 | 0.152 |
CDKL5 |
0.732 | -0.087 | -3 | 0.622 |
P90RSK |
0.732 | -0.071 | -3 | 0.614 |
PKR |
0.732 | -0.109 | 1 | 0.224 |
SKMLCK |
0.732 | -0.121 | -2 | 0.745 |
ERK1 |
0.732 | -0.067 | 1 | 0.120 |
MEK1 |
0.732 | -0.099 | 2 | 0.862 |
CDK5 |
0.731 | -0.065 | 1 | 0.171 |
MLK2 |
0.731 | -0.184 | 2 | 0.832 |
PRP4 |
0.731 | -0.001 | -3 | 0.670 |
TSSK1 |
0.730 | -0.076 | -3 | 0.678 |
PKCD |
0.730 | -0.114 | 2 | 0.805 |
PERK |
0.730 | -0.053 | -2 | 0.847 |
SMG1 |
0.730 | -0.102 | 1 | 0.189 |
PRKD2 |
0.730 | -0.089 | -3 | 0.565 |
AMPKA2 |
0.730 | -0.079 | -3 | 0.623 |
P70S6KB |
0.730 | -0.062 | -3 | 0.615 |
CDK2 |
0.729 | -0.078 | 1 | 0.161 |
RSK3 |
0.729 | -0.080 | -3 | 0.601 |
P38A |
0.729 | -0.080 | 1 | 0.145 |
CDK13 |
0.728 | -0.092 | 1 | 0.152 |
MEKK3 |
0.728 | -0.111 | 1 | 0.198 |
SRPK3 |
0.728 | -0.059 | -3 | 0.577 |
CDK7 |
0.728 | -0.097 | 1 | 0.166 |
WNK3 |
0.728 | -0.273 | 1 | 0.212 |
PKN2 |
0.728 | -0.162 | -3 | 0.639 |
CDK17 |
0.728 | -0.079 | 1 | 0.112 |
SRPK2 |
0.727 | -0.058 | -3 | 0.523 |
NIM1 |
0.727 | -0.139 | 3 | 0.598 |
DRAK1 |
0.727 | -0.094 | 1 | 0.215 |
ICK |
0.726 | -0.112 | -3 | 0.663 |
WNK1 |
0.726 | -0.227 | -2 | 0.786 |
ERK2 |
0.726 | -0.085 | 1 | 0.127 |
CHK1 |
0.726 | -0.050 | -3 | 0.655 |
CDK18 |
0.726 | -0.083 | 1 | 0.127 |
HRI |
0.725 | -0.135 | -2 | 0.852 |
CK1E |
0.725 | -0.019 | -3 | 0.466 |
RSK4 |
0.725 | -0.018 | -3 | 0.583 |
IRE2 |
0.725 | -0.137 | 2 | 0.760 |
PLK4 |
0.725 | -0.129 | 2 | 0.651 |
ALPHAK3 |
0.725 | 0.314 | -1 | 0.757 |
MARK2 |
0.725 | -0.032 | 4 | 0.748 |
VRK2 |
0.724 | -0.257 | 1 | 0.244 |
IRE1 |
0.724 | -0.199 | 1 | 0.193 |
CLK2 |
0.724 | 0.003 | -3 | 0.594 |
QSK |
0.724 | -0.062 | 4 | 0.816 |
MSK2 |
0.724 | -0.081 | -3 | 0.569 |
CAMK4 |
0.723 | -0.142 | -3 | 0.619 |
MARK3 |
0.723 | -0.035 | 4 | 0.786 |
RIPK1 |
0.723 | -0.277 | 1 | 0.202 |
MEKK2 |
0.723 | -0.114 | 2 | 0.823 |
MEKK1 |
0.723 | -0.154 | 1 | 0.209 |
PINK1 |
0.722 | -0.142 | 1 | 0.197 |
TTBK1 |
0.722 | -0.083 | 2 | 0.646 |
NUAK1 |
0.721 | -0.110 | -3 | 0.605 |
HIPK2 |
0.721 | -0.069 | 1 | 0.126 |
ZAK |
0.721 | -0.148 | 1 | 0.206 |
MST2 |
0.720 | -0.024 | 1 | 0.219 |
PAK1 |
0.720 | -0.112 | -2 | 0.650 |
BRSK1 |
0.720 | -0.082 | -3 | 0.601 |
CDK12 |
0.720 | -0.098 | 1 | 0.137 |
CK1G1 |
0.720 | -0.053 | -3 | 0.515 |
DYRK4 |
0.719 | -0.060 | 1 | 0.138 |
PASK |
0.719 | -0.017 | -3 | 0.686 |
CK1D |
0.719 | -0.011 | -3 | 0.416 |
PKACG |
0.719 | -0.119 | -2 | 0.616 |
SIK |
0.719 | -0.078 | -3 | 0.572 |
GSK3A |
0.719 | 0.015 | 4 | 0.406 |
NEK2 |
0.719 | -0.204 | 2 | 0.816 |
EEF2K |
0.718 | 0.041 | 3 | 0.661 |
MSK1 |
0.717 | -0.066 | -3 | 0.573 |
AURA |
0.717 | -0.062 | -2 | 0.485 |
CLK4 |
0.717 | -0.080 | -3 | 0.593 |
MARK1 |
0.717 | -0.062 | 4 | 0.803 |
CHAK1 |
0.717 | -0.192 | 2 | 0.786 |
CDK16 |
0.716 | -0.073 | 1 | 0.122 |
MEK5 |
0.715 | -0.242 | 2 | 0.840 |
TAO3 |
0.715 | -0.119 | 1 | 0.200 |
QIK |
0.714 | -0.171 | -3 | 0.627 |
GAK |
0.714 | -0.053 | 1 | 0.243 |
MELK |
0.714 | -0.161 | -3 | 0.602 |
PAK3 |
0.714 | -0.166 | -2 | 0.656 |
PRKD3 |
0.714 | -0.112 | -3 | 0.544 |
NEK5 |
0.713 | -0.211 | 1 | 0.205 |
CAMKK1 |
0.713 | -0.121 | -2 | 0.743 |
PKCB |
0.713 | -0.133 | 2 | 0.752 |
AURC |
0.713 | -0.083 | -2 | 0.519 |
TAK1 |
0.713 | -0.058 | 1 | 0.249 |
DYRK1B |
0.713 | -0.079 | 1 | 0.139 |
CLK1 |
0.712 | -0.088 | -3 | 0.554 |
CDK9 |
0.712 | -0.122 | 1 | 0.152 |
PKACB |
0.712 | -0.065 | -2 | 0.538 |
MAPKAPK5 |
0.712 | -0.148 | -3 | 0.534 |
HIPK1 |
0.711 | -0.096 | 1 | 0.154 |
PKCA |
0.711 | -0.144 | 2 | 0.741 |
PAK2 |
0.711 | -0.145 | -2 | 0.634 |
PRKX |
0.711 | -0.035 | -3 | 0.502 |
DYRK1A |
0.711 | -0.092 | 1 | 0.177 |
PHKG1 |
0.710 | -0.191 | -3 | 0.634 |
CK1A2 |
0.710 | -0.042 | -3 | 0.409 |
PKCG |
0.710 | -0.154 | 2 | 0.750 |
NEK8 |
0.710 | -0.165 | 2 | 0.823 |
BRSK2 |
0.709 | -0.155 | -3 | 0.608 |
DCAMKL1 |
0.709 | -0.119 | -3 | 0.593 |
MYLK4 |
0.708 | -0.115 | -2 | 0.642 |
PAK6 |
0.708 | -0.110 | -2 | 0.574 |
GSK3B |
0.707 | -0.036 | 4 | 0.397 |
CAMK1G |
0.707 | -0.127 | -3 | 0.569 |
SGK3 |
0.707 | -0.110 | -3 | 0.564 |
PKCH |
0.707 | -0.168 | 2 | 0.738 |
MNK2 |
0.707 | -0.166 | -2 | 0.671 |
PIM2 |
0.706 | -0.078 | -3 | 0.560 |
AURB |
0.706 | -0.101 | -2 | 0.514 |
IRAK4 |
0.705 | -0.223 | 1 | 0.204 |
PKCZ |
0.705 | -0.189 | 2 | 0.787 |
SSTK |
0.705 | -0.075 | 4 | 0.807 |
CAMKK2 |
0.705 | -0.136 | -2 | 0.725 |
MST3 |
0.705 | -0.183 | 2 | 0.841 |
TTK |
0.704 | 0.050 | -2 | 0.823 |
AKT2 |
0.704 | -0.092 | -3 | 0.507 |
SNRK |
0.704 | -0.218 | 2 | 0.690 |
TAO2 |
0.703 | -0.157 | 2 | 0.856 |
CDK14 |
0.703 | -0.118 | 1 | 0.134 |
MPSK1 |
0.703 | -0.155 | 1 | 0.187 |
MST1 |
0.703 | -0.117 | 1 | 0.188 |
DCAMKL2 |
0.703 | -0.131 | -3 | 0.613 |
MNK1 |
0.702 | -0.148 | -2 | 0.685 |
WNK4 |
0.702 | -0.241 | -2 | 0.787 |
HIPK3 |
0.702 | -0.132 | 1 | 0.152 |
GCK |
0.701 | -0.162 | 1 | 0.188 |
PKG2 |
0.701 | -0.117 | -2 | 0.547 |
NEK11 |
0.701 | -0.257 | 1 | 0.188 |
LKB1 |
0.701 | -0.176 | -3 | 0.659 |
ERK7 |
0.701 | -0.066 | 2 | 0.503 |
PDK1 |
0.700 | -0.165 | 1 | 0.213 |
CDK6 |
0.700 | -0.100 | 1 | 0.134 |
DYRK3 |
0.700 | -0.106 | 1 | 0.153 |
DAPK3 |
0.699 | -0.041 | -3 | 0.617 |
CAMK1D |
0.699 | -0.073 | -3 | 0.489 |
MINK |
0.699 | -0.183 | 1 | 0.184 |
SMMLCK |
0.699 | -0.141 | -3 | 0.626 |
TNIK |
0.698 | -0.140 | 3 | 0.646 |
P70S6K |
0.698 | -0.095 | -3 | 0.522 |
IRAK1 |
0.698 | -0.244 | -1 | 0.678 |
CDK4 |
0.698 | -0.100 | 1 | 0.130 |
PHKG2 |
0.698 | -0.182 | -3 | 0.589 |
OSR1 |
0.697 | -0.055 | 2 | 0.817 |
VRK1 |
0.697 | -0.180 | 2 | 0.859 |
HGK |
0.697 | -0.175 | 3 | 0.636 |
CDK10 |
0.696 | -0.110 | 1 | 0.130 |
PDHK3_TYR |
0.696 | 0.174 | 4 | 0.867 |
AKT1 |
0.695 | -0.104 | -3 | 0.515 |
MAP3K15 |
0.694 | -0.224 | 1 | 0.194 |
PKCT |
0.694 | -0.176 | 2 | 0.747 |
DAPK1 |
0.693 | -0.054 | -3 | 0.595 |
PKACA |
0.693 | -0.082 | -2 | 0.488 |
NEK4 |
0.693 | -0.275 | 1 | 0.180 |
TXK |
0.693 | 0.173 | 1 | 0.341 |
MEK2 |
0.692 | -0.179 | 2 | 0.831 |
RIPK2 |
0.691 | -0.233 | 1 | 0.193 |
EPHA6 |
0.691 | 0.206 | -1 | 0.883 |
EPHB2 |
0.691 | 0.267 | -1 | 0.868 |
EPHA4 |
0.690 | 0.266 | 2 | 0.772 |
PDHK1_TYR |
0.690 | 0.125 | -1 | 0.864 |
NEK1 |
0.690 | -0.255 | 1 | 0.198 |
PAK5 |
0.689 | -0.137 | -2 | 0.491 |
EPHB4 |
0.689 | 0.184 | -1 | 0.869 |
PDHK4_TYR |
0.688 | 0.107 | 2 | 0.880 |
MAP2K6_TYR |
0.688 | 0.119 | -1 | 0.838 |
BLK |
0.688 | 0.167 | -1 | 0.832 |
MEKK6 |
0.688 | -0.269 | 1 | 0.197 |
MAP2K4_TYR |
0.688 | 0.112 | -1 | 0.832 |
LRRK2 |
0.688 | -0.233 | 2 | 0.844 |
CK1A |
0.687 | -0.026 | -3 | 0.353 |
PAK4 |
0.687 | -0.122 | -2 | 0.497 |
YSK1 |
0.687 | -0.192 | 2 | 0.812 |
MAK |
0.687 | -0.074 | -2 | 0.637 |
SYK |
0.686 | 0.234 | -1 | 0.825 |
HPK1 |
0.686 | -0.208 | 1 | 0.173 |
SRMS |
0.686 | 0.206 | 1 | 0.379 |
BMPR2_TYR |
0.685 | 0.022 | -1 | 0.857 |
SBK |
0.685 | -0.044 | -3 | 0.395 |
KHS1 |
0.685 | -0.182 | 1 | 0.176 |
SGK1 |
0.684 | -0.069 | -3 | 0.443 |
EPHB1 |
0.684 | 0.176 | 1 | 0.359 |
LOK |
0.684 | -0.206 | -2 | 0.703 |
PBK |
0.684 | -0.133 | 1 | 0.208 |
FYN |
0.684 | 0.132 | -1 | 0.796 |
FER |
0.684 | 0.188 | 1 | 0.378 |
EPHB3 |
0.684 | 0.200 | -1 | 0.858 |
CAMK1A |
0.683 | -0.095 | -3 | 0.465 |
SLK |
0.683 | -0.164 | -2 | 0.652 |
BIKE |
0.683 | -0.086 | 1 | 0.197 |
CHK2 |
0.683 | -0.112 | -3 | 0.445 |
PKN1 |
0.682 | -0.148 | -3 | 0.519 |
LCK |
0.682 | 0.107 | -1 | 0.818 |
KHS2 |
0.682 | -0.162 | 1 | 0.171 |
YES1 |
0.681 | 0.057 | -1 | 0.808 |
STLK3 |
0.680 | -0.117 | 1 | 0.189 |
BUB1 |
0.680 | -0.108 | -5 | 0.756 |
MOK |
0.680 | -0.105 | 1 | 0.143 |
HCK |
0.680 | 0.072 | -1 | 0.813 |
STK33 |
0.679 | -0.202 | 2 | 0.639 |
PKCI |
0.679 | -0.203 | 2 | 0.747 |
AKT3 |
0.679 | -0.092 | -3 | 0.451 |
MRCKA |
0.679 | -0.118 | -3 | 0.567 |
MAP2K7_TYR |
0.679 | -0.099 | 2 | 0.864 |
ASK1 |
0.678 | -0.188 | 1 | 0.204 |
NEK3 |
0.678 | -0.252 | 1 | 0.179 |
PKCE |
0.678 | -0.153 | 2 | 0.733 |
EPHA5 |
0.678 | 0.230 | 2 | 0.755 |
EGFR |
0.678 | 0.039 | 1 | 0.209 |
FRK |
0.678 | 0.122 | -1 | 0.832 |
YANK3 |
0.678 | -0.050 | 2 | 0.412 |
EPHA7 |
0.677 | 0.171 | 2 | 0.776 |
TESK1_TYR |
0.677 | -0.104 | 3 | 0.698 |
MRCKB |
0.677 | -0.117 | -3 | 0.542 |
ROCK2 |
0.676 | -0.122 | -3 | 0.597 |
INSRR |
0.675 | 0.015 | 3 | 0.549 |
PINK1_TYR |
0.675 | -0.140 | 1 | 0.247 |
CK1G3 |
0.674 | -0.024 | -3 | 0.314 |
ITK |
0.673 | 0.031 | -1 | 0.776 |
TEC |
0.673 | 0.093 | -1 | 0.715 |
JAK3 |
0.672 | -0.061 | 1 | 0.217 |
ABL2 |
0.672 | -0.035 | -1 | 0.786 |
CSF1R |
0.672 | -0.086 | 3 | 0.563 |
EPHA8 |
0.672 | 0.116 | -1 | 0.844 |
RET |
0.672 | -0.157 | 1 | 0.210 |
PKMYT1_TYR |
0.672 | -0.164 | 3 | 0.658 |
FGR |
0.672 | -0.065 | 1 | 0.245 |
MYO3A |
0.671 | -0.173 | 1 | 0.174 |
BMX |
0.671 | 0.046 | -1 | 0.702 |
LYN |
0.671 | 0.073 | 3 | 0.517 |
TAO1 |
0.670 | -0.192 | 1 | 0.170 |
TYK2 |
0.670 | -0.185 | 1 | 0.222 |
HASPIN |
0.669 | -0.131 | -1 | 0.555 |
SRC |
0.669 | 0.043 | -1 | 0.794 |
FLT1 |
0.669 | -0.008 | -1 | 0.874 |
TYRO3 |
0.669 | -0.069 | 3 | 0.578 |
PTK2 |
0.669 | 0.084 | -1 | 0.850 |
KIT |
0.668 | -0.068 | 3 | 0.572 |
ABL1 |
0.668 | -0.052 | -1 | 0.777 |
AAK1 |
0.668 | -0.074 | 1 | 0.156 |
MST1R |
0.668 | -0.165 | 3 | 0.589 |
DMPK1 |
0.668 | -0.108 | -3 | 0.564 |
JAK2 |
0.668 | -0.180 | 1 | 0.217 |
ROS1 |
0.668 | -0.102 | 3 | 0.543 |
FGFR2 |
0.667 | -0.059 | 3 | 0.603 |
EPHA2 |
0.667 | 0.129 | -1 | 0.833 |
MYO3B |
0.667 | -0.195 | 2 | 0.820 |
FLT3 |
0.667 | -0.085 | 3 | 0.568 |
MERTK |
0.667 | 0.014 | 3 | 0.572 |
EPHA3 |
0.665 | 0.051 | 2 | 0.747 |
MET |
0.665 | -0.043 | 3 | 0.558 |
ERBB2 |
0.665 | -0.055 | 1 | 0.229 |
PKG1 |
0.665 | -0.131 | -2 | 0.471 |
FGFR1 |
0.664 | -0.085 | 3 | 0.572 |
CRIK |
0.664 | -0.101 | -3 | 0.514 |
FGFR4 |
0.663 | -0.012 | -1 | 0.794 |
PTK6 |
0.662 | 0.003 | -1 | 0.690 |
ROCK1 |
0.662 | -0.131 | -3 | 0.559 |
BTK |
0.662 | -0.035 | -1 | 0.721 |
FGFR3 |
0.662 | -0.044 | 3 | 0.582 |
TEK |
0.661 | -0.009 | 3 | 0.529 |
ERBB4 |
0.661 | 0.019 | 1 | 0.246 |
NTRK1 |
0.660 | -0.071 | -1 | 0.811 |
LIMK1_TYR |
0.660 | -0.210 | 2 | 0.857 |
DDR1 |
0.659 | -0.169 | 4 | 0.802 |
ALK |
0.659 | -0.028 | 3 | 0.511 |
CK1G2 |
0.659 | -0.022 | -3 | 0.414 |
LIMK2_TYR |
0.659 | -0.218 | -3 | 0.713 |
PTK2B |
0.659 | 0.013 | -1 | 0.748 |
NEK10_TYR |
0.659 | -0.167 | 1 | 0.167 |
LTK |
0.658 | -0.039 | 3 | 0.540 |
KDR |
0.658 | -0.126 | 3 | 0.541 |
NTRK3 |
0.658 | -0.071 | -1 | 0.765 |
PDGFRB |
0.657 | -0.176 | 3 | 0.576 |
AXL |
0.656 | -0.093 | 3 | 0.565 |
INSR |
0.656 | -0.081 | 3 | 0.524 |
JAK1 |
0.656 | -0.170 | 1 | 0.184 |
EPHA1 |
0.656 | -0.001 | 3 | 0.533 |
FLT4 |
0.655 | -0.107 | 3 | 0.560 |
NTRK2 |
0.655 | -0.126 | 3 | 0.557 |
TNK2 |
0.654 | -0.113 | 3 | 0.535 |
CSK |
0.654 | -0.061 | 2 | 0.786 |
MATK |
0.651 | -0.058 | -1 | 0.717 |
TNNI3K_TYR |
0.650 | -0.157 | 1 | 0.203 |
PDGFRA |
0.650 | -0.212 | 3 | 0.571 |
IGF1R |
0.649 | -0.048 | 3 | 0.487 |
YANK2 |
0.647 | -0.064 | 2 | 0.428 |
ZAP70 |
0.644 | -0.010 | -1 | 0.713 |
WEE1_TYR |
0.643 | -0.156 | -1 | 0.683 |
MUSK |
0.643 | -0.119 | 1 | 0.188 |
FES |
0.641 | 0.006 | -1 | 0.683 |
TNK1 |
0.638 | -0.246 | 3 | 0.558 |
DDR2 |
0.637 | -0.153 | 3 | 0.538 |